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1.	  Summary	  	  Aneuploidy	  is	  a	  state	  in	  which	  cells	  harbor	  a	  chromosome	  number	  that	  is	  not	  a	  whole	  multiple	  of	  the	  haploid	  chromosome	  set.	  This	  condition	  is	  poorly	  tolerated	  during	  embryogenesis	   and	   it	   the	   cause	  of	  developmental	  disorders	  such	  as	  Down	  syndrome	  (trisomy	  21).	  Beside,	  aneuploidy	   is	  often	  associated	  with	   whole	   chromosomal	   instability	   (CIN),	   a	   constant	   chromosome	   mis-­‐segregation	  ongoing	  from	  one	  cell	  division	  to	  the	  next.	  Aneuploidy	  and	  CIN	  are	  a	   common	   hallmark	   of	  many	   cancers,	   even	   if	   to	   date,	   the	   cellular	   processes	  involved	   in	   aneuploidization	   and	   tumorigenesis	   are	   poorly	   understood.	   This	  raises	   the	  questions	  of	  how	  CIN	  originates,	  how	   it	   is	   tolerated	  at	   the	  cellular	  level,	  and	  which	  cellular	  pathways	  are	   involved	   in	   this	   tolerance.	   In	  order	   to	  try	  to	  solve	  these	  questions,	  I	  performed	  a	  comprehensive	  proteomic	  analysis	  of	  cancer	  cell	  lines	  with	  different	  karyotypic	  and	  chromosome	  stability	  states.	  I	  have	   compared	   stable	   isogenic	   diploid	   and	   tetraploid	   colon	   cancer	   cell	   lines	  with	   descendant	   unstable	   aneuploid	   post-­‐tetraploid	   (PTAs)	   and	   engineered	  trisomic	   clones.	   By	   applying	   quantitative	   mass-­‐spectrometric	   approaches,	   I	  was	   able	   to	   identify	   the	   relative	   abundance	   of	   around	   7’500	   and	   6’000	  proteins	  across	  PTAs	  and	  trisomic	  clones,	  respectively.	  Analysis	  of	  proteomic	  data	   allowed	   me	   to	   conclude	   that	   most	   changes	   of	   protein	   abundance	   and	  phosphorylation,	  present	  in	  aneuploid	  clones,	  already	  occur	  after	  chromosome	  mass	   increase,	   i.e.	   the	   transition	   to	   the	   tetraploid	   state,	   rather	   than	   the	  presence	   of	   CIN.	   In	   particular	   I	   observed	   the	   deregulation	   of	   pathways	  involved	   in	   protein	   folding,	   proteolysis	   and	   response	   to	   oxidative	   stress.	  Additionally,	   in	   order	   to	   identify	   possible	  modifications	   in	   protein	   activity,	   I	  performed	  phospho-­‐enrichment	   analysis	   in	   the	   generated	   cell	   lines,	   and	   this	  resulted	   in	   the	   identification	  of	   13’500	   and	  9’000	  phospho-­‐peptides	   in	  PTAs	  and	   trisomic	   clones,	   respectively.	   Importantly,	   while	   a	   large	   number	   of	  proteins	   previously	   associated	   with	   CIN	   and	   cell	   cycle	   remained	   largely	  unaltered	  in	  their	  expression	  levels	  (compared	  with	  the	  parental	  diploid	  line),	  their	  phosphorylation	  levels	  showed	  substantial	  difference.	  Most	  interestingly,	  I	   observed	   a	   higher	   phosphorylation	   state	   at	   specific	   activation	   sites	   of	   key	  mitotic	  protein	  kinases,	  notably	  Aurora	  A	  and	  Plk1.	  Consequentially,	  tetraploid	  and	   post-­‐tetraploid	   clones	   showed	   similar	   sensitivity	   profiles	   in	   a	  chemotherapeutic	   drug	   screen,	   notably	   increased	   sensitivity	   to	   several	   Plk1	  and	  Aurora	  A	  inhibitors.	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These	   results	   suggest	   that	   in	   transformed	   cancer	   cells,	   a	   gain	   in	  chromosome	  number,	  rather	  than	  an	  increased	  chromosome	  mis-­‐segregation	  rate,	   triggers	   a	   clonal	   stress	   response	   at	   the	   protein	   level.	   Moreover,	   these	  results	   indicate	   that	   chromosome	   gains	   lead	   to	   activation	   or	   deactivation	   of	  pathways	   involved	   in	   cell	   division	   and	   mitosis	   primarily	   through	   hyper-­‐	   or	  hypo-­‐phosphorylation,	   rather	   than	   massive	   changes	   in	   protein	   expression.	  Being	  able	  to	  identify	  deregulated	  pathways	  in	  response	  to	  chromosome	  mass	  increase	   or	   instability	  may	   provide	   new	   opportunities	   to	   specifically	   targets	  cancer	   cells	   and	   block	   disease	   progression.	   Results	   from	  our	   drug	   screening	  approach,	   although	   preliminary,	   support	   this	   notion.	   They	   suggest	   that	   a	  common	   sensitivity	   profile	   may	   exist	   across	   aneuploid	   and	   polyploid	   cells,	  raising	  the	  prospect	  of	  new	  treatment	  strategies	  for	  tumors	  harboring	  a	  large	  excess	  of	  chromosomes.	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2.	  Introduction	  Each	   time	   that	   a	   cell	   divides	   the	   whole	   genome	   has	   to	   be	   precisely	  duplicated	   and	   faithfully	   segregated	   into	   the	   daughter	   cells.	   If	   this	   process	  fails,	   the	   two	  resulting	   cells	  may	  carry	   too	  many	  or	   too	   few	  chromosomes,	   a	  condition	   called	   aneuploidy.	   Chromosome	   segregation	   is	   monitored	   by	   the	  mitotic	   checkpoint;	   also	   known	   as	   spindle	   assembly	   checkpoint	   (SAC)	   that	  ensures	  the	  faithful	  and	  correct	  chromosome	  segregation	  in	  mitosis.	  	  
2.1	  Chromosomal	  abnormalities	  The	   eminent	   biologist	   T.	   Boveri	   reported	   more	   than	   a	   century	   ago	   the	  detrimental	   effects	   of	   aneuploidy	   in	   sea	   urchin	   organogenesis	   1	   and	   the	  deleterious	   effects	   of	   additional	   chromosomes	   has	   subsequently	   been	  confirmed	  in	  many	  different	  organisms	  2-­‐4(Eduardo	  M.	  Torre,	  2007)(Williams	  et	  al	  2008)(Segal	  and	  Mc	  Coy,	  1974).	  In	  yeast,	  aneuploid	  strains	  show	  a	  series	  of	   chromosome	   dependent	   specific	   phenotypes,	   but	   share	   as	  well	   numerous	  common	   features,	   such	   as	   a	   reduction	   of	   cell	   proliferation	   and	   cell	   fitness,	  increased	  glucose	  uptake,	   increased	  sensitivity	   to	  conditions	   interfering	  with	  protein	   synthesis	   and	   protein	   folding	   2(Eduardo	   M.	   Torres,	   2007).	   Mouse	  embryonic	  fibroblasts	  (MEFs)	  from	  trisomic	  mice	  (trisomy	  1,	  13,	  16,	  19)	  show	  similar	   results	   3(Williams	   et	   al	   2008).	   To	   date,	   aneuploidy	   in	   humans	   is	  considered	   as	   the	   primary	   cause	   of	  miscarriage	   and	  mental	   retardation.	   For	  example,	   primary	   fibroblasts	   from	   Down	   syndrome	   patients	   (trisomy	   21)	  show	  growth	  defects	  and	  premature	  aging	  4(Segal	  DJ	  and	  Mc	  Coy,	  1974).	  The	  collectivity	   of	   all	   these	   shared	   phenotypes	   across	   species,	   related	   to	  aneuploidy	   condition,	   has	   been	   called	   by	   several	   authors	   “aneuploidy	   stress	  response”	  5(Torres,	  Cold	  Spring	  Harb.	  Symp	  Quant	  Biol	  2010).	  Although	  aneuploidy	  interferes	  with	  proliferation	  of	  normal	  cells,	  it	  is	  an	  almost	   universal	   feature	   in	   cancer	   cells	   and	   contributes	   to	   the	   tumor	  heterogeneity	   and	   thus	   to	   tumor	   evolution.	   Moreover,	   aneuploidy	   often	  correlates	   in	   cancer	   cells	   with	   the	   presence	   of	   CIN,	   described	   as	   dynamic	  changes	   in	   chromosome	   number	   during	   propagation	   6-­‐8(Haruki	   et	   al.,	   2001)	  (Lengauer	  et	  al.,	  1997)	  (Yoon	  et	  al.,	  2002).	  However,	  whether	  aneuploidy	  and	  CIN	  are	  a	  cause	  or	  a	  consequence	  of	   tumorigenesis	  remains	  debated.	  Clinical	  studies	  show	  that	  CIN	   is	  associated	  with	  resistance	  to	  cancer	  drug	  treatment	  and	  poor	  prognosis,	  most	   likely	  due	  to	  the	   formation	  of	  new	  karyotypes	  that	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confer	  a	  selective	  advantage	  under	  specific	  conditions	  9-­‐11(Carter	  et	  al.,	  2006)	  (Duesberg	  et	  al.,	  2000)	  (Walther	  et	  al.,	  2008).	  However,	  other	  studies	  indicate	  that	   extreme	   CIN	   is	   associated	   with	   better	   clinical	   outcomes.	   It	   has	   been	  suggested	   that	   an	   excess	   of	   instability	   may	   surpass	   a	   threshold	   compatible	  with	   cell	   viability,	   thus	   impairing	   tumor	   fitness	   and	   growth	   12(Nicolai	   J.	  Birkbak,	   2011	   Cancer	   Research).	   Therefore,	   aneuploidy	   may	   have	   tumor-­‐suppressor	  as	  well	  as	  tumor-­‐promoting	  effects,	  which	  could	  differ	  depending	  on	  the	  genetic	  background	  13-­‐15(Silk	  AD	  Proc	  Natl	  Acad	  Sci	  USA	  2013)	  (Weaver	  BA	  2009	   J	   Cell	   Biol)	   (Weaver	  BA	  2008	  Cancer	   Cell)	   (Weaver	  BA	  Cancer	   Cell	  2007).	   In	   conclusion,	   it	   is	   clear	   that	   the	   effects	   of	   aneuploidy	   on	   cells	   and	  organisms	  are	   complex,	   and	   further	   studies	  are	   required	   to	   fully	  understand	  their	  impact.	  	  
2.2	  Roads	  to	  aneuploidy	  In	   order	   to	   better	   understand	   the	   different	   ways	   that	   can	   lead	   to	  aneuploidy,	   it	   appears	   necessary	   to	   distinguish	   between	  whole	   chromosome	  aneuploidy	  and	  structural	  aneuploidy.	  Whole	  chromosome	  aneuploidy	  reflects	  both	   gains	   and	   losses	   of	   entire	   chromosomes,	   whereas	   non-­‐balanced	  rearrangements	   of	   chromosomes,	   such	   as	   deletions,	   amplifications	   or	  translocations	  of	   large	   regions	  of	   the	  genome	  result	   in	   structural	   aneuploidy	  16(Bernardo	  Orr,	  2015	  current	  Biol).	  Structural	  aneuploidies	  likely	  result	  from	  errors	  in	  DNA	  replication	  and	  repair,	  even	  though	  the	  mechanisms	  are	  not	  yet	  fully	   understood.	   (Fig	   1).	   It	   is	   important	   to	  mention	   that	   these	   processes	   do	  not	   happen	   in	   a	   mutual	   exclusivity	   but	   in	   a	   duality	   relation.	   For	   example,	  structural	   aneuploidy	   may	   cause	   whole	   chromosome	   aneuploidy	   and	   vice	  
versa.	  	  In	   this	   section	   I	   will	   focus	   on	   the	   processes	   that	   lead	   to	   whole	  chromosome	   aneuploidy,	   such	   as	   SAC	   defects,	   errors	   in	   kinetochore-­‐microtubule	   (k-­‐MT)	   attachment,	   cohesion	   defects,	   supernumerary	  centrosomes	  and	  tetraploidy	  (Fig	  1).	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Figure	   1.	  Mechanisms	   that	   generate	   aneuploidy.	   Schematic	   representation	  of	   the	   cellular	  mechanisms	   that	   generate	  whole	   chromosomal	   aneuploidy	  and	   structural	   aneuploidy.	  Bi-­‐directional	   arrows	   illustrate	   the	   duality	   relation	   between	   events.	   For	   example,	   the	  formation	  of	  merotelic	  k-­‐MT	  attachments	  and	  the	  induction	  of	  tetraploidy	  (from	  16Bernardo	  Orr,	  2015	  current	  Biol).	  	  2.2.1	  Mitotic	  checkpoint	  defects	  Proper	   chromosomes	   segregation	   depends	   on	   various	   mitotic	  processes,	  notably	  spindle	  formation,	  bi-­‐polar	  attachment	  of	  all	  chromosomes	  on	   the	   spindle	   apparatus	   and	   successful	   cytokinesis.	   I	   will	   discuss	   k-­‐MT	  attachments	   in	   some	   detail	   in	   the	   next	   section,	   but,	   in	   brief,	   chromosomes	  attach	   to	   spindle	   microtubules	   at	   specialized	   protein	   structures	   known	   as	  kinetochores	   (KT),	   which	   are	   assembled	   on	   centromeric	   chromatin	   early	   in	  mitosis.	  Microtubules	  can	  coordinate	  plus-­‐end	  dynamics	   in	  order	  to	  generate	  the	   forces	   required	   for	   both	   chromosome	   movements	   and	   to	   silence	   the	  spindle	  assembly	  checkpoint,	  allowing	  mitotic	  exit	  17(DeLuca	  J,	  Curr	  Opin	  Cell	  Biol	  2012).	  	  	  
	   12	  
	  	  
Figure	  2.	  The	  mitotic	  checkpoint:	  a	  safeguard	  to	  protect	  against	  aneuploidy.	  Microtubules	  nucleated	   by	   the	   centrosomes	   form	   bilaterally	   symmetrical	   mitotic	   spindle.	   The	   bi-­‐orientation	   process	   makes	   sure	   that	   sister	   chromatids	   are	   pulled	   in	   opposite	   directions,	  through	   the	   attachment	   of	   kinetochores	   to	   the	   microtubules	   arising	   from	   the	   opposite	  spindle	  poles.	  Errors	   in	   this	  process	   lead	   to	   the	  mis-­‐segregation	  of	   chromosomes	  and	   the	  production	  of	  aneuploid	  daughter	  cells.	  The	  SAC	  supervises	  these	  all	  processes	  and	  makes	  sure	   that	   correct	   chromosome	   segregation	   occurs	   and	   it	   delays	   the	   onset	   of	   anaphase	   if	  even	  only	  one	  single	  chromosome	  is	  not	  properly	  attached	  and	  bi-­‐oriented	  (from	  1Andrew	  J.	  Holland	  and	  Don	  W.	  Cleveland	  July	  2009	  Nature	  Reviews	  ).	  	   The	  key	  player	  of	  the	  SAC	  is	  the	  microtubule	  checkpoint	  complex	  (MCC),	  formed	  by	  mitotic-­‐arrest	  deficient	  homologue-­‐2	  (MAD2),	  budding	  uninhibited	  by	  benzimidazole	  related	  protein	  1	  (BUBR1),	  BUB3,	  and	  cell	  division	  cycle	  20	  (CDC20).	   This	   complex	   acts	   together	   with	   other	   core	   components,	   such	   as	  BUB1,	  multipolar	  spindle-­‐1	  (Mps1),	  MAD1,	  Aurora	  B	  and	  centromere	  protein	  E	  (CENP-­‐E).	   When	   the	   SAC	   is	   turned	   on,	   these	   proteins	   are	   enriched	   at	   the	  unattached	  or	   incorrectly	  orientated	  kinetochore	  and	  catalytically	  generate	  a	  diffusible	   signal	   that	   inactivates	   an	   E3	   ubiquitin	   ligase,	   the	   anaphase	  promoting	   complex/cyclosome	   (APC/C),	   and	   its	   co-­‐activator	   CDC20	   (Fig	   2).	  The	   SAC	   inhibits	   the	   ability	   of	   CDC20	   to	   activate	   the	   APC/C-­‐mediated	  polyubiquitylation	   of	   two	   key	   substrates,	   cyclin	   B	   and	   securin,	   thereby	  preventing	   their	   destruction	   by	   the	   26S	   proteasome.	   Sister	   chromatids	   are	  kept	   together	   by	   cohesin	   rings	   and	   premature	   separation	   is	   avoided	   by	   the	  chaperone	  securin	  and	  the	  complex	  cyclin-­‐dependent	  kinase	  1	  (CDK1)-­‐cyclin	  B	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that	  keep	  the	  separase	  inactive.	  When	  the	  correct	  attachment	  and	  alignment	  of	  all	  the	  chromosomes	  at	  the	  metaphase	  plate	  is	  reached,	  the	  spindle	  assembly	  checkpoint	   signal	   is	   silenced.	   Only	   after	   the	   ubiquitylation	   of	   securin	   and	  cyclin	   B	   by	   APC/C	   and	   consequentially	   their	   proteasome–mediated	  degradation,	  separase	  is	  activated	  and	  anaphase	  can	  initiate.	  At	  the	  same	  time,	  the	  progressive	  degradation	  of	  cyclin	  B	   inactivates	  CDK1,	   thereby	  promoting	  exit	  from	  mitosis	  (Fig	  2)	  18(Musacchio	  and	  Salmon	  2007).	  Consequently,	  deregulation	  of	  the	  SAC	  as	  well	  as	  the	  spindle	  architecture	  can	   lead	   to	   chromosome	   segregation	   defects	   and	   aneuploidy.	   An	   impaired	  capacity	  to	  sustain	  the	  SAC,	  due	  to	  deregulation	  of	  mitotic	  proteins,	  can	  lead	  to	  aneuploidy	   as	   observed	   in	   several	   tumors	   (Table	   1)	   19(Beth	   AA	   Weaver,	  Current	  Opinion	  in	  Cell	  Biology	  2006).	  In	  agreement,	  both	   in	  vivo	  and	   in	  vitro	  experiments,	   confirm	   an	   impaired	   checkpoint	   and	   a	   consequent	   aneuploidy	  formation	  in	  mice	  and	  human	  cells.	  In	  detail,	  Bub3	  null	  mice	  show	  embryonic	  lethality	  at	  day	  8.5,	  whereas	  heterozygous	  mice	  are	  viable	  and	  show	  increased	  rates	   of	   premature	   sister	   chromatid	   separation	   and	   chromosome	   mis-­‐segregation	  20(J.R.	  Babu,	  J	  Cell	  Biol,	  2003).	  Similar	  results	  were	  obtained	  with	  mice	   heterozygous	   for	   BubR1	   21(D.J.	   Baker,	   2003	   Nat	   Genet,)	   or	  overexpressing	  Mad2	  22(Sottillo	  R.	  2007	  Cancer	  Cell).	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Table	   1.	   Frequent	   impairment	   of	   the	   mitotic	   checkpoint	   in	   human	   cancers	   19(Beth	   AA	  Weaver,	  Don	  W	  Cleveland	  Current	  Opinion	  in	  Cell	  Biology	  2006).	  	  In	   human	   cells,	   it	   has	   been	   shown	   that	   overexpression	  of	  Mad2	   leads	   to	   the	  hyperstabilization	   of	   k-­‐MT	   attachments,	   decreasing	   the	   efficiency	   of	   error	  correction,	   thus	   leading	   to	   chromosome	   mis-­‐segregation	   and	   aneuploidy	  23(Kabeche	  L.	  2012	  Curr	  Biol).	  Similar	  results	  were	  reported	  for	  human	  breast	  cancer	   tumors	   overexpressing	   Mad1	   24(Ryan	   et	   al.,	   2012).	   All	   these	   results	  suggest	   that	   levels	   of	   every	   spindle	   component	  must	   be	   tightly	   regulated	   to	  prevent	   aneuploidy	  and	   transformation	  and	   that	  de-­‐regulation	  may	  promote	  tumors.	  By	   contrast,	   complete	   inactivation	   of	   the	   SAC	   is	   lethal	   in	   different	   cell	  lines	   and	   homozygous	   deletion	   of	   key	   checkpoint	   components	   causes	  embryonic	   lethality	   in	   mice	   25,26(Janssen	   A,	   2009,	   Proc	   Natl	   Acad	   Sci	   USA)	  (Thompson	   et	   al.,	   2010).	   Moreover,	   even	   though	   mutations	   of	   SAC	  components,	   leading	   to	  checkpoint	   inactivation,	  have	  been	   found	   in	  different	  tumor	   types,	   these	   mutations	   are	   not	   commonly	   seen,	   probably	   because	  massive	  chromosome	  mis-­‐segregation	   triggers	  cell	  death	   19(Beth	  AA	  Weaver,	  Current	  Opinion	   in	  Cell	  Biology	  2006).	  Contrarily,	   some	  CIN	  cancer	  cell	   lines	  show	   a	   rather	   robust	   SAC	   response	   to	   spindle	   poisons	   27(Tighe	   A,	   EMBO	  2001);	  moreover,	   in	  CIN	  cell	   lines,	  anaphase	  onset	   is	  blocked	  in	  the	  presence	  of	   misaligned	   chromosomes	   28(Gascoigne	   and	   Taylor,	   2008).	   All	   these	  indications	  show	  that	  upon	  mutation	   in	  SAC	  proteins	   that	   lead	  to	  checkpoint	  defects,	  the	  cell	  fates	  and	  the	  raising	  of	  aneuploidy	  are	  not	  predetermined.	  	  Therefore	  aneuploidy	  is	  not	  necessarily	  associated	  with	  SAC	  impairment	  and	  the	  role	  of	  the	  SAC	  response	  in	  the	  common	  occurrence	  of	  CIN	  and	  cancer	  is	  largely	  debated	  in	  the	  field.	  	  2.2.2	  Microtubule	  attachment	  defects	  As	   mentioned	   before,	   in	   order	   to	   segregate	   correctly	   the	   duplicated	  chromosomes,	  the	  sister	  KTs	  must	  be	  attached	  to	  microtubules	  from	  opposing	  spindle	   poles.	   The	   bi-­‐oriented	   attachment	   is	   called	   amphitely.	   However,	   the	  initial	  attachment	  of	  microtubules	  to	  KTs	  is	  stochastic	  and	  error	  prone.	  During	  this	   process	   different	   incorrect	   attachments	   can	   be	   generated,	   such	   as	  monotelic,	   syntelic	   and	   merotelic,	   and	   these	   need	   to	   be	   solved	   (Figure	   3).	  Monotelic	  attachments	  are	  a	  normal	  condition	  during	  prometaphase	  before	  bi-­‐orientation.	  In	  syntelic	  attachments,	  both	  sister	  chromatids	  attach	  to	  the	  same	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pole.	   In	   these	   two	   cases,	   cells	   experience	   a	   lack	   of	   tension	   between	   sister	  chromatids	   that	   generate	   a	   “wait	   signal”	   and	   the	   consequent	   SAC	   activation.	  Merotelic	  attachments	  occur	  quite	  frequently	  as	  well,	  but	  in	  this	  case	  the	  SAC	  is	   unable	   to	   detect	   them,	   due	   to	   the	  presence	   of	   tension	  between	   chromatid	  sisters.	  Activated	  SAC	  arrests	  cells	  in	  prometaphase	  to	  allow	  correction	  of	  the	  attachment.	  	  
	  	  
Figure	  3.	  Scheme	  showing	  different	  attachment	  configurations	  between	  chromosomes	  and	  microtubules.	  (From	  Maiato,	  H	  2004	  The	  Journal	  of	  Cell	  Biology)	  The	   KT	   is	   a	   large	   macromolecular	   structure	   assembled	   at	   sites	   of	  centromeric	  heterochromatin	  and	  composed	  by	  an	   inner	  and	  outer	  part	   (Fig	  4).	  The	  inner	  KT	  proteins,	  called	  Centromeric	  Proteins	  (CENPs),	  are	  associated	  with	  the	  centromeric	  chromatin	  containing	  the	  histone	  H3	  variant	  centromere	  protein	  A	   (CENP-­‐A)	   29-­‐31(Earnshaw	  WC.	  2015	  Nature	  Reviews	  Molecular	  Cell	  Biology)	   (Bungo	   Akiyoshi	   2012	   Chromosoma)	   (Musacchio	   A.	   2017	   Biolosy).	  The	  outer	  KT	  components	  are	  10	  highly	  conserved	  proteins	  forming	  the	  KMN	  “network”,	   composed	   of	   the	   KNL1	   complex,	   formed	   by	   kinetochore	   null	  protein	  1	  (Knl1)	  and	  ZW10	  interacting	  protein	  (Zwint-­‐1);	  the	  MIS12	  complex	  including	   Mis12,	   Dsn1,	   Nsl1,	   and	   Nnf1;	   and	   the	   NDC80	   complex	   with	  Ndc80/Hec1,	  Nuf2,	  Spc24,	  and	  Spc25	  (Fig	  4)	  17,32(DeLuca	  J.	  Curr	  Opin	  Cell	  Biol	  2012)	  (Godek	  K,	  Nature	  Reviews	  Molecular	  Cell	  Biology	  2015).	  In	  addition	  to	  core	  KT	  components,	  many	  regulatory	  proteins	  also	   localize	   to	  kinetochores,	  such	  as	  spindle	  checkpoint	  proteins,	  microtubule-­‐associated	  proteins	  (MAPs),	  motor	  proteins,	  mitotic	  kinases	  and	  phosphatases.	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Figure	  4.	  Scheme	  showing	  KT	  structure.	  Some	  components	  are	  direct	  targets	  of	  Aurora	  B	  kinase	  phosphorylation	  as	   indicated	   (DSN1,	  KNL1	  and	  NDC80),	  while	  arrows	   indicate	   the	  direct	   k-­‐MT	   binding	   site	   (from	   Godek	   K,	   DA	   Compton.	   Nature	   Reviews	   Molecular	   Cell	  Biology	  2015).	  Erroneous	   attachments	   are	   corrected	   through	   repeated	   cycles	   of	  microtubule	  attachments/detachments	  at	  KTs.	  Only	  when	  correct	  attachment	  is	  achieved	  is	  the	  SAC	  satisfied	  and	  the	  cell	  can	  progress	  through	  anaphase.	  A	  key	  complex	  responsible	  of	  k-­‐MT	  attachment	  correction	  is	  a	  group	  of	  proteins	  forming	   the	   Chromosome	   Passenger	   Complex	   (CPC),	   with	   Aurora	   B	   as	   its	  catalytic	   component.	   Once	   released,	   the	   unattached	   KT	   triggers	   the	   SAC	  response	   that	   in	   turn	  delays	  mitotic	  progression	  until	   the	  error	   is	   corrected.	  CPC	   is	   composed	   of	   Aurora	   B,	   together	   with	   Survivin,	   Borealin	   and	   inner	  centrome	   protein	   (INCENP)	   33(Ruchaud	   et	   al.,	   2007).	   A	   common	   concept	   is	  that	  Aurora	  B,	  a	  serine-­‐threonine	  kinase,	  phosphorylates	  proteins	  localized	  in	  the	   outer	   KMN	   network	   (Fig	   4)	   to	   destabilize	   and	   facilitate	   the	   release	   of	  erroneous	   attachments	   34(Welburn	   J.P.I.	   2010	   Mol	   Cell).	   According	   to	   one	  plausible	  model,	  Aurora	  B	  creates	  a	  gradient	  of	  phosphorylation	  at	   the	   inner	  KT,	  thus	  in	  the	  absence	  of	  tension,	  KT	  substrates	  are	  phosphorylated	  because	  they	   are	   in	   close	   proximity	   to	   Aurora	   B	   at	   the	   inner	   centromere	   35(Liu	   Dan	  2009	  Science).	  The	  released	  KT	  can	  eventually	  be	  reattached	  by	  a	  microtubule	  fiber	  from	  the	  correct	  pole	  and	  tension	  is	  restored,	  thereby	  satisfying	  the	  SAC	  and	  allowing	  progression	  toward	  anaphase.	  Sister	  KTs	  are	  thus	  pulled	  toward	  opposite	   directions,	   away	   from	   the	   inner	   centromere,	   so	   that	   KT	   substrates	  are	   dephosphorylated	   and	   the	   attachment	   is	   stabilized	   35,36(Liu	   Dan	   2009	  Science)	  (Wang	  E	  2011	  JCB).	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Thus,	  Aurora	  B	  deregulation	  leads	  to	  defects	  in	  chromosome	  segregation.	  It	  has	  been	  shown	  that	  cells	  down-­‐regulating	  this	  protein	  undergo	  premature	  anaphase	  onset	  without	  proper	  alignment	  37(Martin-­‐Luesma	  S.	  2002	  Science).	  Moreover,	  overexpression	  of	  Aurora	  B	   it	  has	  been	  observed	   in	  many	   tumors	  showing	  CIN	  38(Lin	  et	  al	  2010).	  However,	   the	   SAC	   does	   not	   always	   detect	   improper	   k-­‐MT	   attachments,	  and	   if	   these	   are	   not	   corrected	   by	   anaphase	   onset,	   the	   probability	   of	  chromosome	   mis-­‐segregation	   increases,	   resulting	   in	   whole	   chromosome	  aneuploidy.	  Furthermore,	  during	   cell	  division	  chromosomes	  with	  unresolved	  merotelic	  attachments	   frequently	  get	   trapped	  in	  the	  cleavage	  furrow,	   leading	  to	   chromosome	   breakup	   and	   consequentially	   structural	   chromosome	  aberrations.	  In	  summary,	  alterations	  in	  the	  k-­‐MT	  errors	  correction	  machinery	  and	  KT	  defects,	   in	   particular	   through	   Aurora	   B	   kinase	   deregulation,	   are	   frequently	  linked	  to	  CIN	  39(Giet	  et	  al.,	  2005;	  Katayama	  et	  al.,	  1999).	  However,	  the	  role	  of	  Aurora	  B	  and	  CPC	  proteins	  in	  carcinogenesis	  remains	  elusive,	  as	  mutations	  in	  this	  machinery	  are	  rather	  rare	  in	  cancer.	  	  2.2.3	  Chromosome	  cohesion	  defects	  Sister	  chromatids	  are	  kept	  together	  by	  a	  protein	  complex	  which	  is	  known	  as	  the	  cohesin	  complex,	  established	  during	  DNA	  replication	  40(Michaelis,	  C.	  Cell	  1997).	   Its	   ring	   structure	   is	   composed	   of	   a	   pair	   of	   rod-­‐shaped	   proteins,	  structural	  maintenance	  of	  chromosomes	  protein	  1	  (Smc1)	  and	  Smc3,	  that	  form	  V-­‐shaped	   heterodimers	   with	   ATP-­‐binding	   cassette	   (ABC)	   -­‐like	   nucleotide-­‐binding	  domains,	   at	   the	   end	  of	   each	  arm,	   interconnected	  by	  a	   subunit	   called	  Scc1	  (also	  known	  as	  Mcd1	  or	  Rad21)	  and	  Scc3	  (known	  in	  mammalian	  cells	  as	  SA1	  and	  SA2)	  41(Gruber,	  Stephan	  2003	  Cell.)	  (Fig	  5).	  Several	  other	  proteins	  are	  essential	   for	   cohesion’s	   association	   with	   chromosomes,	   but	   not	   for	   its	  maintenance	   after	   DNA	   replication,	   such	   as	   Scc2	   (known	   as	   Nipbl	   in	  mammalian	   cells)	   and	   Scc4	   42(Kim	   Nasmyth	   and	   Christian	   H.	   Haering	   2009	  Annual	  Review	  of	  Genetics).	  In	  addition,	  many	  other	  proteins	  are	  necessary	  to	  regulate	   cohesion	   efficiency,	   such	   as	  polo-­‐like	   kinase	  1	   (Plk1),	  Aurora	  B	   and	  Serine/threonine-­‐protein	   phosphatase	   2A	   (PP2A)	   	   43-­‐46	   (Waizenegger	   et	   al.	  2000)	  (Losada	  et	  al.	  2002)	  (Sumara	  et	  al.	  2002)	  (Gimenez-­‐Abian	  et	  al.	  2004).	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Figure	   5.	   Scheme	   showing	   Cohesin	   structure	   47(Raquel	  A.	   Oliveira,	   Kim	   Nasmyth.	   2010	  Biochem	  Soc	  Trans).	  	  As	   mentioned	   above,	   sister	   chromatids	   are	   held	   together	   starting	   from	  the	   time	  of	  DNA	  duplication	   in	  S	  phase	  until	   the	  SAC	   is	  satisfied	  and	  cohesin	  are	   cleaved	   to	   allow	   anaphase	   onset.	   By	   keeping	   sister	   chromatids	   together,	  cohesin	   prevents	   premature	   sister	   chromatid	   separation	   and	   extensive	  chromosome	  mis-­‐segregation.	  Moreover,	  by	  counteracting	  the	  spindle	  pulling	  forces,	   cohesion	   between	   the	   two	   sisters	   generates	   the	   tension	   necessary	   to	  stabilize	   k-­‐MT	   attachments	   47(Raquel	   A.	   2010	   Biochem	   Soc	   Trans).	   An	  important	  player	  required	  to	  protect	  centromere	  cohesion	  is	  shugoshin	  that	  in	  vertebrates	   counteracts	   cohesin	   dissociation	   48(Clift	   D	   2011	   Cytogenet	  Genome	   Res).	   Thus	   sister	   chromatid	   cohesion	   is	   indispensable	   for	  chromosome	   segregation	   and	   defects	   in	   this	   system	   are	   potential	   causes	   of	  mis-­‐segregation.	   For	   example,	   CIN	   cell	   lines	   show	   often	   impairment	   in	   the	  integrity	   of	   the	   conserved	   inner	   centromere-­‐shugoshin	   network	   49(Tanno	   Y,	  2015	   Science)	   and	   SGO1	   haploinsufficiency	   causes	   enhanced	   CIN,	   pre-­‐neoplastic	   lesions	   and	   tumorigenesis	   in	   mice	   50(Yamanada	   HY	   2012	   Cell	  Cycle).	   Moreover	   mutation	   in	   STAG2/Scc3	   promotes	   chromatid	   cohesion	  defects	   and	   aneuploidy	   51,52(Solomon	   DA	   2011	   Science)	   (Djos	   A,	   BMC	   Med	  Genet.	   2013).	   Besides,	   Scc1-­‐deficient	   cells	   frequently	   fail	   to	   complete	  metaphase	   chromosome	   alignment	   and	   show	   chromosome	   segregation	  defects	  53(Morrison	  C	  2003	  Biochem	  Soc	  Trans).	  Taken	  together,	  the	  levels	  of	  cohesin	   complex	   proteins	   and	   their	   cofactors	   should	   be	   tightly	   regulated	   to	  ensure	  chromosome	  segregation	  fidelity.	  2.2.4	  Supernumerary	  centrosomes	  Centrosomes	  are	  responsible	   for	  the	  assembly	  of	  cilia	  and	  the	  formation	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of	   the	   mitotic	   bipolar	   spindle.	   Each	   centrosome	   comprises	   two	   centrioles,	  barrel-­‐shaped	   structures	   that,	   in	   humans,	   are	   composed	   by	   microtubule	  triplets	   assembled	   in	   a	   typical	   nine-­‐fold	   symmetry.	   Centrosomes	   are	  surrounded	   by	   an	   amorphous	   mass	   of	   dense	   material,	   called	   pericentriolar	  material	   (PCM).	   The	   correct	   centriole	   number	   in	   proliferating	   cells	   is	  guaranteed	   at	   several	   levels:	   the	   centriole	   duplicates	   once	   and	   only	   once	   in	  every	  cell	  cycle	  and	  exactly	  one	  new	  centriole	  forms	  next	  to	  every	  pre-­‐existing	  centriole.	   Thus,	   different	   mechanisms	   can	   be	   the	   source	   of	   centrosome	  amplification:	   centrosome	   overduplication,	   abortive	   cell	   division,	   cell	   fusion	  and	   de	   novo	   centriole	   formation	   54(E.A.	   Nigg,	   Nat.	   Cell	   Biol.	   2011).	   It	   is	  important	   to	   note	   that	  while	   the	   presence	   of	   extra	   centrosomes	   is	   a	   serious	  problem	  during	  cell	  division,	  centrosomes	  are	  not	  strictly	  required	  for	  mitosis	  in	   many	   cell	   types,	   even	   though	   they	   are	   often	   active	   participants	   in	   the	  process	  55(Basto,	  R.	  et	  al.	  Cell	  2006).	  Independently	   from	  the	  cause,	  centrosome	  overduplication	  can	  result	   in	  massive	   chromosome	   mis-­‐segregations	   due	   to	   the	   increased	   probability	   to	  form	  multipolar	  spindles	  that	  often	  lead	  to	  aneuploid	  daughter	  cells	  56(EA	  Nigg	  2002).	   Possible	   outcomes	   of	   a	   multipolar	   spindle	   are	   the	   balanced	   or	  unbalanced	   chromosome	   repartition.	   In	   the	   first	   case	   cells	   can	   progress	  through	  anaphase	  in	  a	  tripolar	  manner	  (the	  most	  frequent	  type	  of	  multipolar	  anaphase),	  where	  each	  of	   the	  daughter	  nuclei	   gets	  nearly	  a	   third	  of	  parental	  DNA	  material,	  thus	  resulting	  in	  severely	  compromised	  viability	  57-­‐60(Ganem	  et	  al.	   2007)	   (Genem	   et	   al	   2009)	   (Kwon	   et	   al.	   2008)	   (Gisselsson	   et	   al.,	   2010).	  Meanwhile,	   in	   the	   second	   case	   the	   unbalanced	   multipolar	   chromosome	  segregation	   is	   often	   followed	   by	   an	   asymmetric	   cytokinesis,	   resulting	   in	  overall	   diploid	   daughter	   cells	   carrying	   many	   trisomies	   and	   monosomies.	  Moreover	   daughter	   nuclei	   formed	   during	   unbalanced	   multipolar	   division	  frequently	   displayed	   sister	   chromatid	   non-­‐disjunction	   and	   poorly	   viable	  nullisomies	  60,61(Sansregret,	  2017	  Cold	  Spring	  harb	  perspect	  med)	  (Gisselsson	  et	   al.,	   2010).	   For	   this	   reason	   is	   not	   surprising	   that	   centrosomes	   clustering	  mechanisms	   operate	   in	   cancer	   cells	   to	   suppress	   the	  multipolar	   cell	   division.	  The	   clustering	   leads	   to	   the	   reduction	   of	   spindle	   pole	   numbers,	   resulting	   in	  pseudo	   bipolar	   spindle	   formation,	   which	   then	   decreases	   the	   probability	   of	  nullisomies,	   monosomies	   or	   trisomies	   62,63(Brinkley	   BR.	   2001	   Trends	   Cell	  Biol.)	   (Drosopoulos	   K	   2014	   Nat	   Commun).	   In	   this	   way	   progeny	   after	  multipolar	  mitosis	  could	   limit	  the	  detrimental	  effects	  of	  a	  multipolar	  division	  64(Basto	  R	  2008	  Cell).	  Finally,	  even	  if	  bipolar	  clustering	  and	  cytokinesis	  are	  at	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the	  end	  successful,	  transient	  multipolar	  spindles	  formed	  during	  mitosis	  greatly	  increase	   the	   formation	   rate	   of	   merotelic	   k-­‐MT	   attachments,	   resulting	   in	  increased	  chromosome	  mis-­‐segregation	  rates	  (Fig	  6.)	  58,65(Ganem	  et	  al.,	  2009)	  (Silkworth	  et	  al.,	  2009).	  
	  
Figure	   6.	   The	   formation	   of	   lagging	   chromosomes	   in	   anaphase	   could	   be	   due	   to	   an	  accumulation	   of	   unresolved	   merotelic	   k-­‐MT	   attachments	   due	   to	   the	   extra	   centrosome	  58(Ganem	  et	  al.,	  2009).	  	   Thus,	  supernumerary	  centrosomes	  and	  multipolar	  spindles	  are	  observed	  early	   in	   the	  development	  of	  many	   tumors	  and	  often	  correlate	  with	  advanced	  tumor	  grade	  and	  poor	  clinical	  outcome	  66-­‐69(Godinho	  and	  Pellman,	  2014)	  (Nigg	  and	   Raff,	   2009)	   (Nigg,	   2006)	   (Oncol	   Rep.	   2015	   Telentschak	   S)	   (Figure	   6).	  Moreover	   centrosome	  abnormalities	   correlate	  with	   chromosome	  aberrations	  even	  though	  a	  relation	  of	  causality	  has	  not	  yet	  been	  proven.	  	  Since	  a	  long	  time,	  the	  relation	  between	  loss	  of	  p53,	  a	  transcription	  factor	  that	   causes	   cell-­‐cycle	   arrest	   or	   apoptosis	   in	   response	   to	   DNA	   damage,	   and	  centrosome	   aberrations	   has	   attracted	   great	   interest	   70(Fukasawa,	   Science	  1996).	  Originally,	   it	   has	   been	  proposed	   that	   loss	   of	   p53	   could	  directly	   cause	  centrosome	  overduplication	   71(Tarapore,	  P.	  Oncogene	  2001),	  but	  more	   likely	  is	   an	   involvement	   of	   p53-­‐dependent	   checkpoints	   in	   the	   elimination	   of	   cells	  that	   emerge	   from	   aborted	   divisions	   63,72(Borel,	   F.	   Proc.	   Natl	   Acad.	   Sci	   2002)	  (Drosopoulos	  K	  2014	  Nat	  Commun.)	  Supporting	  this	  idea,	  analysis	  of	  brains	  in	  p53–/–	  mice	   revealed	   that	   these	   animals	   have	   normal	   centrosome	   numbers	  73(Marthiens	  V,	  2013	  Nat.	  Cell	  Biol.).	  A	  good	  example	  of	  how	  loss	  of	  p53	  could	  enhance	   centrosome	   amplification	   is	   represented	   by	   high-­‐risk	   human	  papillomavirus	  (HPV)-­‐associated	  tumors.	  HPV-­‐16	  E7	  protein	  disrupts	  normal	  centriole	   duplication,	   inducing	   centrosome	   amplification	   through	   a	   process	  that	   involves	   increased	   mRNA	   levels	   of	   the	   key	   centriole	   duplication	   factor	  Plk4	  74(Korzeniewski	  N,	  mol	  cancer	  2011).	  At	  the	  same	  time	  Plk4	  mRNA	  levels	  are	  negatively	  regulated	  by	  p53,	  thus,	  loss	  of	  p53	  could	  potentially	  contribute	  to	  centrosome	  amplification	  through	  increased	  levels	  of	  Plk4	  75(Li	  J,	  Neoplasia	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2005).	  	  To	  summarize,	   centrosome	  amplification	  represents	  one	  of	   the	  common	  mechanisms	   of	   CIN	   generation/induction.	   However,	   the	   fact	   that	   increased	  centrosome	  number	  is	  not	  maintained	  for	  a	  long	  period	  after	  formation	  argues	  against	  the	  role	  of	  extra	  centrosomes	  as	  the	  exclusive	  triggers	  of	  CIN.	  	  2.2.5	  Tetraploidization	  Polyploidy	   (triploidy,	   tetraploidy	   and	   so	   on)	   occurs	   very	   frequently	   in	  plants	   and	   fungi	   and	   is	   thought	   to	   generate	   mutations	   that	   would	   favor	  adaptations	   to	   environmental	   changes	   76(Aleza	   et	   al	   2011).	   Polyploidy	   also	  appears	   to	   be	   frequent	   during	   evolution;	   genome	   sequencing	   suggests	   that	  many	   contemporary	   genomes,	   including	   genomes	   of	   higher	   vertebrates,	  evolved	   from	   ancient	   genome	   duplications	   77(M.Kellis	   Nature	   2004).	   In	  animals,	   polyploidy	   occurs	   mainly	   in	   lower	   forms,	   such	   as	   flatworms	   and	  rarely	   in	   higher	   forms	   such	   as	   Xenopus	   laevis	   78(Gallardo	   et	   al	   1999).	   In	  humans,	   polyploidy	   occurs	   in	   some	   somatic	   cells	   and	   it	   mostly	   takes	   place	  during	   developmentally	   programmed	   processes,	   notably	   in	   trophoblasts,	  hepatocytes,	   human	   heart	  muscle	   cells	   and	  megakaryocytes	   79(Guidotti	   et	   al	  2003).	  A	   duplication	   of	   the	   genome	   can	   also	   occur	   aberrantly	   and,	   even	   if	  unscheduled	   polyploidy	   is	   poorly	   tolerated	   by	   mammalian	   organisms,	   it	   is	  frequently	   observed	   in	   human	   cancers	   80(Storchova	   and	   Kuffer,	   2008).	   As	  mentioned	   before,	   abortive	   cell	   division	   or	   cell	   fusion,	   both	   resulting	   in	  genome	  doubling,	  can	  cause	  supernumerary	  centrosomes.	  Yet,	  supernumerary	  centrosomes	   then	  promote	   aberrant	  mitotic	   divisions	   and	   chromosome	  mis-­‐segregation.	  Thus,	  tetraploidy	  is	  an	  unstable	  state	  that	  can	  potentially	  promote	  further	   aneuploidy	   and	   instability.	   Tetraploidy	   is	   found	   in	   early	   stages	   of	  several	   tumors,	   and	   documented	   in	   37%	   of	   cancers,	   moreover	   a	   significant	  proportion	   of	   solid	   tumors	   (11-­‐64%)	   show	   evidence	   of	   genome	   duplication	  events	   81(2013	   Nat	   Genetics	   Zack	   TI,	   et	   al.).	   A	   further	   link	   comes	   from	   the	  observation	  that	  tetraploid	  cells	  lacking	  p53	  can	  initiate	  tumors	  in	  mice,	  while	  diploids	   do	   not	   82(Fujiwara	   T,	   et	   al.	   Nature.	   2005).	   Notably	   these	   tumors	  displayed	   near-­‐tetraploid	   aneuploidy	   with	   chromosome	   gains	   and	   losses	   as	  well	   as	   structural	   chromosome	   rearrangements,	   implying	   that	  tetraploidization	   can	   initiate	   chromosomal	   instability	   57(Ganem	   Neil	   J	   2007	  Current	  opinion	   in	  Genetics	  &	  development).	  A	   later	  study	  further	  confirmed	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the	  role	  of	  tetraploidy	  in	  tumorigenesis	  in	  mice:	  upon	  prolonged	  cell	  passaging	  
in	   vitro,	   diploid	   mouse	   ovarian	   surface	   epithelial	   cells	   (MOSEC)	   underwent	  cytokinesis	   failure	   with	   a	   high	   frequency,	   forming	   tetraploid	   cells	   and,	  subsequently,	  aneuploid	  cells	  83(Lv	  et	  al.,	  2012).	  The	  intraperitoneal	  injection	  of	   aneuploidy	   cells	   (late	   passages)	   into	   C57BL/6	   mice	   induced	   tumor	  formation	   on	   the	   intestinal	   surface,	   whereas	   injection	   of	   diploids	   (early	  passages)	   did	  not.	  Of	   note,	   the	   p53	   status	   in	   the	   cells	   from	   resulting	   tumors	  was	  not	  investigated.	  Thus,	  possible	  p53	  pathway	  deregulation	  likely	  allowed	  the	  proliferation	  in	  an	  aneuploid	  state	  and	  tumor	  growth.	  	  Experimentally	  generated	  tetraploid	  cells	  often	  fail	  to	  propagate,	  as	  these	  cells	  arrest	   in	  G1	  in	  a	  p53-­‐dependent	  manner	  26,84(P.T.	  Stukenberg	  J	  Cell	  Biol.	  2004)	  (S.L.	  Thompson,	  D.A.	  Compton	  J.Cell	  Biol.	  2010).	  A	  recent	  study	  supports	  the	   concept	   that	   changes	   in	   p53	   regulation	   could	   favor	   the	   capacity	   of	  tetraploid	   clones	   to	   proliferate	   after	   chromosome	   mis-­‐segregation.	   In	  particular	   colon	   cancer	   microsatellite	   instable	   (MIN)	   HCT116	   cells,	   upon	  tetraploidization,	  exhibit	  a	  CIN	  positive	  phenotype,	  as	  well	  as	  deregulation	  of	  p53	  signaling.	  Even	  though	  the	  idea	  of	  a	  “tetraploidy	  checkpoint”	  is	  appealing,	  studies	   suggest	   that	   there	   might	   not	   be	   a	   ploidy-­‐sensing	   checkpoint	   that	  necessarily	  arrest	  tetraploidy	  cells	  in	  G1	  57,85,86(Ganem	  Neil	  J.	  2007	  Cell)	  (Mar	  Soto	  2017	  Cell	   reports)	   (Santaguida	  S	  2017	  Dev	  cell).	  Supporting	   this	   idea	   is	  the	   fact	   that	   normal	   hepatocytes	   for	   instance	   are	   capable	   of	   proliferation,	  79(Guidotti	   et	   al	   2003).	   Moreover,	   Uetake	   and	   Sluder	   found	   that	   upon	  treatment	  with	  low	  doses	  of	  DCB	  (dihydrocytochalasin	  B)	  tetraploid	  cells	  did	  not	  necessarily	  undergo	  to	  cell	  cycle	  arrest	  or	  delay	  in	  G1	  87(Y.Uetake	  J	  cell	  biol	  2004).	   In	   the	   next	   section	   I	   will	   present	   the	   role	   of	   p53	   response	   to	  chromosome	  mis-­‐segregation	  and	  aneuploidy	  in	  more	  detail.	  In	   summary,	   evidence	   suggests	   an	   oncogenic	   potential	   of	   transient	  tetraploidy	   and	   an	   association	   of	   transient	   tetraploidy	   with	   complex	  aneuploidy	  and	  CIN,	   even	   if	   little	   is	  known	  about	   the	  molecular	  mechanisms	  underlying	  this	  transition.	  	  	  
2.3.1	   Short	   and	   long	   term	   consequences	   of	   chromosome	  
mis-­‐segregation	  and	  aneuploidy.	  Aneuploidy	  in	  somatic	  cells	  is	  a	  rare	  event	  but,	  when	  it	  occurs,	  the	  effects	  on	  health	  are	  dramatic.	  Below,	  I	  summarize	  the	  current	  understanding	  of	  the	  immediate	   and	   long-­‐term	   effects	   of	   chromosome	   mis-­‐segregation	   and	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aneuploidy.	   I	  will	  explore	   in	  particular	  the	  effect	  of	   the	  aneuploidy-­‐associated	  
stresses,	  a	  mixture	  of	  common	  features	  and	  traits,	  such	  as	  transcriptional	  and	  post-­‐transcriptional	   responses	   and	   proteotoxic	   stress,	   that	   collectively	   are	  responsible	   for	   the	   effects	   on	   cellular	   fitness	   88-­‐90(Santaguida	   S	   et	   al.	   Genes	  Dev.	  2015)	  (Dominigues	  PH	  Cancer	  Res	  2017)	  (Torres	  EM	  2008	  Genetics).	  2.3.1	  DNA	  damage	  Chromosome	   mis-­‐segregation	   can	   impact	   on	   chromosome	   integrity.	   In	  fact,	   chromosomes	   that	   mis-­‐segregate	   are	   frequently	   damaged	   during	  cytokinesis	  (Fig	  7).	  As	  defined	  above,	  merotelic	  attachments	  are	  formed	  when	  microtubules,	   from	   opposite	   spindle	   poles,	   attach	   to	   the	   same	   KT.	   This	  incorrect	  attachment	  can	  cause	  the	  chromosomes	  to	  lag	  in	  the	  midzone	  during	  anaphase.	   Similarly,	   lagging	   chromosomes	   can	   be	   trapped	   in	   the	   cytokinetic	  furrow	   and	   broken	   during	   cytokinesis,	   or	   enclosed	   within	   micronuclei.	   In	  either	   case,	   the	   mis-­‐segregated	   chromosome	   is	   going	   to	   be	   damaged.	   The	  cytokinesis-­‐induced	   DSBs	   can	   cause	   the	   separated	   parts	   of	   the	   broken	  chromosomes	  to	  end	  up	  in	  distinct	  daughter	  cells,	  providing	  a	  platform	  for	  an	  unbalanced	   translocation	   event	   91(A.	   Janssen	  2011	   Science).	  Moreover,	  DSBs	  can	   trigger	   DNA	   double-­‐strand	   break	   responses	   in	   the	   respective	   daughter	  cells,	   involving	   ATM,	   Chk2,	   and	   p53.	   Besides,	   new-­‐formed	   micronuclei	  undergo	   defective	   and	   asynchronous	   DNA	   replication,	   resulting	   in	   DNA	  damage	   and	   often	   in	   an	   extensive	   fragmentation	   of	   the	   chromosome	   in	   the	  micronucleus.	   Finally,	   the	   micronuclei	   persist	   normally	   during	   several	  generations,	  but	  they	  can	  be	  reintegrated	  as	  well	  into	  one	  of	  the	  daughter	  cell	  92(K.	  Crasta	  2012	  Nature).	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Figure	  7.	  Merotelic	  attachments	  lead	  to	  lagging	  chromosomes,	  which	  can	  be	  trapped	  in	  the	  cytokinetic	   furrow	   and	   break	   during	   cytokinesis	   or,	   alternatively,	   form	   their	   own	  micronucleus,	  which	   is	  either	  accurately	  segregated	  (middle)	  or	  mis-­‐segregated	  (bottom).	  Adapted	  from	  S.	  Santaguida	  and	  A.	  Amon	  2015	  Nature	  Review.	  	  The	   complex	   chromosomal	   rearrangements	   that	   form	   in	   micronuclei	   are	  reminiscent	   of	   chromothripsis,	   a	   process	   in	   which	   entire	   chromosomes	  become	   fragmented	   and	   then	   are	   repaired	   in	   a	   seemingly	   random	   manner,	  leading	   to	   dozens	   (sometimes	   even	   hundreds)	   of	   rearrangements	   within	   a	  single	  chromosome	  93(Liu	  P	  2011	  Cell).	  Chromothripsis	  has	  been	  observed	  in	  approximately	   3%	   of	   cancers	   and	   is	   prevalent	   in	   osteosarcomas	   (35%)	   and	  aggressive	   neuroblastomas	   (18%)	   and	   might	   provide	   the	   fuel	   for	   rapid	  genome	  evolution.	  	  	  2.3.2	  Transcriptional	  and	  post	  transcriptional	  responses	  The	   first	   attempt	   to	   find	   a	   conserved	   gene	   expression	   response	   to	  environmentally	   stressful	   changes,	   such	   as	   temperature	   shock,	   oxidative	  stress	  and	  starvation,	  was	  already	  performed	  several	  years	  ago	   94(Gasch	  A.P.	  2000	  Molecular	  Biology	  of	   the	  Cell).	  More	  recently,	  gene	  expression	  analyses	  in	  aneuploid	  budding	  yeast	   strains	  and	  plants,	   as	  well	   as	  aneuploid	  primary,	  untransformed	   mouse	   and	   human	   cells,	   have	   revealed	   a	   conserved	   gene	  expressions	   response	   to	   the	   aneuploid	   state	   across	   species	   95,96(Sheltzer	   J.M.	  2012	  PNAS)	   (Durrbaum	  M.	  2014	  BMC	  Genomics).	   In	  particular,	   analysis	  of	   a	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collection	  of	  different	  yeast	  strains	  carrying	  an	  extra	  copy	  of	  one	  of	  almost	  all	  yeast	  chromosomes	  revealed	  a	  gene	  expression	  signature	  characteristic	  of	  the	  environmental	   stress	   response	   (E.M.	  Torres	  2007	  Science).	  Furthermore,	   the	  stress	   and	   growth	   related	   transcriptional	   signature	   was	   found	   to	   be	  conserved,	  independently	  of	  the	  identity	  of	  the	  extra	  chromosome	  95(Sheltzer	  J.M.	  2012	  PNAS).	  Consistently	  with	  this	  observation,	  different	  aneuploidies	  in	  human	   cells	   trigger	   common	   and	   uniform	   transcription	   profiles,	   such	   as	  consistent	   upregulation	   of	   stress	   and	   acute	   inflammatory	   responses,	   and	  downregulation	  of	  genes	  associated	  with	   the	  cell	   cycle,	   cell	  proliferation	  and	  DNA	  replication	  96(Durrbaum	  M	  2014	  BMC	  Genomics).	  Finally,	  lymphoma	  cells	  of	   engineered	   mice,	   with	   heterozygous-­‐deletion	   p53	   background,	   showed	  changes	  in	  the	  expression	  of	  metabolic,	  splicing	  and	  DNA-­‐synthesis	  genes	  after	  induction	   of	   chromosome	   instability	   97(F.	   Foijer	   2014	   PNAS).	   Notably,	   these	  changes	  were	  very	  similar	  to	  the	  ones	  previously	  found	  after	  the	  introduction	  of	  an	  extra	  chromosome	  into	  mouse	  embryonic	  fibroblasts	  (MEFs)	  3(Williams	  B.R.	  Science	  2008).	  	  An	   important	   question	   is	   if,	   and	   how,	   the	   presence	   of	   an	   extra	  chromosome	   affects	  mRNA	   levels,	   and	  what	   is	   the	   physiological	   response	   to	  these	  changes.	  Of	  particular	  interest	  was	  the	  recent	  finding	  that	  transcription	  levels	   in	   human	   trisomic	   and	   tetrasomic	   cells	   reflect	   the	   chromosome	   copy	  number	  changes.	  Contrarily,	  quantitative	  proteomic	  data	  revealed	  generally	  a	  reduction	  of	  proteins,	  and	  in	  particular	  subunits	  of	  protein	  complexes,	  toward	  diploid	   level,	   even	   if	   not	   completely	   98(Stingele	   S.	   2012	  Mol	   Syst.	   Biol).	   This	  reduction	   was	   observed	   simultaneously	   with	   the	   hyperactivation	   of	   the	  proteasome,	   through	   inactivation	   of	   the	   proteasome-­‐associated	  deubiquitylating	   enzyme	   ubiquitin	   carboxyl-­‐terminal	   hydrolase	   6	   (UBP6),	  raising	   the	   interesting	   possibility	   that	   proteotoxicity	   is	   a	   hallmark	   of	   the	  aneuploid	  state	  (discussed	  below).	  On	  the	  other	  hand,	  transcriptome	  profiling	  from	   in	  vitro	   generated	   aneuploidy	   in	   yeast,	  mouse,	   human	   cells,	   pathogenic	  
Candida	   strains	   and	   plants,	   suggests	   that	   mRNA	   levels	   derived	   from	   genes	  encoded	  on	   the	  extra	   chromosomes,	  mostly	   scale	  up	  proportionally	  with	   the	  gene	  copy	  numbers	  2,3,99-­‐101(Upender	  et	  al,	  2004)	  (Torres	  et	  al,	  2007)	  (Williams	  et	   al,	   2008)	   (Selmecki	   et	   al,	   2006)	   (Makarevitch	   et	   al,	   2008).	   In	   conclusion,	  studies	  supported	  both	  the	   idea	  that	  the	  presence	  of	  extra	  chromosomes	  can	  directly	  affect	  the	  mRNA	  levels	  of	  the	  unbalanced	  genes,	  and	  at	  the	  same	  time	  the	  existence	  of	  feedback	  control	  that	  buffers	  the	  mRNA	  levels	  of	  amplified	  or	  underrepresented	  genes.	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Several	  studies	  report	  a	  correlation	  between	  aneuploidy	  gene	  expression	  profiles	  and	  clinical	  prognosis	   in	  human	  cancers.	  Of	  particular	   interest	   is	   the	  work	  proposed	  by	  Carter	  and	  Szallasi	  9(S.L.	  Carter	  2006	  Natuer	  Genetics)	  that	  identified	  some	  transcripts	  to	  be	  more	  abundant	  in	  cancers	  with	  a	  high	  level	  of	  aneuploidy.	  This	  list,	  known	  as	  CIN70,	  was	  described	  as	  a	  marker	  for	  intrinsic	  CIN,	   its	   overexpression	   in	   patients	   being	   correlated	   with	   a	   poor	   clinical	  outcome.	  Lately,	  however,	  it	  has	  been	  suggested	  that	  this	  list	  correlates	  better	  with	   the	   cell	   proliferation	   rate	   rather	   than	  with	   the	   CIN	   tumor	   level	   102(J.M.	  Sheltzer	  2013	  Cancer	  Res).	  Finally,	   it	   is	   important	   to	   mention	   that	   the	   aneuploidy	   stress	   related	  transcripts	   are	   not	   found	   in	   all	   types	   of	   aneuploidy.	   In	   particular,	   when	  comparing	  highly	  aneuploidy	  breast	   tumor	  cells	  with	   (almost)	  diploid	  breast	  tumors,	   it	  has	  been	  observed	   that	   transcriptional	  patterns	  are	  different.	  This	  has	   led	   to	   the	   idea	   of	   two	   “types”	   of	   aneuploidy	   that	   are	   common	   to	   cancer	  cells.	  The	  first	  one	  is	  clonally	  selected	  and	  stable	  aneuploidy,	  which	  is	  present	  in	  the	  bulk	  of	  a	  tumor	  but	  arises	  due	  to	  the	  selective	  advantages	  that	  it	  gives.	  The	   second	   type	   is	   a	   spontaneous	   aneuploidy,	   resulting	   from	   chromosome	  mis-­‐segregation	  and	  decreasing	  cellular	  fitness,	  that	  changes	  continuously	  the	  karyotypes,	  102	  (J.M.	  Sheltzer	  2013	  Cancer	  Res).	  In	  this	  perspective,	  aneuploidy	  cannot	   always	   be	   deleterious	   for	   fitness,	   as	   some	   chromosome	   aberrations	  confer	  a	  proliferative	  advantage	  and	  then	  become	  predominant.	  Thus,	  tumors	  with	   a	   high	   grade	   of	   aneuploidy,	   like	   the	   ones	   investigated	   by	   Carter	   and	  Szallasi,	   could	   have	   acquired	   more	   growth-­‐promoting	   genetic	   alterations,	  explaining	  the	  tight	  link	  between	  CIN70	  and	  cell	  proliferation.	  	  2.3.3	  Proteotoxic	  stress	  Proteotoxic	  stress	  is	  another	  aspect	  of	  the	  aneuploidy-­‐associated	  stresses.	  Proteostasis	   is	   defined	   as	   a	   complex	   regulatory	   network	   that	   maintains	  cellular	   proteins	   functional	   and	   at	   the	   appropriate	   level	   103(Balch	  W.E.	   2008	  Science).	   This	   regulatory	   network	   is	   maintained	   by	   several	   processes:	   the	  chaperone-­‐mediated	   folding	  pathway	   is	   responsible	   of	   protein	   folding,	  while	  autophagy	  and	  the	  ubiquitin	  proteasome	  system	  make	  sure	  that	  the	  misfolded	  proteins	   are	   degraded	   104(Tyedmers	   J.	   2010	   Nat.	   Rev.	   Mol.	   Cell.).	  When	   this	  equilibrium	   is	   disturbed,	   unfolded	   and	  misfolded	   proteins	   accumulated	   and	  generate	   proteotoxic	   stress.	   In	   aneuploid	   cells	   the	   stoichiometry	   of	   protein	  complex	   subunits	   is	   altered.	   Every	   protein	   encoded	   by	   an	   unbalanced	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chromosome	   that	   functions	   in	   a	   protein	   complex	   and	   lacks	   its	   binding	  partner	  (or	  partners)	  risks	  to	  form	  aggregates	  and	  be	  insoluble.	  Thus,	  cellular	  chaperones	   and	  proteases	   have	   extra	  work	   to	   keep	   the	   unbalanced	  proteins	  soluble	   and	   eventually	   degrade	   them.	   Consistent	   with	   this	   idea,	   proteome	  analysis	  of	  disomic	  budding	  yeast	  revealed	  that	  most	  of	  the	  proteins	  scale	  with	  the	   gene	   dosage,	   and	   the	   those	   that	   do	   not	   are	   indeed	   subunits	   of	   protein	  complexes	   98,105,106(Stingele	   S.	  Mol	   Syst	  Miol	   2012)	   (Dephoure	  N	   eLife	   2014)	  (Torres	  E.M.	  Cell	  2010).	  This	  effect	   is	  even	  more	  pronounced	  in	  haploid	  cells	  as	  compared	  with	  diploid	  ones.	  Indeed,	  in	  haploid	  cells	  the	  addition	  of	  a	  single	  chromosome	   results	   in	   the	   doubling	   of	   gene	   expression,	   while	   in	   a	   diploid	  background	   the	   relative	   increase	   is	   only	   50%.	  Moreover,	   aneuploid	   budding	  yeast	   strains	   reveal	   an	   increased	   sensitivity	   to	   high	   temperature	   and	   to	  inhibitors	  of	  protein	  synthesis	  and	  folding,	  as	  well	  as	  to	  chemical	  and	  genetic	  perturbation	   of	   proteasomal	   degradation	   2,106(Torres	   2007	   Science)	   (Torres	  2010	  Cell).	  A	  recent	  study	  confirms	  that	  aneuploid	  strains	  are	  more	  prone	  to	  form	  proteins	  aggregates,	  most	   likely	  due	  to	  the	  defective	  heat	  shock	  protein	  90	  (HSP90)	  107(Oromendia	  A.B.	  Genes	  Dev	  2012).	  In	  line	  with	  these	  findings	  in	  yeast,	  aneuploidy	  in	  murine	  and	  human	  cells	  also	  showed	  profound	  changes	  in	  proteostasis.	   In	   particular,	   heat	   shock	   factor	   1	   (HSF1)	   transcription	   is	  compromised	   in	   the	   aneuploid	   colon	   cancer	   cells	   HCT116	   108(Donnelly	   N	  EMBO	   J	   2014).	   Moreover,	   human	   trisomic	   cells	   show	   an	   accumulation	   of	  cytoplasmic	   foci	   positive	   for	   ubiquitin	   and	   autophagy	   markers	   98(Stingele	   S	  Mol	  Syst	  Biol.2012).	   In	  agreement	  with	   this	   finding,	   chromosomally	  unstable	  aneuploid	   cancer	   cell	   lines	   are	   more	   sensitive	   to	   HSP90	   inhibition	   than	  chromosomally	   stable	   cell	   lines.	   Furthermore,	   primary	   trisomic	   MEFs	   are	  sensitive	   to	   chemical	   inhibition	   of	   the	   chaperone	   HSP90	   as	   well	   as	   to	   the	  inhibitor	  of	  autophagy	  chloroquine	  109(Tang	  et	  al,	  2011).	  Proteomic	  analyses	  in	  aneuploid	   human	   cells	   further	   revealed	   an	   altered	   metabolism	   and	   redox	  homeostasis.	  Even	  if	  the	  reason	  for	  this	  is	  not	  completely	  clear,	  results	  indicate	  that	  disruption	  of	  protein	  homeostasis	  may	  be	  responsible	  of	  the	  redox	  stress	  and	  the	  generation	  of	  reactive	  oxygen	  species	  (ROS),	  whose	  levels	  are	  indeed	  increased	  in	  aneuploid	  cells	  105(Dephoure	  eLife	  2014).	  	  To	  summarize,	  aneuploidy	  unbalances	  the	  expression	  of	  proteins	  encoded	  by	  the	  additional	  chromosomes	  and	  thus	  increases	  burden	  on	  protein	  quality	  control	   processes.	   This	   finding	   is	   potentially	   significant,	   because	   proteotoxic	  stress	  becomes	  an	  important	  target	  for	  cancer	  therapy	  and	  could	  represent	  a	  way	  to	  kill	  aneuploid	  cancers	  selectively.	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2.3.4	  Inhibition	  of	  cell	  proliferation	  	  Aneuploidy	   has	   been	   shown	   to	   be	   profoundly	   detrimental	   at	   both	   the	  cellular	   and	   organismal	   levels	   in	   all	   species	   investigated	   to	   date	   110(Gordon	  et	  al.,	  2012).	  One	  consequence	  of	  aneuploidy,	  originally	  observed	  in	  fibroblast	  from	  Down	   syndrome	  patients,	   is	   the	   inhibition	  of	   cell	   proliferation	   3,4(Segal	  and	  McCoy,	  1974)	   (Williams	  B.R.	  2008	  Science).	  This	  phenotype	   is	  now	  well	  described	   for	   different	   species,	   such	   as	   yeast	   2(Torres	   et	  al.,	   2007),	   where	  progenies	   from	   triploid	   meiosis	   delay	   in	   G1	   111(Niwa	   O	   2006	   Yast).	  Furthermore,	   experiments	   in	   mice,	   carrying	   an	   extra	   copy	   of	   one	   of	   four	  different	   chromosomes,	   revealed	   impaired	   proliferation	   independently	   from	  the	   identity	   of	   the	   extra	   chromosome	   3(Williams	   et	   al.,	   2008).	   Finally,	   in	  mammalian	  cells,	  mutations	  in	  spindle	  assembly	  checkpoint	  components,	  such	  as	  BubR1,	   lead	   to	   chromosome	  mis-­‐segregation,	   aneuploidy	   and	   a	   variety	   of	  features	   such	   as	   proliferation	   defects	   21(Baker	   D.J.	   2004	   Nature	   Genetics).	  Notably,	  however,	  not	  all	  mutations	  that	  cause	  mis-­‐segregation	  lead	  to	  defects	  in	   proliferation	   15,20(Weaver	   B.A.	   2007	   Cancer	   Cell)	   (Babu	   J.R.	   J.	   Cell	   Biol.	  2003).	  This	  could	  be	  explained	  by	  the	  fact	  that	  the	  percentage	  of	  cells	  showing	  mis-­‐segregation	  events	  is	  low,	  and	  so	  the	  proliferation	  defects	  could	  be	  missed	  in	  the	  total	  population.	  A	  fundamental	  question	  regards	  the	  reason	  why	  aneuploidy	  would	  cause	  proliferation	   defects.	   One	   possible	   explanation	   could	   be	   that	   copy	   number	  changes	  of	  few	  deleterious	  genes,	  or the cooperation of many	  genes	  that	  cause	  no	   growth	   defects	   if	   altered	   alone,	   could	   be	   responsible.	   The	   most	   likely	  answer	   is	   that	   a	   mixture	   of	   both	   situations	   causes	   proliferation	   defects.	  Moreover,	   the	  proliferative	  disadvantage	  might	  be	  explained	   in	   several	  ways	  since,	   as	   just	   described	   in	   the	   previous	   sections,	   aneuploid	   cells	   exhibit	   a	  variety	   of	   stress-­‐related	  phenotypes	   (DNA	  damage,	   transcriptional	   response,	  proteotoxic	  stresses)	  109(Y.C.	  Tang	  Cell	  2011). 2.3.5	  Chromosome	  mis-­‐segregation	  and	  p53	  response	  It	   has	   been	   shown	   that	   chromosome	   mis-­‐segregation	   leads	   to	   p53	  activation	  and	  cell	  cycle	  arrest	  in	  G1;	  moreover	  in	  human	  cells	  the	  deletion	  of	  p53	  leads	  to	  the	  accumulation	  of	  non-­‐diploid	  cells	  26(Thompson	  S	  &	  Compton	  D.A.	   J.Cell	   Biol.	   2010).	   Similar	   effects	   were	   observed	   in	   vivo.	   Mutant	   mice	  lacking	   MAD2	   are	   embryonic	   lethal,	   similarly	   the	   derived	   blastocysts	   die	   in	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culture	   after	   a	   short	   time.	   But	   when	   p53	   is	   deleted,	   blastocysts	   manage	   to	  survive	  for	  several	  weeks	  112(Burds	  A.A.	  Proc	  Natl	  Acad	  Sci	  2005).	  To	  date,	  the	  reason	   why	   chromosome	   mis-­‐segregation	   leads	   to	   p53	   activation	   and	   cell	  cycle	   arrest	   is	   not	   fully	   understood.	   It	   has	   been	   proposed	   that	   DNA	   damage	  might	  be	  an	  upstream	  activator	  of	   the	  p53	  pathway.	   In	   this	  scenario,	   lagging	  chromosomes,	  frequently	  produced	  during	  mitosis	  of	  aneuploidy	  cells,	  can	  be	  damaged	  during	  cytokinesis	  by	  cleavage	  furrow	  91(Janssen	  et	  al.,	  2011)	  or	  can	  be	   exposed	   to	   conflicting	   forces	   generated	   by	   microtubules	   from	   multiple	  poles	   and	   finally	   form	  DNA	   double-­‐strand	   breaks	   (DSBs)	   113(Guerrero	   et	   al.,	  2010).	   Alternatively,	   other	   studies	   point	   towards	   the	   increase	   of	   ROS	   after	  mis-­‐segregation	  as	  a	  cause	  of	  p53	  arrest.	   In	  this	  case,	  the	  elevated	  amount	  of	  ROS	  causes	  an	  activation	  of	  the	  DNA	  damage	  checkpoint,	  dependent	  on	  ataxia-­‐telangiectasia	  mutated	  (ATM)	  and	  p53	  114(Li	  M.	  2010	  Proc.	  Natl.	  Acad.	  Sci.).	  Interestingly,	   some	   recent	   studies	   proposed	   that	   not	   all	   types	   of	   mis-­‐segregation	   induce	   p53	   dependent	   cell	   cycle	   arrest	   85,86(Soto	   M.	   2017	   Cell	  Reports)	   (S.	   Santaguida	   Cell	   Dev	   2017).	   In	   particular,	   a	   clear	   distinction	   has	  been	   proposed	   between	   cells	   presenting	   structural	   aneuploidy,	   and	   those	  displaying	   a	   whole	   numerical	   aneuploidy.	   RPE1	   cells,	   presenting	   structural	  aneuploidy	  (induced	  by	  Mps1	  inhibition),	  continued	  to	  proliferate	  only	  in	  p53	  deficient	   background	   even	   after	  mis-­‐segregation	   events.	   Contrarily,	   in	  whole	  aneuploidy	  (obtained	  by	  combining	  a	  low	  dose	  of	  Mps1	  inhibitor	  with	  CENPF	  inhibition),	   at	   least	   a	   fraction	   of	   cells	   continued	   to	   proliferate	   also	   in	   a	   p53	  proficient	   genetic	   background.	   This	   would	   suggest	   that	   the	   degree	   of	  aneuploidy	   is	   an	   important	   determinant	   factor:	   mild	   whole-­‐chromosome	  aneuploidies	   can	   be	   tolerated	   and	   propagated	   even	   in	   a	   p53	   proficient	  background.	  A	  parallel	  study	  confirms	  that	  cells	  with	  complex	  karyotypes	  do	  not	   proliferate	   anymore,	   and	   instead	   increase	   p53	   levels	   and	   senescence	  markers.	   Moreover,	   these	   non-­‐proliferating	   cells	   with	   complex	   karyotypes	  show	  an	   increase	   in	  a	  pro-­‐inflammatory	  gene	  expression	  profile,	   such	  as	   the	  phosphorylation	   of	   STAT3	   and	   the	   secretion	   of	   interleukin.	   Together,	   these	  findings	   indicate	   that	   aneuploid	   p53	   arrested	   cells	   could	   elicit	   an	   immune	  response	  86,115(S.	  Santaguida	  Dev	  Cell	  2017)	  (Karen	  J	  Mackenzie	  Nature	  2017).	  To	  date	  the	  prevailing	  thinking	  is	  that	  the	  aneuploid	  state	  per	  se	  does	  not	  lead	   to	   p53	   activation	   and	   G1	   arrest,	   whereas	   events	   associated	   with	  chromosome	  mis-­‐segregation	  such	  as	  DNA	  damage	  and	  aneuploidy-­‐associated	  stresses	  do.	  Thus,	  p53	  activation	  is	  a	  potential	  but	  not	  an	  obligatory	  outcome	  of	  aneuploidy.	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2.4	  Ambivalent	  role	  of	  aneuploidy	  in	  transformation	  2.4.1.	  Aneuploidy	  in	  cancer	  	  The	  presence	  of	   aneuploidy	   in	   cancer	   it	   has	  been	  observed	   since	   a	   long	  time	  ago	   1(Boveri	  T	  1902,	  Boveri	  T.	  1014).	  Around	  90%	  of	   solid	   tumors	  and	  50%	  of	  blood	  cancers	  present	  aneuploidy	  116(Mitelman	  F.	  2014	  Chromosomes)	  (Beroukhim	   R.	   Nature	   2010).	   This	   notwithstanding,	   the	   relation	   between	  aneuploidy	  and	  cancer	  has	  not	  yet	  been	  fully	  clarified,	  and	  whether	  aneuploidy	  is	   a	   consequence	   or	   a	   cause	   of	   tumorigenesis	   is	   still	   debated.	   It	   has	   been	  shown,	   in	   different	   organisms,	   that	   aneuploidy	   could	   sometimes	   fuel	   CIN	  117,118(Storchova	  Z,	  et	  al.	  2006	  Nature)	  (Li	  R.	  et	  al	  1997	  Proc	  Natl	  Acad	  Sci	  U	  S	  A).	  Moreover,	   it	  has	  been	  shown	  in	  human	  cells	   that	   the	  presence	  of	  a	  single	  extra	   chromosome	   appears	   to	   be	   sufficient	   to	   initiate	   chromosome	   mis-­‐segregation	  events	  119,120(Nicholson,	  et	  al.	  2015)	  (Passerini,	  et	  al.	  2016).	  On	  the	  other	  hand,	  as	  mentioned	   in	   the	  previous	  section,	   induction	  of	  aneuploidy	   in	  diploid	   systems	   can	   lead	   to	   multiple	   cellular	   changes,	   including	   cell	   cycle	  arrest	  121(Santaguida	  and	  Amon	  2015).	  Thus,	  it	  becomes	  more	  and	  more	  clear	  that	   aneuploidy	   can	   both	   promote	   and	   inhibit	   tumorigenesis.	   For	   example,	  patient	   from	   Down	   syndrome	   have	   less	   chances	   to	   develop	   solid	   tumors	  compared	  with	   the	   rest	  of	  diploid	  population	   122(Hasle	  H.	  2001	  Nature),	   and	  mice	  carrying	  chromosome	  16	  in	  three	  copies	  are	  resistant	  to	  cancer-­‐inducing	  APC	  mutations	  123(Sussan	  T	  2008	  Nature).	  Contrarily,	  a	  different	  trisomy	  8	  has	  been	   frequently	   found	   in	   a	  high	  percentage	  of	   chronic	   and	  acute	   leukaemias	  124(Paulsson	  K.	  Path.	  Biol	  2007).	  Adding	   another	   level	   of	   complexity	   in	   the	   relation	   between	   aneuploidy	  and	   tumorigenesis,	   is	   CIN.	   Cancer	   cells	   are	   also	   often	   associated	   with	   CIN,	  which	  involves	  loss	  or	  rearrangement	  of	  partial	  or	  entire	  chromosomes	  during	  cell	   division,	   resulting	   in	   even	   further	   whole	   and	   structural	   aneuploidy	  7,125(Lengauer,	   et	   al.	   1998)	   (McGranahan,	   et	   al.	   2012).	   Again,	   the	   positive	   or	  negative	   contribution	   of	   CIN	   to	   tumorigenesis	   is	   still	   discussed.	   The	   best	  example	   of	   this	   dual	   nature	   of	   CIN	   in	   cancer	   development	   is	   CENPE.	   As	  discussed	   before,	   CENPE	   is	   a	   motor	   protein	   that	   participates	   in	  making/maintaining	  the	  kinetochore-­‐microtubule	  attachment.	  When	  CENPE	  is	  reduced	  by	  50%	  in	  heterozygous	  MEFs,	  aneuploidy	  and	  mis-­‐segregations	  are	  increased,	  as	  is	  the	  apparition	  of	  spontaneous	  lung	  tumors	  in	  vivo.	  However,	  at	  the	   same	   time,	   mice	   are	   less	   prone	   to	   develop	   liver	   tumors	   and	   chemically	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induced	   tumors	   15(Weaver	   B.A.A.	   Cancer	   cell	   2007).	   These	   findings	   indicate	  that	  low	  rates	  of	  chromosome	  mis-­‐segregation	  can	  promote	  tumorigenesis	  by	  increasing	  the	  odds	  to	  generate	  a	  tumor-­‐promoting	  karyotype.	  However,	  when	  chromosome	   mis-­‐segregation	   is	   too	   high,	   tumor	   cells	   cannot	   sustain	   such	  tumorigenesis-­‐promoting	   karyotypes.	   Finally,	   in	   a	   CIN	   genetic	   background,	  unviable	  karyotypes	  are	  constantly	  generated	  and	  those	  lead	  to	  cell	  death	  and	  eventually	  tumor	  suppression.	  	  Positive	   or	   negative	   contributions	   of	   CIN	   represent	   also	   a	   clinical	  problem.	  It	  has	  been	  proposed	  that	  instability	  can	  predict	  the	  drug	  resistance	  and	   poor	   prognosis	   126-­‐128(Swanton	   C.	   2009)	   (Jamal	   Hanjani	   2017	   N	   Engl	   J	  Med)	   (Murugaesu	   2015	   Cancer	   Discov).	   Tumors	   that	   show	   chromosomal	  instability	  are	  more	  resistant	  to	  cancer	  drugs,	  thus	  more	  difficult	  to	  treat.	  For	  example,	  cells	  derived	  from	  tumors,	  or	  after	  Mad1	  deregulation,	  show	  CIN	  and	  are	   more	   resistant	   to	   chemotherapy	   26,129(Thompson	   and	   Compton	   2010)	  (Rutledge	   2016	   Sci	   Rep).	   Several	   reasons	   have	   been	   indicated	   behind	   the	  increase	  of	  drugs	  resistance.	  In	  particular,	  it	  has	  been	  proposed	  that	  cells	  could	  acquire	  resistance	  due	  to	  the	  massive	  genomic	  variation	  caused	  by	  CIN.	  There	  is	   also	   evidence	   that	   chromosomal	   instability	   can	   act	   as	   an	   adaptive	  mechanism	  to	  allow	  cancer	  cells	  to	  survive	  during	  periods	  of	  stress,	  promoting	  advantageous	   karyotypes.	   In	   this	   model	   CIN	   can	   lead	   to	   intra-­‐tumor	  heterogeneity	   that	   upon	   selective	   pressure	   like	   cancer	   therapy,	   promote	   the	  ‘ideal’	   genetic	   configuration	   to	   survive	   26,129(Thompson	   and	   Compton	   2010)	  (Rutledge	   2016	   Sci	   Rep).	   At	   the	   same	   time,	   as	   already	   presented,	   CIN	   and	  aneuploidy	  can	  have	  a	  negative	  impact	  on	  cellular	  fitness.	  In	  particular,	  some	  studies	  analyzed	   the	  CIN70	  gene	  expression	  signature	   9(Carter	  SL.	  Nat	  Genet	  2006)	   in	  relation	  with	  tumor	  outcome,	  proposing	  the	   interesting	  finding	  that	  extreme	   levels	   of	   CIN70	   signature	   are	   associated	   with	   better	   outcomes,	  compared	   with	   tumors	   with	   intermediate	   CIN70	   scores	   130(Birbak	   NJ	   2011	  Cancer	  Res).	  However,	  in	  the	  same	  study,	  examples	  of	  ovarian,	  gastric	  and	  lung	  cancers	   showing	   an	   intermediate	   level	   of	   CIN70	   expression,	   presented	   the	  poorest	   outcome,	   suggesting	   a	   non-­‐linear	   relation	   between	   survival	   and	  presence	  of	  instability	  130(Birbak	  NJ	  2011	  Cancer	  Res).	  These	  studies	  open	  more	  unresolved	  questions.	  For	  example,	  what	  is	  the	  action	  of	  CIN	  during	   tumor	  evolution?	  Does	   it	  act	  constantly	  or	   just	  during	  a	  short	  period/window	  of	  time.	  Moreover,	   is	  CIN	  increased	  upon	  specific	  types	  of	   cancer	   therapy?	   Answering	   these	   questions	   could	   potentially	   help	   cancer	  treatment	  by	  finding	  the	  weak	  points	  of	  chromosomally	  instable	  cells	  and	  thus	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providing	  information	  for	  the	  drug	  discovery	  process.	  This	  could	  also	  provide	  inputs	   for	   the	   development	   of	   personalized	   and	   targeted	   therapies,	  with	   the	  aim	   to	  avoid	   the	   rapid	  adaptation	  of	   tumors	  after	   treatments	  and	  eventually	  further	  relapses.	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3.	  Introduction	  Aneuploidy	   is	   detrimental	   in	   embryonic	   cells,	   interfering	   with	   cell	  proliferation	   and	   cell	   fitness;	   on	   the	   other	   hand,	   it	   is	   an	   almost	   universal	  feature	   in	   cancer	   cells.	  Moreover,	   aneuploidy	  often	   correlates	   in	   cancer	  with	  the	  presence	  of	  CIN,	  defined	  as	  dynamic	  changes	  in	  chromosome	  number	  and	  structure	   during	   cell	   propagation.	   Mechanisms	   that	   lead	   to	   CIN	   have	   been	  studied,	  but	   the	   link	  between	  aneuploidy,	  CIN,	  and	  tumorigenesis	  remains	   to	  be	   fully	   understood.	   In	   particular,	   the	   question	   of	   whether	   aneuploidy	   is	   a	  cause	  or	  consequence	  of	  the	  transformation	  process	  is	  still	  without	  definitive	  answer.	  The	  aim	  of	  my	  study	  was	  to	  find	  a	  proteomic	  and/or	  phospho-­‐proteomic	  signature	   associated	   with	   CIN,	   in	   order	   to	   begin	   dissecting	   the	   deregulated	  processes	   and	  pathways	   that	  make	   cells	   tolerant	   to	   aberrant	   karyotypes.	   To	  pursue	  this	  goal	  I	  performed	  the	  following	  steps:	  1. Generation	   of	   cell	   lines	   carrying	   various	   karyotypic	   states	   that	   have	   the	  same	  parental	  source.	  These	  lines	  included:	  
• diploid	  (microsatellite	  instable)	  colon	  cancer	  cell	  line	  DLD-­‐1	  
• derived	  tetraploid	  line,	  obtained	  by	  inhibition	  of	  cytokinesis;	  
• spontaneously	   derived	   post-­‐tetraploid	   aneuploidy	   single	   clones	  (PTAs)	  with	  a	  near-­‐triploid	  or	  hyper-­‐triploid	  ploidy	  content;	  
• cell	   lines	   carrying	   a	   single	   extra	   chromosome	   (chromosome	   7),	  generated	  by	  microcell	  fusion.	  2. Cell	  biology	  characterization,	  including:	  
• confirmation	  of	  chromosome	  and	  ploidy	  content;	  
• determination	   of	   chromosome	   segregation	   fidelity	   and	   rate	   of	  instability.	  3. Comparison	  of	  protein	  expression,	  applying	  a	  state-­‐of-­‐art	  quantitative	  mass	  spectrometry	   technique	   Tandem	   Mass	   Tag	   labeling	   (TMT)	   to	   identify	  deregulated	   cellular	   processes	   or	   pathways	   in	   DLD-­‐1	   derived	   cells	   of	  different	  ploidy	  states.	  4. Comparative	   phospho-­‐proteomic	   analysis	   by	   phospho-­‐enrichment	   mass	  spec	  analysis	  in	  DLD-­‐1	  derived	  cells	  of	  different	  ploidy	  states.	  5. Determination	   of	   sensitivity	   of	   the	   DLD-­‐1	   derived	   cell	   lines	   to	   a	   panel	   of	  mitotic	  anti-­‐cancer	  drugs.	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With	   this	   study	   I	   was	   hoping	   to	   shed	   some	   light	   on	   the	   changes	   in	   cellular	  processes	   and	  pathways	   that	   lay	   behind	   the	  presence	   of	   aneuploidy	   and	   the	  rising	  of	  CIN.	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4.	  Results	  	  
4.1.	   Establishment	   of	   DLD-­‐1-­‐derived	   cell	   lines	   harboring	  
various	  levels	  of	  ploidy	  and	  aneuploidy	  The	   current	   proteomics	   study	   aims	   to	   clarify	   events	   responsible	   for	  and/or	  associated	  with	  CIN,	  as	  well	  to	  provide	  information	  about	  proteins	  and	  pathways	   potentially	   conferring	   tolerance	   to	   CIN.	   The	   identification	   of	  deregulated	   pathways	   in	   different	   cancer	   cell	   lines	   associated	   with	   CIN	   is	  difficult	   due	   to	   the	   continuous	   karyotypic	   reshuffling	   and	   the	   high	   inter-­‐line	  variation	   caused	   by	   clonal,	   tissue	   origin	   or	   cancer	   type	   differences	  131,132(Rebecca	   R.	   Beach	   Cell	   2017)(McGranahan	   N	   Cell	   2017).	   Using	  multiplexed	   tandem	   mass	   tag	   (TMT)	   labeling,	   I	   nevertheless	   tested	   if	   the	  quantification	   of	   relative	   protein	   levels	   in	   a	   well-­‐described	   panel	   of	  karyotypically	   stable	   and	   unstable	   human	   adenocarcinoma	   cell	   lines	   (Fig.	   8)	  28(Gascoigne	  KE,	  Taylor	  S.	  Cancer	  Cell	  2008)	  would	  allow	  to	  discriminate	  the	  two	  groups	  based	  on	  proteome	  data.	  	  
	  
Figure	  8:	  Table	  listing	  ploidy	  and	  chromosome	  numbers	  for	  8	  human	  cancer	  cell	  lines	  used	  in	   the	   pilot	   experiment,	   including	   diploid	   telomerase-­‐immortalized	   (hTERT)	   RPE1	   cells,	  diploid	   microsatellite	   instable	   (MIN)	   and	   aneuploid	   chromosomally	   instable	   (CIN)	   cells.	  Chromosome	  counts	  were	  obtained	  from	  the	  American	  Tissue	  Culture	  Consortium	  (ATCC).	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I	  found	  the	  differences	  in	  global	  protein	  expression	  between	  cell	  lines	  to	  be	  too	  profound	  to	  distinguish	  between	  karyotypically	  stable	  und	  unstable	  cell	  lines,	  since	  hierarchical	   cluster	  analysis	  did	  not	  group	   the	  cell	   lines	  based	  on	   their	  karyotypic	  stability	  (Fig.	  9).	  
	  
Figure	  9:	  Hierarchical	  clustering	  based	  on	  the	  LC-­‐MS/MS	  results	  for	  the	  cell	  lines	  listed	  in	  table	  8	  using	  the	  tandem	  mass	  tag	  (TMT)-­‐labeling	  approach.	  The	  vertical	  dimension	  depicts	  ~7.500	   proteins	   detected	   in	   the	   indicated	   cell	   lines.	   The	   heat	   map	   shows	   the	   degree	   of	  deregulation	  versus	  the	  diploid	  control	  cell	  line	  hTERT-­‐RPE1.	  	   Thus,	   in	  order	   to	   reduce	   inter-­‐line	  variation	  due	   to	   tissue	  origin,	   cancer	  type	   or	   clonal	   variation,	   I	   decided	   to	   generate	   cell	   lines	   carrying	   various	  karyotypic	   states	   that	   have	   the	   same	   parental	   genetic	   source.	   By	   comparing	  chromosomally	   stable	   diploid,	   tetraploid	   and	   trisomic	   cells	   with	  chromosomally	   unstable	   aneuploid	   cells,	   I	   aimed	   at	   dissecting	   the	   effects	   of	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chromosome	  mass	  gains	  from	  the	  influence	  of	  chromosomal	  instablility	  (CIN)	  (Fig.	  10).	  	  	  
	  	  
Figure	   10:	   Schematic	   showing	   the	   approach	   to	   human	   DLD-­‐1	   colon	   cancer	   cell	   line	  generation	   and	   analysis.	   From	  a	   diploid	   (2N)	   parental	   culture,	   tetraploid	   (4N)	   cells	  were	  obtained	  by	  inhibition	  of	  cytokinesis.	  These	  were	  then	  used	  for	  the	  clonal	  isolation	  of	  post-­‐tetraploid	   aneuploid	   (PTAs)	   descendants.	   Clones	   harboring	   trisomies	   of	   chromosome	   7	  (Tr7)	  were	  generated	  from	  the	  diploid	  parental	  culture	  by	  microcell	  fusion.	  	  	   I	  used	  the	  microsatellite	  instable	  (MIN)	  diploid	  colon	  cancer	  cell	  line	  DLD-­‐1,	  which	  has	  been	  described	  to	  remain	  viable	  after	  chromosomal	  gains	  due	  to	  its	  p53	  deficiency	  7(Lengnauer,	  Nature	  1997).	  As	  discussed	  in	  the	  introduction,	  aneuploidy	   is	   often	   preceded	   by	   tetraploidy	   in	   early	   stage	   cancers,	   which	  correlates	   with	   the	   loss	   of	   p53	   functionality	   26,57,133(Galipeau	   et	   al.,	   1996)	  (Thompson	   S	  &	   Compton	  D.A.	   J.Cell	   Biol.	   2010)	   (Ganem	  Neil	   J	   2007	   Current	  opinion	  in	  Genetics	  &	  development).	  It	   is	  believed	  that	  a	  polyploid	  karyotype	  provides	  a	  protective	  buffer	  against	  gene	   loss	  or	  haploinsufficiency	  and	   thus	  offers	  a	  breeding	  ground	  for	  spontaneously	  arising	  aneuploid	  clones	  76,77(Aleza	  et	  al	  2011)	  (M.Kellis	  Nature	  2004).	  I	  made	  use	  of	  a	  culture	  of	  tetraploid	  DLD-­‐1	  cells	  that	  was	  previously	  generated	  through	  inhibition	  of	  cytokinesis,	  obtained	  by	  the	  actin	  inhibitor	  dihydro-­‐cytochalasin	  B	  (DCB).	  This	  cell	   line	  was	  shown	  to	   have	   largely	   lost	   super-­‐numerary	   centrosomes	   63(Drosopoulos	   et	   al	   Nat.	  Comms	   2014),	   thus	   providing	   a	   stable	   reference	   line	   for	   polyploidy	   and	   a	  
	   38	  
potential	  source	  for	  aneuploid	  descendants.	  Next,	  I	  performed	  single	  cell	  FACS	  sorting	   from	   this	   tetraploid	   culture	   to	   select	   for	   spontaneously	   arisen	  aneuploid	   cells	   showing	   a	   DNA	   content	   shift,	   hereafter	   referred	   to	   as	   post-­‐tetraploid	  aneuploid	  cells	  (PTAs).	  After	  almost	  one	  month	  of	  clonal	  expansion	  I	  obtained	  4	   clones,	   presenting	   near	   triploid	   and	  near-­‐tetraploid	  DNA	   content	  (Fig.	  11).	  These	  4	  lines	  are	  considered	  to	  represent	  highly	  complex	  aneuploidy	  states.	  	  	  
	  	  
Figure	  11:	  Histograms	  represent	  flow	  cytometric	  results	  the	  cell	  lines	  generated	  and	  used	  in	  this	  study.	  Cells	  were	  stained	  with	  propidium	  iodine	  to	  verify	  DNA	  content.	  Dotted	  lines	  indicate	  G1	  and	  G2/M	  peaks	  expected	  for	  a	  diploid	  culture.	  	  	  I	   also	   sought	   to	   generate	   a	   cell	   line	   with	   a	   defined	   chromosome	   gain	   that	  would	  serve	  as	  a	  control	  for	  low-­‐complexity	  and	  defined	  aneuploidy.	  Thus,	  in	  collaboration	   with	   Dr.	   Zuzana	   Storchova’s	   laboratory	   at	   the	   Max-­‐Planck	  institute	   for	   Biochemistry	   in	   Martinsried	   (DE),	   I	   applied	  microcell-­‐mediated	  chromosome	  transfer	  to	  the	  diploid	  parental	  DLD-­‐1	  120(Passerini	  V.	  et	  al	  Nat.	  Comms	  2016),	  in	  order	  to	  obtain	  trisomic	  clones	  (Fig.	  12).	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Figure	  12:	  Microcell	  Fusion	  workflow.	  Adapted	  from	  98Stingele	  S.	  et	  al.	  2012	  Mol	  Syst	  Biol.	  Micronucleation	   was	   induced	   in	   mouse	   A9(Neo5)	   donor	   cells,	   containing	   an	   additional	  human	   chromosome	   with	   an	   antibiotic	   resistance	   gene,	   through	   colchicine.	   Micronuclei	  were	   separated	   by	   several	   centrifugation	   and	   filtration	   steps	   and	   then	   added	   to	   the	  recipient	  cell	  line.	  	  I	  had	  originally	  planned	  to	  generate	  clones	  carrying	  chromosomes	  4,	  7	  and	  21	  in	  three	  copies	  (Tr	  4,	  Tr	  7	  &	  Tr	  21),	  but	  few	  single	  clones	  survived	  the	  double	  antibiotics	   selection	   and	   chromosome	   painting	   often	   revealed	   only	   partial	  trisomies.	   (Most	   likely,	   the	   chromosome	   part	   integrated	   into	   recipient	   cells	  contained	  the	  antibiotic	  resistance,	  thus	  allowing	  these	  cells	  to	  survive	  with	  a	  partial	  trisomy).	  Importantly,	  however,	  two	  viable	  clones	  carrying	  trisomies	  of	  chromosome	  7	  (Tr	  7)	  were	  obtained	  successfully	  (Fig.	  11	  and	  13).	  For	   all	   generated	   cell	   lines	   (diploid,	   tetraploid,	   PTAs	   and	   Tr	   7),	   DNA	  content	  was	  confirmed	  by	  chromosome	  counting	  and	  chromosome	  painting	  in	  spread	   cells	   (Fig.	   13	   upper	   and	   lower	   panels).	   While	   the	   parental	   cell	   line	  presents	   typical	   diploid	   DNA	   content,	   the	   derived	   tetraploid	   cells	   show	   the	  double	  amount	  of	  chromosomes,	  PTAs	  show	  mainly	  a	  triploid	  karyotype	  and,	  finally,	  Tr	  7	  clones	  show	  a	  chromosome	  number	   that	   resembles	   the	  parental	  one	  (Fig.	  13	  upper	  panel).	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Figure	   13:	   Upper	   panel:	   micrographs	   depict	   mitotic	   spreads	   of	   indicated	   cell	   lines;	  chromosomes	  were	  stained	  with	  DAPI.	  The	  dot	  plot	  panel	  shows	  chromosome	  numbers	  for	  each	  cell	   line;	  bars	  represent	  mean	  values,	  numbers	  refer	  to	  counted	  cells.	  Data	  represent	  results	   from	   three	   biological	   replicates.	   Lower	   panel:	   whole	   FISH	   in	   diploid,	   tetraploid,	  PTAs	   and	   Tr7	   clones.	   Cells	   were	   stained	   for	   chromosome	   3	   and	   4	   in	   2N,	   4N	   and	   PTAs;	  stainings	  for	  chromosomes	  5	  and	  7	  were	  performed	  in	  Tr7	  clones.	  Below	  histograms	  show	  chromosome	  numbers	   for	  each	  cell	   line,	  and	  the	  color	  code	  represents	  chromosome	  copy	  numbers	  (as	  indicated).	  Values	  were	  normalized	  for	  the	  number	  of	  counted	  cells	  (n).	  	  	  Chromosome	  painting	   further	   confirm	   the	   chromosome	   copy	   numbers	   in	   all	  the	   cell	   lines	   (Fig.	   13	   lower	   panel).	   In	   particular,	   diploid	   culture	   reveal	   two	  copies	  for	  the	  two	  investigated	  chromosomes	  (Chromosome	  3	  in	  green	  and	  4	  in	  red).	  Around	  80%	  of	  tetraploid	  cells	  show	  4	  copies	  of	  the	  above	  mentioned	  chromosomes.	  Notably,	  the	  PTA	  clones	  present	  high	  intra-­‐cell	   line	  variability,	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which	   is	   in	   line	  with	   the	   presence	   of	   aneuploidy	   and	   instability.	   Specifically,	  PTA2	   and	   PTA4	   show	   extensive	   intra-­‐line	   variation,	   with	   cells	   presenting	   4	  copies	   of	   chromosome	  4	   or	   3,	   but	   also	   a	   high	   percentage	   of	   cells	   showing	   3	  copies	   of	   the	   same	   chromosomes.	   Very	   nicely,	   PTA1	   and	   PTA3	   show	   a	  reduction	  of	   chromosome	  3	   and	  4	   respectively,	   in	   line	  with	   a	   corresponding	  reduction	  revealed	  by	  array	  chromosome	  genomic	  hybridization	  (aCGH)	  (Fig.	  20).	  Finally	  90%	  of	  trisomic	  clones	  reveal	  3	  copies	  of	  chromosome	  7	  and	  only	  2	  copies	  of	  the	  control	  chromosome	  5,	  as	  expected.	  In	   conclusion,	   I	   successfully	   created	   cell	   lines	   with	   different	   karyotype	  and	  stability	  states,	  setting	  the	  stage	  for	  proteomic	  studies	  aimed	  at	  identifying	  pathways	  that	  are	  deregulated	  by	  changes	  in	  karyotypes	  and	  CIN.	  
4.2.	   Analysis	   of	   chromosome	   segregation	   fidelity,	   mitotic	  
duration	  and	  cell	  fate	  in	  DLD-­‐1	  derived	  cells	  	  I	   next	   verified	   the	   occurrence	   of	   chromosomal	   instability	   in	   post-­‐tetraploid	  and	  trisomic	  cells	  by	  microscopy.	  As	  discussed	  in	  the	  introduction,	  formation	  of	  micronuclei,	  anaphase	  bridges	  and	  lagging	  chromosomes,	  and	  as	  well	   multipolar	   spindle,	   are	   signs	   of	   a	   chromosome	   instability	   phenotype.	  When	   compared	   to	   the	   diploid	   culture,	   the	   rates	   of	   chromosomal	   mis-­‐segregation	   and	   micronuclei	   formation	   were	   significantly	   elevated	   in	   most	  PTA	  clones,	  but	  not	  in	  the	  tetraploid	  parent-­‐culture	  nor	  in	  the	  trisomic	  clones	  (Fig.	  14).	  Specifically,	  in	  PTAs	  the	  percentage	  of	  anaphase	  bridges,	  multipolar	  spindles,	  lagging	  chromosomes	  and	  micronuclei	  increased	  up	  to	  25%.	  Notably	  in	  trisomic	  clones	  I	  observed	  a	  trend	  towards	  similar	  increases,	  but	  these	  were	  not	  significant	  and	  accompanied	  by	  high	  standard	  deviations.	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Figure	   14:	  Top	  panel:	   representative	   images	  of	   chromosome	  mis-­‐segregation	  events	   and	  micronucleation.	   Lower	   panel:	   histograms	   showing	   the	   frequency	   of	   chromosome	   mis-­‐segregation	   events	   and	   micronucleation	   observed	   in	   the	   indicated	   cell	   lines.	   Scale	   bar	  represents	   5	   μm.	   All	   fixed	   cells	   were	   stained	   with	   DAPI.	   Error	   bars	   indicate	   standard	  deviation	  (SD),	  numbers	  refer	  to	  counted	  cells.	  Data	  represent	  results	  from	  three	  biological	  replicates.	  Two-­‐tailed	  t-­‐test:	  *P<0.05,	  **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	  	  	  In	   agreement	  with	   the	   presence	   of	   a	   CIN	   phenotype,	   I	   observed	   an	   increase	  also	   of	   structural	   aberrations	   in	   post-­‐tetraploid	   clones	   and,	   in	   line	   with	   a	  previous	  report	  120(Passerini	  V.	  et	  al	  Nat.	  Comms	  2016),	  in	  trisomic	  clones	  as	  well.	   Specifically,	   I	   observed	   increases	   of	   chromosome	   arm	   breaks	   and	  chromosome	  constrictions.	   In	   contrast,	   frequencies	  of	   such	  aberrations	  were	  low	  in	  diploid	  and	  tetraploid	  cultures	  (Fig.	  15).	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Figure	   15:	  Micrographs	  show	  mitotic	  spreads	  prepared	   from	  the	   indicated	  cell	   lines,	  and	  arrows	  point	  at	  structural	  chromosome	  aberrations	  depicted	  in	  inlays.	  Scale	  bar	  represents	  10	  µm.	  Right	  panel:	  histogram	  shows	  the	  frequency	  of	  chromosome	  structural	  aberrations	  observed	  for	  the	  indicated	  cell	  lines.	  Error	  bars	  indicate	  standard	  deviation	  (SD),	  numbers	  refer	   to	  counted	  cells.	  Data	   represent	   results	   from	  two	  biological	   replicates.	  Two-­‐tailed	   t-­‐test:	  *P<0.05,	  **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	  	  	   From	   these	   results	   I	   conclude	   that	   PTAs	   present	   different	   types	   of	  aneuploidy:	  whole	   chromosome	   aberrations	   (Fig.	   13	   and	   Fig.	   20),	   as	  well	   as	  structural	   aberrations	   (Fig.	   15).	   In	   principle,	   both	   could	   contribute	   to	   the	  observed	   increase	   of	   an	   instability	   phenotype.	   Together,	   these	   findings	  support	   the	   notion	   that	   the	   unbalanced	   gain	   of	   chromosomes	   leads	   to	   an	  increase	   in	   chromosome	   segregation	   stress	   and/or	   genetic	   instability	  120,134(Passerini	  V.	  et	  al	  2016	  Cell	  Cycle)	  (Dodgson	  SE	  et	  al	  2016	  Genetics).	  In	  order	  to	  see	  if	  any	  other	  signs	  of	  instability	  were	  present	  in	  PTAs	  I	  thus	  decided	  to	  also	  investigate	  the	  presence	  of	  alterations	  in	  spindle	  morphology.	  However,	  mitotic	  spindle	  angle,	  which	  was	  considered	  an	  indicator	  of	  proper	  spindle	  geometry,	  was	  not	  significantly	  altered	   in	  either	  of	   the	  cell	   lines	  (Fig.	  16).	   However,	   tetraploid	   and	   PTAs	   cultures	   presented	   a	   bigger	   spindle	  apparatus,	   represented	   by	   the	   increased	   width	   and	   length,	   most	   likely	  reflecting	  the	  fact	  that	  these	  cells	  have	  to	  deal	  with	  an	  substantical	  increase	  in	  chromosome	  mass.	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Figure	   16:	   Upper	   panel,	   representative	   α-­‐tubulin	   staining	   used	   for	   spindle	   geometry	  measurements	  in	  metaphase	  cells.	  Scale	  bar	  represents	  5	  μm,	  DNA	  was	  stained	  with	  DAPI.	  Lower	   left	  panel:	   schematic	   showing	  approach	  used	   for	   spindle	   geometry	  measurements.	  Lower	   right	   panels:	   dot	   plots	   showing	   mitotic	   spindle	   length,	   width	   and	   angle	  measurements	   for	   the	   indicated	   cell	   lines.	   Horizontal	   bars	   indicate	   mean	   values.	   Data	  represent	   results	   from	   two	   biological	   replicates,	   two-­‐tailed	   t-­‐test:	   *P<0.05,	   **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	  Next,	   I	   investigated	   the	  possibility	   that	   sister	   chromatid	   cohesion	  might	  be	  attenuated	  in	  the	  post-­‐tetraploid	  cell	  lines,	  which,	  as	  previously	  discussed,	  in	   turn	   results	   in	   chromosome	   mis-­‐segregation	   and	   merotelic	   attachments.	  Specifically,	   I	   measured	   the	   distance	   between	   the	   sister	   chromatid	  centromeres,	   as	   marked	   by	   the	   centromere	   antibody	   calcinosis,	   Raynaud's	  syndrome,	  esophageal	  dysmotility,	   sclerodactyly,	   telangiectasia	   (CREST)	   (Fig.	  17).	  Analysis	  of	  primary	  constrictions	  in	  mitotic	  spreads	  from	  diploid	  control	  cells	  and	  PTA	  cells	  did	  not	  reveal	  an	  elevated	  frequency	  of	  cohesion	  defects.	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Figure	  17:	  Upper	  panel:	  micrographs	  of	  fixed	  cells	  stained	  with	  CREST	  antibodies,	  marking	  centromeres.	   Scale	   bar	   represents	   5	   μm,	   DNA	   was	   stained	   with	   DAPI.	   Lower	   left	   panel:	  schematic	   showing	   the	   approach	   used	   for	   measurements	   of	   inter-­‐kinetochore	   distances.	  Lower	  right	  panel:	  model	  dot	  plots	  showing	  inter-­‐kinetochore	  distance	  in	  the	  indicated	  cell	  lines.	   Horizontal	   bars	   indicate	   mean	   values	   and	   numbers	   refer	   to	   counted	   cells.	   Data	  represent	   results	   from	   two	   biological	   replicates,	   two-­‐tailed	   t-­‐test:	   *P<0.05,	   **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	  Measurements	   of	   inter-­‐kinetochore	   distances	   revealed	   no	   significant	  differences	   between	   diploid	   cells,	   4N	   and	   PTA1	   and	   PTA3;	   the	   measured	  distances	   in	   fixed	   cells	   were	   0.71±0.16	   (mean±SD)	   for	   2N	   and	   between	  0.53±0.11	   and	   0,85±0.021	   for	   PTA2	   and	   PTA4	   respectively	   (Fig.	   18).	   These	  data	  indicate	  that	  inter-­‐kinetochore	  distance	  does	  not	  appear	  to	  be	  the	  leading	  cause	  in	  all	  post-­‐tetraploid	  cells.	  Cytokinesis	   failure	   induces	   not	   only	   formation	   of	   binucleated	   tetraploid	  cells	  but	   also	   results	   in	   the	  gain	  of	   an	  extra	   centrosome.	  As	  discussed	   in	   the	  introduction,	   duplication	   of	   centrosomes	   in	   the	   following	   cell	   cycle	   can	   then	  lead	  to	  the	  formation	  of	  multipolar	  spindles,	  causing	  severe	  chromosome	  mis-­‐segregation.	  The	  tetraploid	  culture	  used	   in	   this	  study	  had	  essentially	   lost	   the	  supernumerary	   centrosomes,	   and	   only	   5.8%	   of	   the	   cells	   still	   showed	  centrosome	  amplification	  at	  25	  days	  after	  DCB	  release	  63(Drosopoulos	  K.	  Nat	  Commun	   2014).	   Thus,	   I	   investigated	   for	   the	   eventual	   presence	   of	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abnormalities	  in	  centrosome	  and	  centriole	  numbers,	  using	  typical	  markers	  for	  these	  organelles,	  such	  as	  CP110	  and	  CEP135,	  respectively.	  The	  large	  majority	  of	   mitotic	   figures	   in	   all	   cell	   lines	   contained	   the	   diploid	   equivalent	   of	  centrosomes	   and	   centrioles	   (Fig.	   18),	   which	   is	   in	   agreement	   with	   the	   low	  percentage	  of	  multipolar	  spindle	  in	  tetraploid	  culture	  (Fig.	  14)	  and	  with	  data	  shown	   in	   the	   literature	   63	   (Drosopoulos	   K.Nat.Commun	   2014).	   This	  notwithstanding,	   it	   remains	   possible	   that	   very	   few	   cells	   in	   the	   tetraploid	  culture	  presented	  an	  aberrant	  centrosome	  number,	  and	  these	  could	  have	  been	  generating	   the	   various	   PTA	   clones.	   In	   agreement	  with	   this	   hypothesis,	   FACS	  profiles	   of	   the	   tetraploid	   culture	   showed	   the	   presence	   of	   a	   small	   population	  with	  a	  decreased	  DNA	  content,	  after	  one	  month	  of	  culturing	  63	  (Drosopoulos	  K.	  Nat.	  Commun	  2014).	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Figure	   18:	  Upper	  panel:	  micrographs	  of	   fixed	  cells	  stained	  with	  antibodies	  raised	  against	  the	  centriole	  maker	  CP110	  and	  α-­‐tubulin.	  Scale	  bar	  represents	  5	  μm,	  DNA	  was	  stained	  with	  DAPI.	  Lower	  panel:	  dot	  plots	  showing	  centrioles	  and	  centrosomes	  numbers	  in	  the	  indicated	  cell	   lines.	  Horizontal	   bars	   indicate	  mean	   values	   and	  numbers	   refer	   to	   counted	   cells.	  Data	  represent	   results	   from	   two	   biological	   replicates,	   two-­‐tailed	   t-­‐test:	   *P<0.05,	   **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	  Since	   extra	   chromosomes	   are	   likely	   to	   prolong	   the	   time	   required	   for	  proper	   chromosome	   alignment	   on	   the	   mitotic	   spindle,	   I	   next	   used	   live	   cell	  imaging	   to	   perform	   a	   cell	   fate	   analysis.	   Specifically,	   I	   used	   histone	  H2B-­‐GFP	  transfected	   cells	   and	   scored	   cell	   fates	   (notably	   division	   with/without	  chromosome	   mis-­‐segregation,	   mitotic	   checkpoint	   slippage,	   death	   in	  interphase/mitosis)	   after	   the	   completion	   of	   a	   cell	   division	   displaying	   a	  chromosomal	  mis-­‐segregation	  event	  (Fig.	  19).	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Figure	   19:	   Upper	   panel:	   schematic	   showing	   the	   approach	   to	   cell	   fates	   analysis	   by	   time-­‐lapse	  microscopy	  of	  asynchronously	  growing	  cultures	  stably	  expressing	  GFP-­‐tagged	  histone	  H2B.	  Lower	  panel:	  dashed	  lines	  indicate	  mean	  mitotic	  duration.	  Frequencies	  of	  cell	  fates	  are	  shown	  to	  the	  right	  of	  each	  histogram.	  Two-­‐tailed	  t-­‐test:	  *P<0.05,	  **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	  Data	  represent	  results	  from	  two	  biological	  replicates.	  	  While	   in	   the	   diploid	   culture	   chromosomal	   mis-­‐segregation	   was	   largely	  followed	   by	   error	   free	   cell	   division	   in	   the	   ensuing	   cell	   cycle,	   I	   observed	   an	  elevated	  rate	  of	  chromosomal	  mis-­‐segregation	  and	  a	  significant	  prolongation	  of	   mitotic	   duration	   in	   all	   post-­‐tetraploid	   clones.	   In	   the	   tetraploid	   culture,	  mitotic	   length	  was	   significantly	   increased	  but	   it	  was	  not	   accompanied	  by	   an	  elevated	  rate	  of	  mis-­‐segregation,	  whereas	  trisomic	  clones	  only	  responded	  with	  a	   non-­‐significant	   prolongation	   of	   mitosis	   and	   increased	   cell	   death.	   These	  observations	  indicate	  that	  a	  gain	  in	  chromosome	  number	  provokes	  increased	  mitotic	  duration	  and	  occasional	  chromosome	  aberrations,	  but	  not	  necessarily	  a	   rampant	   increase	   of	   chromosomal	   mis-­‐segregation.	   The	   latter	   was	   only	  observed	  in	  post-­‐tetraploid	  clones	  that	  display	  CIN,	  i.e.	  a	  persistently	  increase	  rate	   of	   mis-­‐segregation.	   Thus,	   the	   PTAs	   display	   an	   increased	   frequency	   of	  abnormal	  mitoses,	  but,	  remarkably,	  this	  mis-­‐segregation	  is	  not	  associated	  with	  an	   accumulation	   of	   non-­‐proliferating	   cells	   (Fig.	   19).	   In	   this	   context,	   it	   is	  relevant	   that	   DLD-­‐1	   cells	   lack	   a	   functional	   p53	   gene	   135(Nanda	   R	   Rodrigues	  Proc	  Natl	   Acad	   Sci	  USA	  1990)	   and,	   as	   already	   discussed	   in	   the	   introduction,	  mis-­‐segregating	   cells	   have	   previously	   been	   observed	   to	   proliferate	   in	   p53	  deficient	  cells	  82(Fujiwara	  et	  al.,	  2005).	  Thus,	  it	  seems	  reasonable	  to	  conclude	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that	   the	   lack	   of	   functional	   p53	   allowed	   the	   proliferation	   of	   mis-­‐segregating	  PTA	  cells.	  Having	   characterized	   the	   different	   cell	   lines,	   I	   was	   hopeful	   that	   a	  comparison	  of	  karyotypically	  stable	  diploid,	  tetraploid	  and	  trisomic	  cells	  with	  karyotypically	   unstable	   post-­‐tetraploid	   clones	   might	   allow	   me	   to	   study	   the	  effects	   of	   altered	   chromosome	  mass	   versus	   altered	   chromosome	   stability	   on	  protein	  expression	  and	  protein	  phosphorylation	  (see	  also	  Fig.	  10).	  
4.3.	   Comparison	   of	   chromosome	   copy	   number	   and	  
corresponding	  protein	  expression	  To	   test	   the	   impact	   of	   chromosome	   copy	   number	   on	   protein	   levels,	   I	  teamed	  up	  with	  Dr.	  Thomas	  Lorber	   (University	  Hospital	  Basel)	   to	   submit	   all	  cell	   lines	   to	   aCGH	   (Fig.	   20,).	   In	   parallel,	   taking	   advantage	   of	   the	   Proteomics	  Core	   Facility	   at	   the	   Biozentrum,	   I	   subjected	   all	   cell	   lines	   to	   quantitative	  proteome	   analysis	   using	   tandem	   mass	   tag	   (TMT)	   labeling	   (Fig.	   22).	   Array	  hybridization	  assays	  showed	  that,	  firstly,	  prominent	  whole-­‐chromosome	  copy	  number	  reductions,	  notably	  of	  chromosomes	  3,	  4	  and	  9,	  were	  detected	  in	  only	  two	   post-­‐tetraploid	   clones	   (Fig.	   20	   and	   13).	   The	   latter	   observation	   can	   be	  rationalized	  by	   the	  assumption	   that	  post-­‐tetraploid	  clones	  were	  subjected	   to	  selective	  pressure	   that	   resulted	   in	  near-­‐triploid	  or	  hyper-­‐triploid	  karyotypes	  prior	  to	  clonal	  isolation	  from	  the	  tetraploid	  culture,	  except	  for	  chromosomes	  3,	  4	   and	   9	   which	   had	   possibly	   undergone	   copy	   number	   losses	   prior	   to	   clonal	  isolation	  by	  FACS	  and	  are	  thus	  present	  in	  most	  sub-­‐clones.	  Less	  frequent	  copy	  number	   alterations	   in	   post-­‐tetraploid	   clones	   were	   likely	   masked	   by	   clonal	  heterogeneity	   due	   to	   increased	   chromosome	   mis-­‐segregation	   rates	   of	   post-­‐tetraploids	  and	  were	  thus	  not	  readily	  detectable	  by	  this	  assay.	  This	  result	  is	  in	  agreement	  with	  the	  increased	  frequency	  of	  structural	  aberrations	  in	  PTAs	  that	  would	   be	   expected	   to	   cause	   rearrangements,	   amplifications	   and	   deletions	   of	  small	  DNA	  portions.	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Figure	  20:	  aCGH	  assay	  showing	  chromosome	  copy	  number	  changes	  relative	  to	  the	  generic	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diploid	  (2N)	  DLD-­‐1	  reference	  cell	   line	   for	   the	   indicated	  cell	   lines	  and	  chromosomes.	  Copy	  number	   variations	   that	   remained	   largely	   unchanged	   in	   all	   cell	   lines	   are	   highlighted	   in	  yellow,	  individual	  variations	  are	  highlighted	  in	  red.	  	  	  In	   contrast,	   single	   chromosome	   gains	   could	   be	   readily	   observed	   in	   the	  karyotypically	   stable	   trisomy	   7	   clones	   (Fig.	   20),	   further	   confirming	   the	  presence	  of	  one	  extra	   copy	  of	   chromosome	  7	   (Fig.	  13).	   Secondly,	  most	   small	  structural	   aberrations	   present	   in	   the	   diploid	   parental	   cell	   line	   were	  propagated	   to	   the	   cells	   harboring	   tetraploid,	   post-­‐tetraploid	   and	   trisomic	  karyotypes	  (Fig.	  20),	  and	  they	  were	  also	  detected	  in	  a	  diploid	  DLD-­‐1	  cell	   line	  originating	   from	   a	   different	   laboratory	   99(Madhvi	   B.	   U.	   et	   al	   2004	   Cancer	  Research)	  (Fig.	  21).	  These	  regions	  are	  likely	  to	  be	  typically	  aberrant	  in	  DLD-­‐1	  colon	  cancer	  cells.	  	  
	  	  
Figure	  21:	  aCGH	  assay	  in	  DLD-­‐1,	  from	  a	  different	  lab,	  showing	  chromosome	  copy	  number	  changes	   relative	   to	   a	   generic	   diploid	   (2N)	   reference	   cell	   line	   for	   indicated	   cell	   lines	   and	  chromosomes.	   Copy	   number	   variations	   that	   remained	   largely	   unchanged,	   compare	   with	  other	  DLD-­‐1	  used	  in	  this	  study,	  are	  highlighted	  in	  yellow.	  	   As	  discussed	  in	  the	  introduction,	  analyses	  of	  genome,	  transcriptome	  and	  proteome	   changes	   in	   response	   to	   aneuploidy	   in	   human	   cells,	   and	   other	  species,	   have	   yielded	   contradictory	   results	   2,103,131,136(Torres	   at	   al	   2007)	  (William	  et	   al	  2008)	   (Kvitek	   et	   al	  2008)	   (Stenberg	  et	   al	  2009).	   In	  particular,	  both	   positive	   and	   negative	   correlations	   between	   extra	   chromosomes	   and	  corresponding	  protein	  levels	  have	  been	  reported	  98,106,131,137(Torres	  et	  al	  2010)	  (Pavelka	  et	  al	  2010)	  (Stingele	  et	  al	  2012	  Mole	  Syst	  Biology)	  (Rebecca	  R.	  Beach	  Cell	   2017).	   This	   being	   said,	   it	   is	   generally	   agreed	   that	   the	   expression	   of	  subunits	  of	  protein	  complexes	  is	  generally	  compensated	  in	  order	  to	  maintain	  correct	  stoichiometry	  106(Torres	  et	  al	  2010).	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Figure	   22:	  LC-­‐MS/MS	  analysis	  using	   the	   tandem	  mass	   tag	  (TMT)-­‐labeling	  approach.	  Box-­‐whisker	  plots	  show	  protein	  abundance	  relative	  to	  the	  parental	  diploid	  (2N)	  DLD-­‐1	  culture	  for	   the	   indicated	   cell	   lines.	   Proteins	   are	   ordered	   by	   chromosome	   origin,	   blue	   shading	  indicates	  the	  level	  of	  significance.	  Data	  are	  from	  three	  biological	  replicates.	  	  Comparison	   of	   data	   from	   array	   hybridization	  with	   data	   from	  proteomic	  analyses	   indicates	   that	   chromosomal	   copy	   number	   alterations	   positively	  correlated	  with	  the	  average	  relative	  expression	  levels	  of	  the	  genes	  encoded	  by	  the	  respective	  chromosomes	   in	  2	  PTAs	  and	  both	   trisomic	  clones	  (Fig.	  22).	   In	  comparable	  expression	  analyses,	  the	  tetraploid	  line	  and	  one	  PTA	  clone	  (PTA2)	  did	   not	   show	   chromosome-­‐specific	   deregulations,	   likely	   due	   to	   a	   balanced	  karyotype	  (in	  the	  case	  of	  4N)	  or	  mild	  and	  clonally	  heterogeneous	  aneuploidy	  (in	   the	   case	   of	   PTA2).	   Supporting	   this	   hypothesis	   is	   the	   fact	   that	   in	   PTA4	  presented	  small,	  but	  significant,	  proteomic	  deregulations	  in	  proteins	  encoded	  by	  chromosome	  5-­‐9	  and	  16	  (Fig.	  20),	  meanwhile	  no	  corresponding	  aberration	  could	   be	   detected	   by	   the	   aCGH	   in	   the	   same	   chromosomes	   (Fig.	   22,).	   These	  results	  lead	  me	  to	  speculate	  that	  in	  PTA4	  the	  aneuploidy	  may	  be	  modest	  and	  more	   heterogeneous	   when	   compared	   to	   PTA1	   or	   PTA3,	   and	   that	   the	   gene	  aberrations	  are	  likely	  buffered	  by	  clonal	  variability.	  In	  any	  case,	  it	  is	  important	  to	   bear	   in	   mind	   that	   the	   sensitivities	   of	   the	   two	   experimental	   techniques	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(aCGH	  and	  TMT	  proteomics)	  are	  not	   the	  same.	   In	   fact,	   in	   two	  PTAs	  and	  both	  trisomic	   clones,	   I	   identified	   further	   statistically	   significant	   reductions	   in	  protein	   expression	   for	   chromosomes	   that	   did	   not	   show	   deviations	   in	   copy	  number	  in	  the	  array	  hybridization	  assays	  (Fig.	  22).	  On	  the	  other	  hand,	  in	  PTA1,	  PTA3	   and	   trisomic	   clones	   the	   comparative	   genomic	   hybridization	   showed	   a	  chromosome	  copy	  number	   reduction	   (PTA1	  and	  PTA3)	  or	   increase	   (Tr	  7)	  of	  0.5	   log2,	   corresponding	   to	   one	   fold	   change.	   However,	   the	   corresponding	  protein	  abundance	  analysis	  showed	  a	   less	  pronounced	  reduction/increase	   in	  protein	  content	  (log2	  around	  0.25).	  This	  discrepancy	  is	  likely	  to	  be	  explained	  by	  the	  technical	  ratio	  compression	  in	  the	  Tandem	  Mass	  Tag	  labeling	  technique	  131,138(Erik	  Ahrné	  2016	   Journal	   of	   Proteome	   research)	   (Rebecca	  R.Beach	  Cell	  2017).	   In	   conclusion,	   the	   above	   observations	   confirm	   the	   high	   sensitivity	   of	  proteomic	   analyses	   and	   that	   gene	   dosage	   can	   directly	   impact	   on	  corresponding	  protein	  expression	  levels	  106,131(Torres	  et	  al	  2010)	  (Rebecca	  R.	  Beach	  Cell	  2017).	  	  
4.4.	  Comparative	  proteomic	  analysis	  of	  DLD-­‐1	  derived	  cells	  Data	  from	  proteomic	  TMT	  experiments,	  presented	  in	  the	  previous	  section,	  were	   next	   subjected	   to	   detailed	   analysis	   in	   order	   to	   identify	   specific	   protein	  expression	  patterns	  across	  stable	  and	  unstable	  cell	  lines.	  Notably,	  comparative	  proteomics	   analyses	   were	   performed	   independently	   in	   three	   biological	  replicates,	  using	  the	  6-­‐	  plex	  (for	  2N,	  4N	  and	  trisomic	  clones)	  and	  10-­‐plex	  (for	  2N,	  4N	  and	  PTAs)	  TMT	  labeling	  approach	  138(Ahrné	  E.	  2016	  J	  Proteome	  Res.).	  These	  studies	  identified	  a	  total	  of	  6’000	  and	  7’500	  proteins	  across	  the	  DLD-­‐1	  trisomic	  and	  PTA	  cells,	  respectively.	  It	  is	  important	  to	  notice	  that	  even	  when	  a	  stringent	  q-­‐value	  cut	  off	  was	  applied	  (False	  discovery	  rate	  (FDR)	  score	  0.05)	  I	  was	  able	  to	  identify	  many	  proteins	  that	  were	  significantly	  deregulated	  (Fig.	  23	  left	   and	   right	   panel).	   (For	   information	   on	   the	  meaning	   of	   q-­‐values,	   p-­‐values,	  and	   false-­‐discovery	   rates	   in	   data	   analysis,	   please	   refer	   to	  http://www.nonlinear.com/progenesis/qi-­‐for-­‐proteomics/v3.0/faq/pq-­‐values.aspx).	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Figure	   23:	   Left	   and	   right	   graphs	   showing	   the	   number	   of	   significant	   down-­‐	   and	   up-­‐regulations	   of	   protein	   expression	   in	   relation	   to	   the	   false	   discovery	   rate.	   Dashed	   lines	  indicate	  a	  false	  discovery	  rate	  of	  5%.	  Proteomic	  data	  are	  from	  three	  biological	  replicates.	  It	  should	   be	   noted	   that	   the	   two	   experiments	   were	   performed	   separately,	   resulting	   in	  independent	   results/numbers	   of	   identified	   hits.	   Importantly,	   the	   two	   experiments	  presented	  here	  were	  done	   independently,	  using	   in	  one	  case	  a	  6-­‐plex	   tag	  system	  (trisomic	  clones;	   right	   graph)	   and	   in	   the	   other	   a	   10-­‐plex	   assay	   (PTAs;	   left	   graph),	   resulting	   in	   the	  identification	   of	   6’000	   and	   7’500	   proteins,	   respectively.	   This	   likely	   explains	  why	   the	   two	  curves	  for	  the	  tetraploid	  cell	  cultures	  are	  not	  identical	  between	  the	  two	  dataset.	  	   As	   discussed	   in	   the	   introduction,	   it	   has	   been	   reported	   that	   aneuploidy-­‐induced	  stresses	  promote	  global	  proteolytic	  activity,	  mainly	  due	  to	  unbalanced	  protein	   expression	   (due	   to	   additional	   chromosomes)	   and	   the	   consequently	  increased	  burden	  on	  protein	  quality	   control	  processes	   88,108(Santaguida	  et	  al.	  2015)	  (Donnelly	  N,	  Storchova	  Z.	  Mol	  Cell	  Oncol.	  2015).	  Thus	  I	  tested	  if	  stress	  response	   proteins,	   including	   proteins	   regulating	   proteolysis,	   folding	   and/or	  oxidative	   stress,	   were	   upregulated	   in	   the	   various	   cultures.	   To	   this	   end,	   I	  created	   a	   list	   of	   gene	   ontology	   (GO)	   terms	   associated	   with	   these	   processes	  (Fig.	   24	   lower	   panel)	   and	   analyzed	   the	   relative	   abundance	   of	   proteins	  associated	  with	  these	  GO	  terms	  (Fig.	  24	  upper	  panel).	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Figure	  24:	  Upper	  panel:	  box	  whisker	  plot	  showing	  relative	  abundance	  of	  proteins	  (versus	  parental	  diploid	  DLD-­‐1	  cells)	  functionally	  related	  to	  protein	  proteolysis,	  protein	  folding	  and	  oxidative	  stress	  response	  regulation	  for	  the	  indicated	  cell	  lines.	  Below	  panel:	  tables	  listing	  gene	  ontology	  (GO)	  terms	  that	  were	  used	  to	  select	  proteins	  associated	  with	  the	  mentioned	  processes.	  	  	  I	  detected	  a	  moderate	  increase	  in	  the	  average	  expression	  of	  proteins	  relevant	  to	   all	   three	   processes	   in	   tetraploid	   cells	   and	  most	   PTAs,	   but	   not	   in	   trisomic	  clones	  (Fig.	  24	  ).	  These	  results	  suggest	  that	  a	  gain	  in	  chromosome	  mass	  per	  se	  provokes	  a	  deregulation	  of	  protein	  expression,	  which	  results	   in	  upregulation	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of	  protein	  quality	  control	  processes,	  such	  as	  protein	  folding	  and	  protein	  lysis	  88,139(Santaguida	  et	  al.	  2015)	  (Donnelly	  N,	  Storchova	  Z.	  Mol	  Cell	  Oncol.	  2015).	  I	   next	   decided	   to	   perform	   an	   unbiased	   data	   analysis	   testing	   for	   the	  presence	   of	   deregulated	   protein	   expression	   that	   would	   correlate	   with	  chromosome	  mass	  gain	  (in	  tetraploid,	  PTA	  and	  trisomic	  clones)	  or	  the	  genetic	  imbalance	  present	  in	  CIN	  cells	  (in	  PTAs	  and,	  perhaps	  to	  a	  minor	  extent,	  also	  in	  trisomic	  clones).	  To	  this	  end,	  I	  examined	  the	  proteome	  datasets	  by	  comparing	  the	  300	  most	  deregulated	  proteins	  (based	  on	  an	  FDR	  of	  <10%,	  and	  in	  most	  of	  the	  cases	  less	  than	  5%)	  (Fig.	  25	  table	  below)	  in	  each	  of	  the	  PTAs,	  trisomic	  and	  tetraploid	   samples.	   Surprisingly,	   I	   observed	   very	   few	   deregulations	   that	  correlated	  with	  the	  presence	  of	  extra	  chromosome	  mass	  (tetraploid,	  PTAs	  and	  trisomic	  clones)	  or	  the	  presence	  of	  CIN	  (only	  PTA	  clones)	  (Fig.	  25	  left	  and	  right	  panels).	   In	   particular,	   I	   found	   that	   only	   12	   proteins	  were	   commonly	   shared	  across	   unstable	   PTAs	   (Fig.	   25	   left).	   Of	   these	   12	   common	   proteins	   the	   great	  majority	  (11)	  correlated	  with	  the	  strong	  gain	  of	  extra	  chromosomes	  in	  stable	  tetraploid	   (Fig.	  25	   left	  panel),	   suggesting	   that	  most	  of	   the	  proteome	  changes	  occur	  already	  in	  response	  to	  chromosome	  mass	  gain,	  rather	  than	  the	  presence	  of	  CIN.	  Similar	  analyses	  in	  trisomic	  clones	  revealed	  that	  only	  18	  proteins	  were	  commonly	   deregulated	   across	   4N	   and	   trisomic	   clones	   (Fig.	   25	   right).	   In	  contrast,	   when	   I	   considered	   proteins	   overlapping	   between	   the	   two	   trisomic	  clones,	   I	   observed	   a	   high	   number	   of	   share	   hits	   (Fig.	   25	   right	   panel),	   as	  expected.	   Indeed,	   these	   100	   shared	   proteins	   are	   likely	   explained	   by	   the	   fact	  that	   in	   trisomic	   clones	   I	   artificially	   introduced	   only	   one	   additional	  chromosome	   in	   a	   mostly	   diploid	   background.	   Thus,	   the	   amount	   of	   genetic	  heterogeneity	  is	  definitively	  less	  compared	  with	  the	  PTAs.	  Moreover	  trisomic	  clones	  showed	  a	   less	  pronounced	  level	  of	  chromosomal	   instability	  than	  PTAs	  (Fig.	   14	   and	   15),	  which	   results	   in	   increased	   genetic	   complexity	   in	   the	   latter	  lines.	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Figure	   25:	   Left	   panel:	   Venn	   diagrams	   representing	   the	   number	   of	   shared	   protein	  deregulations	   across	   the	   indicated	   cell	   lines.	   Results	  were	   obtained	   by	   selecting	   the	   300	  most	   deregulated	   proteins	   per	   cell	   line	   (based	   on	   an	   FDR	   of	   <10%).	   Panel	   below:	   table	  listing	  the	  false	  discovery	  rates	  (FDR)	  for	  the	  analyzed	  cell	  lines.	  	  Among	  the	  11	  proteins	  deregulated	  in	  4N	  and	  PTAs,	  5	  proteins	  (IFIT2,	  IFIT3,	  OASL,	   STAT1	   and	  DDX58)	   are	   annotated	   to	   be	   involved	   in	   the	   regulation	   of	  interferon	   signaling	   (Fig.	   26	   left	   panel),	   and	   these	   proteins	   were	   also	  functionally	  linked	  by	  STRING	  analysis	  (Fig.	  26	  right	  panel).	  This	  observation	  is	   reminiscent	   of	   a	  previous	   study	   that	  detected	   a	  deregulated	   expression	  of	  interferon	  signaling	  genes	  in	  human	  HCT116	  colon	  cancer	  cells	  engineered	  to	  harbor	  trisomies/tetrasomies	  96(Dürrbaum	  et	  al.	  BMC	  Genomics	  2015).	  
	  	  
	   58	  
Figure	  26:	  Left	  panel,	   list	  of	  the	  11	  proteins	  commonly	  deregulated	  across	  tetraploid	  and	  PTA	  clones	  as	  shown	  in	  Fig.	  25.	  Asterisk	  demarks	  the	  single	  protein	  found	  to	  be	  deregulated	  across	  only	  PTA	  clones	  as	  shown	  in	  Fig.	  25	  Shaded	  area	  highlights	  proteins	  involved	  in	  type	  I	   interferon	  signaling.	  Right	  panel:	  STRING	  functional	  network	  analysis	  of	   the	  11	  proteins	  commonly	  deregulated	  in	  4N	  and	  PTA	  clones.	  Nodal	  connections	  are	  based	  on	  a	  confidence	  value	  of	  0.9	  using	  experimental	  and	  database	  evidence.	  	  Most	   recently,	   it	   has	   been	   shown	   that	   cells	   with	   complex	   karyotypes,	  generated	  by	  experimentally	   inducing	  chromosome	  mis-­‐segregation,	  produce	  pro-­‐inflammatory	  signals	  that	  promote	  their	  clearance	  by	  the	  immune	  system	  86(Santaguida	  S.	  2017	  Dev	  Cell).	  Moreover,	  a	  cytosolic	  sensor	  of	  dsDNA,	  GMP-­‐AMP	  synthase	  (cGAS),	  was	  recently	  found	  to	  be	  activated	  by	  DNA	  damage	  and,	  more	   importantly,	   localize	   to	   micronuclei	   arising	   from	   genome	   instability	  115(Karen	   J	  Mackenzie	  Nature	  2017).	  Our	   findings	   thus	   fall	   in	   line	  with	   these	  independent	  observations.	  On	  the	  other	  hand,	  none	  of	  the	  18	  genes	  commonly	  upregulated	  in	  chromosomally	  stable	  4N	  and	  trisomic	  clones	  were	  annotated	  for	   interferon	   signaling	   (and	   they	   also	   did	   not	   show	   any	   other	   obvious	  functional	  relationships)	  (Fig.	  27).	  	  
	  	  
Figure	   27:	   List	  of	  18	  proteins	   that	   are	   commonly	  deregulated	  across	  4N	  and	  Tr7	  clones.	  Relates	  to	  data	  shown	  in	  Fig.	  24.	  	  	  I	   hypothesized	   that	   the	   observed	   expression	   signature	   related	   to	   interferon	  signaling,	  in	  4N	  and	  PTA	  clones,	  could	  be	  elicited	  by	  the	  increased	  presence	  of	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cytoplasmic	   DNA.	   It	   could	   be	   that	   increased	   replication	   stress	   in	   tetraploid	  cells	  and	  the	  presence	  of	  more	   frequent	  chromosome	  mis-­‐segregation	   in	  CIN	  cells	  result	  in	  higher	  abundance	  of	  chromosomal	  lesions,	  cytosolic	  shedding	  of	  DNA	  fragments	  and,	  consequently,	  an	   induction	  of	   type	  I	   interferon	  signaling	  140-­‐143(Samantha	  et	  al.,	   Immunity,	  May	  2016)	  (Weichselbaum	  et	  al.	  PNAS	  Nov	  2008)	  (Erdal	  et	  al.	  Genes	  Dev	  March	  2017)	  (Shen	  et	  al.	  Cell	  Reports	  2015).	  In	  line	   with	   this	   possibility,	   I	   observed	   that	   tetraploid	   and	   post-­‐tetraploid	  aneuploid	   clones	   showed	   upregulated	   expression	   of	   interfeon	   proteins	   (Fig.	  28).	  
	  	  
Figure	  28:	  Box	  whisker	  plots	  showing	  the	  relative	  abundance	  of	  proteins	  involved	  in	  type	  I	  interferon	  signaling	  across	  tetraploid,	  post-­‐tetraploid	  and	  trisomic	  cell	  lines.	  	  
	  Supporting	   this	   data	   is	   the	   observation	   that	   cell	   lines	   presenting	   extra	  chromosomes	   showed	   an	   elevated	   number	   of	   cytoplasmic	   ssDNA	   foci,	   as	  determined	   by	   BrdU	   incorporation	   and	   microscopic	   analysis	   in	   non-­‐denaturing	   conditions	   (Fig.	   29).	   These	   results	   indicate	   that	   DNA-­‐damage,	  which	   is	  a	  common	  consequence	  of	  mis-­‐segregation	  and	  aneuploidy,	   leads	  to	  the	  release	  of	  ssDNA	  fragments	  from	  the	  cell	  nucleus	  into	  the	  cytosol,	  engaging	  an	  innate	  immune	  response.	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Figure	  29:	  Left	  panel:	  micrographs	  of	  cells	  treated	  with	  BrdU	  and	  stained	  with	  anti-­‐BrdU	  and	   DAPI.	   Acid	   denaturing	   of	   the	   DNA	   was	   omitted,	   extra-­‐nuclear	   BrdU	   foci	   represent	  cytoplasmic	  DNA.	  Scale	  bar	   represents	  10	  µm.	  Right	  panel:	  box	  whisker	  plot	   showing	   the	  number	   of	   cytoplasmic	   BrdU	   foci	   for	   the	   indicated	   cell	   lines.	   Two-­‐tailed	   t-­‐test:	   *P<0.05,	  **P<0.01,	   ***P<0.001	   and	   ****P<0.0001.	   Data	   represent	   results	   from	   two	   biological	  replicates.	  
	  I	  next	  asked	  if	  I	  could	  detect	  an	  upregulation	  of	  these	  interferone	  genes	  in	  our	  dataset	  on	  established	  MIN	  and	  CIN	  cell	  lines	  (Fig.	  8).	  While	  none	  of	  the	  diploid	  MIN	  cell	  lines,	  notably	  HCT116,	  RKO	  as	  well	  as	  diploid	  DLD-­‐1	  (from	  a	  distinct	  source),	   showed	   upregulated	   expression,	   3	   out	   of	   4	   tested	   CIN	   cell	   lines,	  including	  the	  near-­‐triploid	  aneuploid	  HeLa	  and	  HT29	  cells	  as	  well	  as	  the	  hypo-­‐diploid	   SW837	   cells,	   showed	   an	   elevated	   expression	   of	   interferon	   signaling	  genes	  (Fig.	  30).	  Together	  this	  data	   indicates	   that	  a	  deregulated	  expression	  of	  genes	   associated	   with	   interferon	   signaling	   correlates	   with	   strongly	   altered	  chromosomal	  burden	  found	  in	  both	  chromosomally	  stable	  tetraploid	  cells	  and	  in	  chromosomally	  instable	  aneuploid	  cells.	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Figure	  30:	  Box	  whisker	  plots	  showing	  the	  relative	  abundance	  of	  proteins	  involved	  in	  type	  I	  interferon	  signaling	  across	  microsatellite	  instable	  (MIN)	  and	  chromosomally	  instable	  (CIN)	  cell	  lines.	  The	  graph	  is	  based	  on	  experimental	  data	  shown	  in	  Fig.	  8	  and	  9.	  	  	   Interestingly,	  it	  has	  been	  recently	  shown	  that	  factors	  controlling	  DNA	  end	  resection	   during	   double-­‐strand	   break	   repair,	   including	   the	   Bloom	   syndrome	  (BLM)	   helicase,	   could	   play	   a	   role	   in	   the	   generation	   of	   cytosolic	   and	   nuclear	  ssDNA	  142(Erdal	  et	  al.	  Genes	  Dev	  March	  2017).	  In	  particular,	  depletion	  of	  BLM	  brings	  about	  a	  reduction	  of	  both	  nuclear	  and	  cytoplasmic	  ssDNA	  in	  MCF7	  cells.	  Thus,	   I	   analyzed	   the	   occurrence	   of	   ultrafine	   anaphase	   DNA	   bridges	   (UFBs),	  strand-­‐like	  DNA	   structures	   that	   associate	  with	   the	  BLM	  protein	   and	   link	   the	  dividing	   DNA	   masses	   (Fig.	   31).	   UFBs	   originate	   either	   from	   DNA	   catenae	   or	  from	   replication	   or	   recombination	   intermediates	   that	   form	   during	   double	  strand	  repair;	  thus,	  the	  occurrence	  of	  UFBs	  can	  be	  indicative	  of	  un-­‐replicated	  or	  abnormal	  DNA	  structures	  144(Chan,	  K	  2011	  Semin.	  Cell	  Dev.	  Biol).	  Staining	  with	  an	  antibody	  against	  BLM	  revealed	  an	  increased	  frequency	  of	  UFBs	  by	  up	  to	   30%	   in	   the	   trisomic	   clones	   and	   by	   ca.	   20%	   in	   tetraploid	   and	   PTA	   cells,	  compared	  with	  controls	  (Fig.	  31).	  	  	  




Figure	  31:	  Upper	  panel:	  plot	  showing	  the	  percentage	  of	  cells	  showing	  UFBs	  marked	  by	  BLM	  staining.	  Below	  panel:	  micrographs	  of	  cells	  stained	  with	  anti-­‐BLM	  and	  DAPI.	  Two-­‐tailed	  t-­‐test:	  *P<0.05,	  **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	  	   All	  these	  results	  support	  the	  hypothesis	  that	  an	  increase	  in	  chromosome	  mass	  can	  lead	  to	  an	  increase	  in	  DNA	  damage	  (including	  double	  strand	  breaks),	  as	  discussed	   in	   the	   introduction,	   and,	  moreover,	   to	   the	  generation	  of	   ssDNA.	  Finally,	   the	   presence	   of	   ssDNA	   in	   aneuploidy	   cells	   could	   then	   trigger	  upregulation	  of	  an	  innate	  immune	  response	  in	  order	  to	  promote	  the	  clearance	  of	  damaged	  cells	  by	  the	  immune	  system	  86(Santaguida	  S.	  2017	  Dev	  Cell).	  	  
4.5.	   Targeted	   analysis	   of	   protein	   expression	   in	   DLD-­‐1-­‐
derived	  cells	  In	   order	   to	   determine	   whether	   increases	   in	   chromosome	  mass	   or	   mis-­‐segregation	   rate	   lead	   to	   effects	   on	   deregulation	   of	   cell	   cycle	   and	   mitotic	  proteins,	   I	   took	   advantage	   of	   past	   efforts	   and	   designed	   a	   targeted	   data	  analysis.	  Firstly,	   I	  made	  use	  of	  an	  inclusion	  list	   featuring	  550	  common	  tumor	  suppressor	   genes	   (TSGs)	   and	  oncogenes	   (OGs)	   145(Davoli	   Science	  2017)	   that	  encompasses	   14	   signaling	   pathways	   involved	   in	   cancer	   cell	   transformation	  (TSG/OG	  inclusion	  list,	  Table	  S1).	  Secondly,	  I	  generated	  an	  inclusion	  list	  of	  737	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proteins	  that	  was	  compiled	  from	  a	  CIN	  signature	  determined	  by	  meta-­‐analysis	  of	  gene	  expression	  datasets	  9(Carter	  SL,	  Nat	  Genet.	  2006),	  from	  a	  list	  of	  genes	  that	  were	  associated	  with	  cell	  division	  by	  the	  MitoCheck	  project	  146(Neumann	  et	   al.	   Nature	   2010),	   as	  well	   as	   from	   a	   list	   of	   genes	   that	  were	   assigned	   gene	  ontology	  (GO)	  terms	  attributed	  i.e.	  to	  kinetochore-­‐,	  centrosome-­‐,	  microtubule-­‐,	  cell	   cycle	   checkpoint-­‐,	   cell	   division-­‐	   and	   chromosome	   segregation-­‐related	  processes	   (CIN/cell	   division	   inclusion	   list,	   Table	   S1).	   Thirdly,	   I	   generated	  smaller	   inclusion	   lists	   that	  contained	  hallmark	  genes	  of	   the	  spindle	  assembly	  checkpoint,	   the	   anaphase-­‐promoting	   complex/cyclosome	   (APC/C),	   the	  kinetochore-­‐microtubule	  interface	  as	  well	  as	  the	  DNA	  replication	  licensing	  and	  origin	   complexes	   MCM	   and	   ORC,	   representing	   pathways	   and	   protein	  complexes	  that	  have	  been	  previously	  linked	  to	  chromosomal	  mis-­‐segregation	  19-­‐23(Beth	  AA	  Weaver,	  Current	  Opinion	   in	  Cell	  Biology	  2006)	  (J.R.	  Babu,	   J	  Cell	  Biol,	   2003)(D.J.	   Baker,	   2003	   Nat	   Genet,)	   (Sottillo	   R.	   2007	   Cancer	   Cell)	  (Kabeche	   L.	   2012	   Curr	   Biol)	   and	   genetic	   instability	   120(Passerini	   et	   al	   2016	  Nature	   Communications).	   Analyzing	   the	   300	   most	   deregulated	   proteins	   in	  each	   cell	   line	  with	   the	   TSG/OG	   inclusion	   list,	   I	   could	   not	   detect	   a	   significant	  enrichment	  in	  tetraploid,	  post-­‐tetraploid,	  nor	  trisomic	  samples	  (Fig.	  32).	  	  
	  	  
	   64	  
	  
	  
Figure	   32:	   Tables	   showing	  an	  enrichment	  analysis	  of	   the	  300	  most	  deregulated	  proteins	  per	  cell	  line	  based	  on	  the	  TSG/OG.	  The	  number	  of	  inclusion	  list	  matches	  (signlList)	  and	  non-­‐matches	  (totSign)	  were	  compared	  to	  random	  inclusion	  list	  matches	  (nonSignlList)	  and	  non-­‐matches	   (totNonSign)	   in	   a	   human	   proteome	   background.	   Significance	   (ftPValue)	   was	  calculated	   using	   Fisher’s	   exact	   test.	   Shaded	   areas	   highlight	   the	   most	   significant	  enrichments.	  	  Unfortunately,	  use	  of	  the	  CIN/cell	  division	  inclusion	  list	  also	  failed	  to	  identify	  any	   intriguing	   hits,	   since	   none	   of	   the	   expression	   deregulations	   found	   in	   the	  generated	   cell	   lines	   showed	   significant	   enrichment	   of	   CIN-­‐	   or	   cell	   division-­‐related	   genes	   among	   the	   most	   deregulated	   expressions	   (Fig.	   33).	   The	   only	  exception	  was	  an	  apparently	  significant	  enrichment	  in	  one	  of	  the	  two	  trisomic	  clones	   (Fig.	   33	   grey	   cluster	   and	   zoom	   in	   square).	   Unfortunately,	   STRING	  analysis	   of	   these	   19	   proteins,	   only	   yielded	   a	   small	   network	   composed	   by	   8	  proteins,	  which	  is	  unlikely	  to	  be	  a	  ubiquitous	  marker	  for	  aneuploidy.	  	  
	  




Figure	   33:	  Tables	   showing	  an	  enrichment	  analysis	  of	   the	  300	  most	  deregulated	  proteins	  per	  cell	  line,	  considering	  tetraploid	  and	  PTAs,	  based	  on	  CIN/cell	  division	  inclusion	  lists.	  The	  number	  of	   inclusion	   list	  matches	  (signlList)	  and	  non-­‐matches	  (totSign)	  were	  compared	  to	  random	   inclusion	   list	   matches	   (nonSignlList)	   and	   non-­‐matches	   (totNonSign)	   in	   a	   human	  proteome	   background.	   Significance	   (ftPValue)	   was	   calculated	   using	   Fisher’s	   exact	   test.	  Shaded	   areas	   highlight	   the	   most	   significant	   enrichments.	   STRING	   functional	   network	  analysis	  of	  the	  phospho-­‐peptides	  is	  indicated	  in	  the	  zoom	  in	  square.	  Nodal	  connections	  are	  based	  on	  a	   confidence	  value	  of	  0.9	  using	  experimental	   and	  database	  evidence.	   Solid	   lines	  indicate	  intra-­‐network	  connections.	  	  Lastly,	  I	  could	  also	  not	  detect	  significant	  deregulation	  of	  genes	  involved	  in	  the	  spindle	   assembly	   checkpoint,	   APC/C	   complex,	   or	   kinetochore-­‐microtubule	  interface	  that	  would	  have	  correlated	  with	  a	  gain	   in	  chromosome	  mass	  or	  the	  presence	  of	  CIN	  in	  most	  clones	  (Fig.	  34).	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Figure	  34:	  Dot	  plots	  showing	  the	  relative	  abundance	  of	  selected	  mitotic	  proteins	  in	  4N,	  PTA	  and	  Tr7	  clones.	  Note	  that	  a	  less	  stringent	  p-­‐Value	  cut	  off	  0.1	  was	  applied.	  	   I	   also	   tested	   the	   expression	   of	   the	   DNA	   replication-­‐licensing	   complex	  MCM,	   for	   which	   low	   expression	   levels	   were	   previously	   described	   to	   drive	  genetic	   instability	   in	   low-­‐complexity	   aneuploidy	   120(Passerini	   et	   al.,	   Nat	  Comms	  2016),	  but	  while	  most	  MCM	  subunits	  were	  slightly	  down-­‐regulated	  in	  one	  post-­‐tetraploid	  clone,	  I	  found	  no	  marked	  deregulation	  in	  any	  of	  the	  other	  clones	   (Fig.	  35,	   left	  panel).	  Furthermore,	   I	   could	  not	  detect	  a	  deregulation	  of	  the	   origin	   of	   replication	   complex	   (ORC)	   subunits	   (Fig.	   35,	   right	   panel).	  Regardless	  of	  whether	  or	  not	  the	  observed	  change	  in	  MCM	  expression	  could	  be	  rate	  limiting	  for	  the	  licensing	  of	  DNA	  replication	  in	  an	  aneuploid	  cell	  (which	  a	  priori	   seems	   unlikely	   given	   the	   abundance	   of	   MCM	   proteins)	   147,148(Debbie	  McIntosh	  &	  Blow	   JJ	  Cold	  Spring	  harb	  Perspect	  Biol	  2012)	   (Stephanie	  A.	  Hills	  Current	   Biology	   2014),	   deregulated	   MCM	   expression	   is	   unlikely	   to	   be	   a	  ubiquitous	   maker	   for	   aneuploidy.	   The	   most	   plausible	   explanation	   for	   the	  absence	   of	   common	   expression	   patterns	   in	   the	   analyzed	   cultures	   is	   that	  deregulations	   occur	   at	   a	   level	   that	   is	   easily	  masked	   by	   clonal	   heterogeneity,	  especially	  in	  aneuploid	  cultures	  that	  show	  elevated	  rates	  of	  chromosomal	  mis-­‐segregation.	   Another	   plausible	   explanation	   is	   that,	   as	   previously	   discussed,	  there	   is	   a	   positive	   correlation	   between	   the	   presence	   of	   extra	   chromosomes	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and	   the	   corresponding	   protein	   levels	   106,131(Torres	   et	   al	   2010)	   (Rebecca	   R.	  Beach	  Cell	  2017),	  with	  the	  exception	  of	  subunits	  of	  protein	  complexes,	  where	  stoichiometry	  is	  generally	  maintained	  106(Torres	  et	  al	  2010).	  In	  line	  with	  this	  interpretation,	   MCM	   protein	   levels	   are	   close	   to	   Log2	   0.0	   in	   4N,	   most	   of	   the	  PTAs	  and	  trisomic	  clones	  (Fig.	  35).	  	  
	  
	  
Figure	  35:	  Dot	  plots	  showing	  the	  relative	  abundance	  of	  proteins	  belonging	  to	  the	  MCM	  and	  ORC	  complexes	  in	  4N,	  PTA	  and	  Tr7	  clones.	  	  It	   is	   also	   possible	   that	   components	   associated	   with	   the	   occurrence	   of	   -­‐	   or	  tolerance	   towards	   -­‐	   chromosomal	   gains	   and	  CIN	  are	   less	   rate	   limiting	   in	   the	  transformed	  background	  found	  in	  the	  parental	  MIN	  cells.	  For	  instance,	  the	  lack	  of	  functional	  p53	  alleles	  in	  DLD-­‐1	  cells	  135(Rodrigues	  NR	  Natl.	  Acad.	  Sci	  1990)	  could	   exert	   weaker	   selective	   pressure	   and	   could	   thus	   allow	   for	   a	   broader	  range	  of	  genetic	  variation.	  Yet,	  I	  reasoned	  that	  small	  expression	  changes	  could	  have	   synergistic	   effects	   on	   enzyme	   activity,	   especially	   in	   dynamic	   mitotic	  networks,	   and	   that	   polygenic	   phenotypes	   such	   as	   CIN	   might	   therefore	   be	  accompanied	   by	   detectable	   deregulation	   at	   the	   level	   of	   post-­‐translational	  modifications.	   I	   therefore	   submitted	   all	   cell	   lines	   to	   phospho-­‐proteome	  analysis	  in	  order	  to	  quantify	  possible	  correlations	  of	  phospho-­‐occupancy	  with	  the	  gain	  of	  chromosome	  mass	  and	  elevated	  rates	  of	  chromosomal	  instability.	  	  
4.6.	   Comparative	   phospho-­‐proteomic	   analysis	   of	   DLD-­‐1	  
derived	  cells	  Since	   the	   effects	   of	   aneuploidy	   and	   increased	   chromosome	   mis-­‐segregation	   could	   be	   reflected	   at	   a	   post-­‐translational	   level,	   I	   decided	   to	  perform	  TiO2	  phospho-­‐peptide	  enrichment	  and	  HPLC-­‐MS/MS.	  This	  resulted	  in	  the	   identification	   of	   15’300	   phospho-­‐peptides	   from	   3’192	   proteins	   across	  biological	  triplicate	  samples	  of	  the	  diploid,	  tetraploid	  and	  three	  post-­‐tetraploid	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DLD-­‐1	  cell.	  Unfortunately,	  due	  to	  technical	  reasons,	  one	  post-­‐tetraploid	  clone	  revealed	   poor	   FDR	   scores	   for	  most	   of	   the	   phospho-­‐peptides	   found,	   and	   so	   I	  decided	  to	  not	  consider	  the	  corresponding	  data	  for	  further	  analysis.	  The	  same	  approach	   was	   applied	   in	   parallel	   to	   the	   trisomic	   cell	   lines,	   resulting	   in	  identification	   of	   8’960	   phospho-­‐peptides	   from	   2’553	   proteins.	   As	   previously	  done	  for	  protein	  abundance	  analysis,	  when	  I	  set	  up	  a	  stringent	  q-­‐value	  cut-­‐off	  of	   0.05,	   I	   observed	   a	   considerable	   number	   of	   phosphopeptides	   to	   be	  significantly	  deregulated	  in	  all	  cell	  lines	  (Fig.	  36).	  	  
	  	  
Figure	   36:	   Graphs	   showing	   the	   numbers	   of	   significant	   down-­‐	   and	   up-­‐regulations	   of	  phospho-­‐peptide	  counts	  in	  relation	  to	  the	  false	  discovery	  rate.	  Dashed	  lines	  indicate	  a	  false	  discovery	  rate	  of	  5%.	  Data	  are	  from	  three	  biological	  replicates.	  It	  should	  be	  noted	  that	  the	  number	  of	  phospho-­‐peptides	  identified	  in	  the	  trisomic	  clone	  experiments	  was	  lower	  than	  in	  the	  PTA	  experiment	  (because	  the	  two	  experiments	  were	  performed	  separately,	  resulting	  in	  independent	  results/numbers	  of	  identified	  hits).	  	   To	  identify	  changes	  in	  protein	  phosphorylation	  that	  correlate	  with	  a	  gain	  in	  chromosome	  mass,	  I	  compared	  the	  500	  most	  deregulated	  phospho-­‐peptides	  (based	  on	  an	  FDR	  of	  <10%,	  comprising	  both	  up	  and	  down	  regulation)	   in	  4N,	  PTAs	  and	  trisomic	  clones	  (Fig.	  37	  left	  and	  right	  panel).	  I	  identified	  63	  proteins	  showing	  significantly	  deregulated	  phosphorylation	  across	  4N	  and	  PTA	  clones	  (Fig.	  37	  right	  panel,	  Table	  S2)	  and	  75	  proteins	  across	  4N	  and	  trisomic	  clones	  (Fig.	   37	   left	   panel,	   Table	   S2).	   These	   results	   indicate	   that	   changes	   in	  chromosome	   number	   not	   only	   have	   an	   impact	   on	   protein	   expression,	   as	  discussed	   above	   for	   the	   TMT	   data	   analyses,	   but	   also	   on	   protein	  phosphorylation.	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Figure	   37:	   Left	  panel:	  Venn	  diagrams	   representing	   the	  number	  of	   statistically	   significant	  shared	  phospho-­‐protein	  deregulations	  across	  the	  indicated	  cell	  lines.	  Results	  were	  obtained	  by	  selecting	  the	  500	  most	  deregulated	  phospho-­‐peptides	  per	  cell	  line	  (based	  on	  an	  FDR	  of	  <10%).	  Right	  panel:	  table	  listing	  the	  false	  discovery	  rates	  (FDR)	  for	  the	  analyzed	  cell	  lines.	  	  Interestingly,	  as	  observed	  for	  the	  deregulation	  of	  protein	  expression	  (Fig.	  25),	  I	  detected	  only	   few	  proteins	   that	  shared	  deregulated	  phosphorylation	  across	  only	  PTA	  clones	  (Fig.	  37	  left	  panel,	  S6),	  which	  would	  have	  been	  indicative	  of	  a	  correlation	   with	   the	   presence	   of	   CIN.	   This	   suggests	   that	   a	   big	   gain	   of	  chromosome	   mass	   is	   a	   stronger	   determinant	   for	   deregulated	   protein	  phosphorylation	   than	   frequent	   chromosome	   mis-­‐segregation.	   To	   detect	  regulatory	   patterns	   that	   were	   shared	   among	   4N	   and/or	   PTA	   clones,	   I	  submitted	   phospho-­‐enrichment	   data	   to	   cluster	   analysis	   using	   the	   fuzzy	   C-­‐means	   algorithm	   “MFuzz”	   149(Futschik	   &	   Carlisle,	   J	   Bioinform	   Comput	   Biol.	  2005).	  For	  cells	  that	  had	  gained	  a	  greater	  number	  of	  chromosomes,	  such	  as	  in	  4N	  and	  PTA	  clones,	  I	  was	  able	  to	  identify	  only	  patterns	  of	  phopho-­‐peptide	  up-­‐regulation	  (Fig.	  38,	  Table	  S6)	  but	  not	  down-­‐regulation.	  Most	  likely	  this	  is	  due	  to	   the	   fact	   that	   increases	   in	   phosphorylation	   are	   technically	   less	   difficult	   to	  detect	  than	  decreases	  in	  phosphorylation.	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Figure	  38:	  Cluster	  analysis	  based	  on	  the	  500	  most	  deregulated	  phospho-­‐peptides	  (FDR	  of	  <10%,	   yielding	   a	   total	   of	   1410	  phospho-­‐peptides	   from	  807	  proteins)	   per	   condition	  using	  the	   fuzzy	   C-­‐means	   algorithm	   “MFuzz”.	   Depicted	   clusters	   show	   phospho-­‐peptide	   up-­‐regulations	   common	   to	  PTA	   (left	   graph)	  or	  4N	  and	  PTA	   (right	   graph)	   clones.	   Log2	   ratios	  were	  normalized	   to	  have	  a	  standard	  deviation	  of	  1	  and	  a	  mean	  of	  0	   (z-­‐score).	  Black	   lines	  indicate	  the	  optimal	  membership	  of	  1,	  color-­‐coding	  represents	  cluster	  membership	  values.	  Note	  that	  clusters	  were	  formed	  based	  on	  peptides	  that	  showed	  significant	  deregulation	  in	  at	  least	  one	  condition.	  	  The	   single	   chromosome	   gains	   in	   trisomic	   clones,	   however,	   allowed	   me	   to	  detect	   common	  phospho-­‐peptide	  up-­‐	   (Fig.	  39	  upper	   left	   and	   right	  panels)	   as	  well	  as	  down-­‐regulations	  (Fig.	  39	  Lower	  panel).	  	  	  
	  
	  
Figure	  39:	  Cluster	  analysis	  based	  on	  the	  500	  most	  deregulated	  phospho-­‐peptides	  (FDR	  of	  <10%,	   yielding	   a	   total	   of	   1410	  phospho-­‐peptides	   from	  807	  proteins)	   per	   condition	  using	  the	   fuzzy	   C-­‐means	   algorithm	   “MFuzz”.	   Depicted	   clusters	   show	   phospho-­‐peptide	   up-­‐
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regulations	  and	  down	  regulations	  common	  to	  Tr	  7	  (upper	  left	  graph	  and	  lower	  graph)	  and	  upregulations	   common	   to	   4N	   and	   Tr	   7	   clones	   (upper	   right	   graph).	   Log2	   ratios	   were	  normalized	  to	  have	  a	  standard	  deviation	  of	  1	  and	  a	  mean	  of	  0	  (z-­‐score).	  Black	  lines	  indicate	  the	  optimal	  membership	  of	  1,	  color-­‐coding	  represents	  cluster	  membership	  values.	  Note	  that	  clusters	  were	  formed	  based	  on	  peptides	  that	  showed	  significant	  deregulation	  in	  at	  least	  one	  condition.	  	   In	   order	   to	   identify	   which	   proteins	   were	   contained	   in	   these	   clusters,	   I	  next	   submitted	   the	   peptide	   lists	   obtained	   to	   GO-­‐term	   enrichment	   analysis.	  Different	  processes	  showed	  highly	  significant	  enrichment	  in	  clones	  displaying	  CIN	   (Fig.	   40	   upper	   panel),	   polyploidy	   (Fig.	   40	   lower	   panel)	   and	   defined	  aneuploidy	   (Fig.	   41).	   Analyses	   of	   clusters	   showing	   phospho-­‐peptide	   up-­‐regulations	  mostly	   identified	   enrichments	   of	   GO-­‐terms	   related	   to	   cell	   cycle-­‐,	  cytoskeleton	  (Fig.	  40	  upper	  and	  lower	  panel	  and	  Fig.	  41	  upper	  and	  lower	  panel	  green	  square).	  This	   finding	   is	  consistent	  with	   the	  hypothesis	   that,	   in	  general,	  aneuploidy	   can	   lead	   to	   increases	   in	   anaphase	   bridges,	   lagging	   chromosomes	  and	  micronuclei,	  as	  presented	  in	  the	  introduction	  91(A.	  Janssen	  2011	  Science).	  As	  a	  consequence,	  an	  increased	  burden	  on	  the	  SAC	  or,	  generally,	  the	  cell	  cycle,	  can	  be	  detected.	  Moreover,	  from	  cluster	  analysis	  several	  GO	  terms	  associated	  with	  transcription	  could	  be	  identified	  in	  both	  PTAs	  and	  4N	  (Fig.	  40	  light	  grey	  marked	  terms).	  As	  mentioned	  in	  the	  introduction,	  one	  of	  the	  effects	  commonly	  found	   in	   aneuloid	   cells	   is	   the	   presence	   of	   conserved	   gene	   expressions	  responses.	  This	  transcriptional	  response	  in	  aneuploid	  cells	  is	  associated	  with	  a	  characteristic	   enviromental	   stress	   and	   decreased	   cell	   proliferation	  95,96(Sheltzer	   J.M.	   2012	   PNAS)	   (Durrbaum	   M.	   2014	   BMC	   Genomics).	   This	  concept	   is	   in	   line	   with	   the	   observation	   that	   PTAs	   and	   4N	   cells	   up-­‐regulate	  RNA-­‐related	  pathways	  and	  show	  at	  the	  same	  time	  an	  increase	  in	  oxidative	  and	  proteolytic	  stress	  (Fig.	  24)	  and	  innate	  immune-­‐responses	  (Fig.	  26	  and	  28).	  	  	  
	   72	  
	  
	  	  
Figure	   40	   Tables	   listing	   the	   results	   of	   gene	   ontology	   (GO)-­‐term	   enrichment	   analysis	   of	  phospho-­‐peptides	  up-­‐regulated	  across	  PTA	  clones	  (upper	  panel);	  and	  4N	  plus	  PTAs	  (lower	  panel).	   Enrichment	   analysis	   was	   carried	   out	   for	   the	   500	   most	   deregulated	   phospho-­‐peptides	  per	  condition	  (p>0.05),	  the	  20	  most	  significant	  enrichments	  are	  shown.	  	  Remarkably,	   all	   these	   observations	   were	   made	   for	   cell	   lines	   that	   had	  undergone	   any	   kind	   of	   chromosome	   gain,	   notably	   4N	   and	   PTAs	   (Fig.	   40)	   as	  well	  as	   the	   trisomic	  clones	  (Fig.	  41).	  Thus,	   I	  made	   the	  assumption	   that	   these	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Figure	   41:	   Tables	   listing	   the	   results	   of	   gene	   ontology	   (GO)-­‐term	   enrichment	   analysis	   of	  phospho-­‐peptides	  up-­‐regulated	  across	  Trisomic	  clones	  (upper	  panel);	  and	  4N	  plus	  Trisomic	  clones	   (lower	   panel).	   Enrichment	   analysis	  was	   carried	   out	   for	   the	   500	  most	   deregulated	  phospho-­‐peptides	  per	  condition	  (p>0.05),	  the	  20	  most	  significant	  enrichments	  are	  shown.	  	   Similar	  results	  were	  obtained	  by	  submitting	  clusters	  of	  phospho-­‐peptide	  upregulations	   to	   STRING	   for	   functional	   protein	   network	   analysis.	   Firstly,	   I	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observed	  a	  greater	  number	  of	   functional	  clusters	   in	  cells	  that	  had	  undergone	  major	   chromosome	   gains,	   including	   4N	   and	   PTA	   clones	   (Fig.	   42	   &	   Fig.	   43),	  when	  compared	  to	  trisomic	  clones	  (Fig.	  44).	  	  
	  	  
Figure	   42:	   STRING	   functional	   network	   analysis	   of	   the	   phospho-­‐peptides	   belonging	   to	  clusters	  shown	  in	  Figure	  37	  left	  panel.	  Nodal	  connections	  are	  based	  on	  a	  confidence	  value	  of	  0.9	   using	   experimental	   and	  database	   evidence.	   Solid	   lines	   indicate	   intra-­‐network,	   dashed	  lines	  inter-­‐network	  connections.	  	  Secondly,	   the	  majority	  of	   the	  networks	   identified	   in	  clones	  of	  cells	  harboring	  both	  minor	   (trisomic	   clones)	   and	  major	   chromosome	   burdens	   (4N	   and	   PTA	  clones)	  was	  related	  to	  processes	  that	  are	  likely	  to	  be	  affected	  by	  an	  increase	  in	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chromosome	   mass:	   replication,	   transcription	   and	   translation,	   transport	  through	  nuclear	  pores,	  DNA	  damage	  response,	  chromatin	  organization	  as	  well	  as	  microtubule-­‐	  and	  centrosome-­‐regulation	  (Fig.	  42	  &	  Fig.	  43,	  Fig.	  44).	  	  
	  	  
Figure	   43:	   STRING	   functional	   network	   analysis	   of	   the	   phospho-­‐peptides	   belonging	   to	  clusters	  shown	  in	  Figure	  37	  right	  panel.	  Nodal	  connections	  are	  based	  on	  a	  confidence	  value	  of	  0.9	  using	  experimental	  and	  database	  evidence.	  Solid	  lines	  indicate	  intra-­‐network,	  dashed	  lines	  inter-­‐network	  connections.	  	  Thirdly,	   while	   networks	   for	   DNA-­‐	   and/or	   RNA-­‐related	   processes	   were	  identified	   in	   all	   clones	   (Fig.	   42	   &	   Fig.	   43,	   Fig.	   44),	   proteins	   regulating	   the	  mitotic	   apparatus	   and	  DNA	   damage	   response	   only	   formed	   networks	   in	   cells	  carrying	  a	   strongly	   increased	  chromosome	  mass,	  notably	   tetraploid	  and	  PTA	  clones	  (Fig.	  42	  and	  43).	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Figure	  44:	  STRING	  functional	  network	  analysis	  of	  the	  phospho-­‐peptides	  of	  fuzzy	  C-­‐means	  algorithm	  clusters	  shown	  in	  Fig.	  38.	  Nodal	  connections	  are	  based	  on	  a	  confidence	  value	  of	  0.9	   using	   experimental	   and	  database	   evidence.	   Solid	   lines	   indicate	   intra-­‐network,	   dashed	  lines	  inter-­‐network	  connections.	  	   Taken	   together,	   these	   observations	   suggest	   that	   the	   most	   prominent	  changes	   in	   protein	   phosphorylation	   observed	   in	   this	   study	   correlate	   with	   a	  gain	  in	  chromosome	  number,	  rather	  than	  the	  presence	  of	  CIN.	  It	  is	  likely	  that	  a	  strong	   increase	   in	   chromosome	   mass	   imposes	   a	   stress	   on	   mitotic	   spindle	  organization	  and	  provokes	  a	  DNA	  damage	  response,	  while	  a	  numerically	  lower	  gain	   of	   chromosomes	   appears	   to	   elicit	   a	   response	   in	   DNA	   and	   RNA-­‐related	  processes.	  	  
4.7.	  Targeted	  analysis	  of	  protein	  phosphorylation	  in	  DLD-­‐1-­‐
derived	  cells.	  As	   previously	   done	   for	   the	   protein	   abundance	   analysis,	   these	   un-­‐biased	  analyses	   of	   the	   phosphoproteome	   dataset	   were	   also	   supported	   by	   targeted	  enrichment	   analysis	   using	   the	   CIN/cell	   division	   inclusion	   list,	   representing	  markers	  that	  have	  been	  already	  associated	  with	  CIN	  and	  mitotic	  cell	  division	  (Table	   S1).	   I	   identified	   enrichments	   of	   some	   phospho-­‐peptides	   that	   were	  upregulated	  in	  both	  tetraploid	  and	  PTA	  clones,	  as	  well	  as	  in	  one	  trisomic	  clone	  (Fig.	  45),	  whereas	  most	  clones	  did	  not	  show	  enrichments	  for	  down-­‐regulated	  phospho-­‐peptides	  (Fig.	  45).	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Figure	  45:	  Tables	  showing	  an	  enrichment	  analysis	  of	  the	  500	  most	  deregulated	  phospho-­‐peptides	  per	  cell	  line	  using	  the	  CIN/cell	  division	  inclusion	  list.	  The	  numbers	  of	  inclusion	  list	  matches	   (signlList)	   and	   non-­‐matches	   (totSign)	   were	   compared	   to	   random	   inclusion	   list	  matches	   (nonSignlList)	  and	  non-­‐matches	   (totNonSign)	   in	  a	  human	  proteome	  background.	  Significance	  (ftPValue)	  was	  calculated	  using	  Fisher’s	  exact	  test.	  Shaded	  areas	  highlight	  the	  most	  significant	  enrichments.	  	  Filtering	  all	  phospho-­‐peptides	  deregulated	  by	  at	  least	  2-­‐fold	  with	  the	  CIN/cell	  division	   inclusion	   list	   (Table	   S1),	   for	   closer	   inspection,	   revealed	   that	   no	  proteins	   included	   in	   the	   CIN/cell	   division	   inclusion	   list	   were	   exclusively	  observed	   to	   have	   altered	   phosphorylation	   states	   across	   all	   PTA	   clones.	   In	  contrast,	   I	   found	  phosphorylation	  for	  a	  number	  of	  proteins	  related	  to	  mitotic	  spindle	   and	   chromosome	   segregation	   to	   be	   commonly	   altered	   in	   both	  tetraploid	  as	  well	  as	  PTA	  clones	   (Fig.	  46),	  and,	   to	  a	   lesser	  extent,	   in	   trisomic	  clones	  (Fig.	  47).	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Figure	   46:	   Dot	   plots	   showing	   the	   phospho-­‐peptide	   ratios	   (versus	   parental	   2N	   cells)	   of	  detected	  proteins	  belonging	   to	   the	  CIN/cell	  division	   inclusion	   list	  and	  showing	  at	   least	  2-­‐fold	  deregulation	  in	  4N	  and	  PTAs.	  Dots	  represent	  significant	  (p≤0.05)	  phospho-­‐peptide	  log2	  ratios.	   Proteins	   related	   to	   mitotic	   spindle	   regulation	   and	   chromosome	   segregation	   are	  shown	  in	  bold.	  	  These	   proteins	   included	   regulators	   of	   microtubule	   dynamics,	   kinetochore-­‐microtubule	   interactions,	   centrosome	   function	   as	   well	   as	   spindle	   assembly	  checkpoint	  signaling	  (bold	  protein	  names	  in	  Fig.	  46	  and	  47).	  	  	  
	  
	  
Figure	   47:	   Dot	   plots	   showing	   the	   phospho-­‐peptide	   ratios	   (versus	   parental	   2N	   cells)	   of	  detected	  proteins	  belonging	   to	   the	  CIN/cell	  division	   inclusion	   list	  and	  showing	  at	   least	  2-­‐fold	  deregulation	  in	  4N	  and	  Trisomic	  clones.	  Dots	  represent	  significant	  (p≤0.05)	  phospho-­‐peptide	   log2	   ratios.	   Proteins	   related	   to	   mitotic	   spindle	   regulation	   and	   chromosome	  segregation	  are	  shown	  in	  bold.	  	   Network	  analysis	  of	  phospho-­‐peptides	  jointly	  deregulated	  in	  4N	  and	  PTA	  clones	   as	   well	   as	   in	   4N	   and	   trisomic	   clones	   identified	   mitotic	   spindle-­‐	   and	  chromatin-­‐related	  processes,	  and,	  as	  expected	  for	  an	  increase	  in	  chromosome	  number,	  processes	  related	  to	  DNA	  replication	  and	  transcription	  (Fig.	  48	  lower	  and	   upper	   panels).	   Taken	   together,	   I	   conclude	   that	   a	   strong	   increase	   in	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Figure	   48:	   STRING	   functional	   network	   analysis	   of	   the	   data	   shown	   in	   44	   and	   45.	   Nodal	  connections	   are	   based	   on	   a	   confidence	   value	   of	   0.9	   using	   experimental	   and	   database	  evidence.	  Solid	  lines	  indicate	  intra-­‐network,	  dashed	  lines	  inter-­‐network	  connections.	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In	   line	  with	   the	  above	   interpretation,	   changes	  were	  predominantly	  observed	  in	   tetraploids	   as	  well	   as	   post-­‐tetraploids	   and	   only	   to	   a	   lesser	   extent	   in	   cells	  carrying	  one	  additional	  chromosome.	  	  As	   mentioned	   in	   the	   introduction,	   CIN	   has	   been	   observed	   to	   correlate	  with	  increased	  resistance	  to	  anti-­‐cancer	  drugs,	  some	  of	  which	  are	  inhibitors	  of	  mitotic	   kinases	   150,151(Kuznetsova	   AY	   2015	   Cell	   Cycle)	   (Lee	   AJ	   Cancer	   Res	  2011).	   In	   a	   final	   set	   of	   experiments,	   I	   therefore	   asked	  whether	   inhibitors	   of	  spindle	   and	   cell	   cycle	   regulatory	   kinases	  would	   show	  a	   differential	   effect	   on	  cell	  survival	  that	  might	  be	  correlated	  with	  gains	  in	  chromosome	  number.	  	  
4.8.	   Drug	   sensitivity	   assays	   in	   cultures	   of	   DLD-­‐1-­‐derived	  
cells.	  Aneuploidy	   is	   generally	   associated	  with	   poor	   prognosis	   in	   solid	   tumors	  9,11,151(Lee	   AJ	   Cancer	   Res	   2011)	   (Walther	   A	   Gut	   2008)	   (Carter	   SL	   Nat	   Genet	  2006).	   Thus,	   the	   stratification	   of	   tumor	   responses	   according	   to	   CIN	   status	  should	  be	  considered	  within	  the	  context	  of	  clinical	  trials.	  With	  this	  context	  in	  mind,	   I	  used	  a	  panel	  of	  38	  well-­‐annotated	  anti-­‐cancer	  drugs	   largely	  targeting	  cell	   division-­‐related	   protein	   kinases	   and	   performed	   drug-­‐sensitivity	   assays.	  These	   assays	  measured	   intracellular	   ATP	   content	   as	   an	   indirect	   readout	   for	  cell	  survival	  150(Kuznetsova	  AY,	  2015,	  Cell	  Cycle).	  I	  oberserved	  several	  changes	  in	  drug	  resistance,	  which	  were	  common	  for	  tetraploid	  and	  PTA	  cultures	  (Fig.	  49	  and	  Table	  S3).	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Figure	   49:	   Dot	   plots	   showing	   the	   significance	   (unpaired	   two-­‐tailed	   t-­‐test)	   and	   IC50	  difference	  (relative	  to	  the	  parental	  diploid	  DLD-­‐1	  cell	  line,	  2N)	  observed	  after	  applying	  the	  compounds	   shown	   in	   Table	   S3	   to	   the	   indicated	   cell	   cultures.	   Dashed	   lines	   demark	   the	  quadrants	   of	   significant	   increases	   in	   sensitivity	   (upper	   left),	   significant	   decreases	   in	  sensitivity	   (upper	   right)	  and	   insignificant	  changes	  of	   IC50	  values	   (lower	  quadrants).	  Data	  are	  from	  three	  biological	  replicates.	  	  
	  Specifically,	   I	   detected	   an	   increased	   drug	   resistance	   towards	   inhibitors	   of	  Aurora	   A	   kinase	   (GSK-­‐1070916)	   152(Adams	   ND	   J	   Med	   Chem	   2010),	   Chk1	  kinase	   (CHIR-­‐124	   and	   SCH-­‐900776)	   153,154(Tse	   AN	   Clin	   Cancer	   Res	   2007)	  (Karp	   JE	   Clin	   Cancer	  Res	   2012),	   and	  Cyclin-­‐dependent	   kinases	   (Roscovitine)	  155(Meijer	  L	  Acc	  CHem	  Res	  2003)	  that	  correlated	  with	  a	  gain	   in	  chromosome	  mass	   in	   tetraploid	   and/or	   post-­‐tetraploid	   aneuploidy	   clones.	   This	   trend	  was	  similar	   to	   a	   study	   that	   observed	   multi-­‐drug	   resistance	   in	   response	   to	  aneuploidy	   151(Lee	   et	   al	   Cancer	   Research	   2011).	   Although	   I	   did	   not	   observe	  altered	  phosphorylation	   at	  phosphorylation	   sites	   regulated	  by	  Chk1	  or	  Cdk1	  156,157(Smits	   VA	   FEBS	   J	   2015)	   (M	   Malumbres	   2014	   Genome	   Biol)	   in	   our	  phospho-­‐proteome	   analyses	   of	   tetraploid	   or	   PTA	   cells,	   I	   had	   observed	  increased	   phosphorylation	   of	   the	   Aurora	   A	   T-­‐loop	   phosphorylation	   site	  158(Evers	  P.A	  Curr	  Biol	  2003)	  (Fig.	  50).	  	  
	  
Figure	  50:	  Dot	  plot	  showing	  selected	  detection	  ratios	  of	  regulatory	  phosphorylation	  sites	  of	  the	   centrosome	  and	  mitotic	   spindle	  kinase	  Aurora	  A	   (AURKA	  P-­‐T288),	   the	  mitotic	  kinase	  Cdk1	  (CDK1	  P-­‐T14,	  P-­‐Y15),	   the	  cell	  cycle	  checkpoint	  kinase	  Chk1	  (CHK1	  P-­‐S286,	  CHK1	  P-­‐S301)	   and	   the	  mitotic	   spindle	   kinase	  Plk1	   (PLK1	  P-­‐T210).	  Dashed	   line	   indicated	   a	   2-­‐fold	  cutoff.	  Aurora	  A	  is	  required	  for	  the	  phosphorylation	  and	  activation	  of	  the	  T-­‐loop	  (on	  Thr210)	   of	   the	   essential	   spindle	   regulator	   Plk1,	   an	   important	   regulator	   of	  mitotic	  spindle	  formation	  and	  kinetochore	  function	  159(von	  Schubert	  et	  al	  Cell	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Rep	   2015)	   (Fig.	   49	   and	   Fig.	   52,	   Table	   S3).	   Most	   interestingly,	   I	   observed	   a	  trend	   towards	   increased	   Plk1	   T-­‐loop	   phosphorylation	   (at	   Thr210)	   in	  tetraploid	   and	   PTA	   clones	   even	   if	   this	   change	   was	   not	   always	   statistically	  significant	   (Fig.	   50	   and	   Fig.	   51).	   In	   line	   with	   this	   observation,	   cells	   with	  strongly	   increased	   chromosome	   mass	   (4N	   and	   PTAs)	   showed	   a	   stronger	  sensitivity	   towards	   two	   inhibitors	   of	   Plk1	   (GSK-­‐461364	   and	   volasertib)	  160(Shin	  SB	  J	  Cell	  Physiol	  2015),	  possibly	  reflecting	  a	  higher	  demand	  for	  Plk1	  function	  in	  these	  cells,	  but	  not	  in	  trisomic	  cells.	  	  
	  
	  	  
Figure	  51:	  Table	  listing	  the	  p-­‐values	  for	  phospho-­‐peptide	  measurements	  shown	  in	  Figure	  50.	  
	  
	  
Figure	   52:	   Graphs	   showing	   dose-­‐response	   curves	   using	   the	   Plk1	   inhibitor	   Volasertib	   on	  indicated	  cell	   cultures.	  Dashed	   lines	   indicate	   IC50	  values.	  Table	   listing	   IC50	  average	   from	  three	  biological	  replicates	  (see	  table	  S3)	  and	  p-­‐values	  for	  indicated	  cell	  lines	  (unpaired	  two-­‐tailed	  t-­‐test).	  
	   This	   trend	  was	  also	  partially	  confirmed	  by	  a	  different	  approach,	  notably	  immunofluorescence	   microscopy	   (IFA)	   (Fig.	   53).	   In	   particular,	   using	   a	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phospho-­‐specific	  antibody	  I	  observed	  a	  slightly	  higher	  phosphorylation	  at	  the	  Plk1	   T-­‐loop	   site	   in	   4N	   and	   PTAs	   (even	   though	   this	   was	   always	   statistically	  significant),	  which	  was	  not	  accompanied	  by	  stronger	  staining	  for	  Plk1	  protein.	  
	  
	  
Figure	   53:	   Upper	   panel:	  micrographs	   of	   cells	   stained	  with	   anti-­‐Plk1,	   pT210	  Plk1,	   CREST	  and	  DAPI.	  Note	  that	   in	  trisomic	  clones	  Plk1	  staining	  could	  not	  be	  recorded,	  because	  these	  cells	   expressed	   histone	   H2B-­‐GFP,	   blocking	   the	   fluorescein	   channel.	   Below	   panel:	   plot	  showing	   the	   quantification	   of	   pT210	   Plk1	   in	   all	   cell	   lines;	   normalization	  was	   done	   using	  CREST	  signal	  and	  ratios	  were	  calculated	  relative	  to	  the	  signals	  obtained	  for	  2N	  cells	  (set	  to	  1.0).	  Experiments	  were	  done	  in	  duplicates,	  bar	  represent	  10	  μm,	  two-­‐tailed	  t-­‐test:	  *P<0.05,	  **P<0.01,	  ***P<0.001	  and	  ****P<0.0001.	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As	  discussed	  in	  the	  introduction,	  one	  factor	  triggering	  chromosomal	  instability	  is	   the	   presence	   of	   uncorrected,	   erroneus	   microtubule-­‐kinetochore	  attachments,	   and	   this	   phenotype	   is	   linked	   to	   the	   presence	   of	   extra	  chromosomes.	   Higher	   levels	   of	   T-­‐loop	   phosphorylated	   Plk1	   could	   thus	   be	  explained	   by	   an	   increased	   need	   of	   the	   activated	   version	   of	   Plk1	   to	   correct	  erroneous	  microtubule-­‐kinetochore	  attachments.	  	  In	  order	  to	  check	  whether	  I	  could	  detect	  increased	  merotelic	  attachments	  in	   cells	   that	   present	   an	   increase	   in	   chromosome	   mass,	   I	   also	   performed	  stainings	   on	   metaphase	   cells	   of	   diploid,	   tetraploid	   and	   PTA	   clones	   with	   α-­‐tubulin	  and	  CREST	  antibodies	  (Fig.	  54).	  	  
	  
	  
Figure	  54:	  Upper	  panel:	  quantification	  of	  correct	  and	  incorrect	  attachments	  in	  non	  treated	  cells.	  Lower	  panel:	  micrographs	  of	  metaphase	  cells	  stained	  with	  anti-­‐	  α-­‐tubulin,	  CREST	  and	  DAPI.	  	  
	  Image	   analysis	   revealed	   indeed	   a	   small	   increase	   of	   uncorrect	   kinetochore-­‐microtubule	  attachments,	  which	  could	  explain	  the	  presence	  of	  higher	  levels	  of	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activated	   (T-­‐loop	   phosphorylated)	   Plk1	   at	   kinetochores.	   These	   observations	  suggest	   that	   the	   observed	   changes	   in	   the	   phosphorylation	   dynamics	   of	   the	  mitotic	   spindle	   phospho-­‐proteome	   described	   in	   this	   study	   could	   potentially	  translate	  into	  differential	  responses	  to	  clinically	  used	  anti-­‐cancer	  drugs.	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5.	  Discussion.	  The	  potential	  molecular	  causes	   triggering	  aneuploidy	  have	  been	  studied	  extensively,	  but	  most	  of	  the	  molecular	  mechanisms	  are	  still	  poorly	  understood.	  Moreover,	   even	   if	   the	   presence	   of	   aneuploidy	   in	   tumor	   cells	   has	   been	  extensively	  documented	   116(Mitelman	  F.	   2014	  Chromosomes)	   (Beroukhim	  R.	  Nature	   2010),	   it	   is	   still	   debated	   if	   aneuploidy	   fuels	   tumorigenesis	   117,119-­‐121(Storchova	  Z,	   et	   al.	   2006	  Nature)	   (Nicholson,	   et	   al.	   2015)	   (Passerini,	   et	   al.	  2016)	  (Santaguida	  and	  Amon	  2015).	  Adding	  another	  level	  of	  complexity	  to	  the	  causality	   relation	   between	   aneuploidy	   and	   tumorigenesis,	   is	   CIN	   15(Weaver	  B.A.A.	   Cancer	   cell	   2007).	   It	   has	   indeed	   been	   proposed	   that	   CIN	   can	   both	  promote	  and	  suppress	  carcinogenesis	  127,128(Jamal	  Hanjani	  2017	  N	  Engl	  J	  Med)	  (Murugaesu	  2015	  Cancer	  Discov).	  Thus,	  the	  relationship	  between	  aneuploidy,	  chromosomal	  instability	  and	  cancer	  has	  not	  yet	  been	  clarified.	  In	   this	   study	   I	   aimed	   at	   distinguishing	   the	   effects	   of	   chromosome	   gains	  and	   CIN	   on	   protein	   expression	   and	   protein	   phosphorylation,	   with	   the	   hope	  that	  these	  studies	  might	  contribute	  to	  answer	  which	  molecular	  pathways	  are	  deregulated	   in	   cancer	   cells	  harboring	  aneuploidy	  and/or	  CIN,	   allowing	   these	  cells	  to	  survive.	  My	  results	  revealed	  that	  post-­‐tetraploid	  aneuploidy	  cells	  and,	  to	   a	   lesser	   extent,	   trisomic	   aneuploid	   cells,	   displayed	   increased	   rates	  of	  mis-­‐segregation,	  while	  tetraploid	  cells	  had	  a	  level	  of	  chromosome	  mis-­‐segregation	  that	  was	  comparable	  to	  the	  diploid	  state.	  Second,	  in	  agreement	  with	  previous	  studies	  98,99,102,105(Upender	  et	  al	  Cancer	  Res.	  2004;	  Dephoure	  et	  al.	  eLife	  2014;	  Stingele	   et	   al.	   Mol	   Syst	   Biol	   2012;	   Sheltzer	   Cancer	   Research	   2013),	   I	   have	  found	  that	  changes	  in	  chromosomal	  copy	  number	  had	  proportional	  effects	  on	  the	   levels	   of	   proteins	   encoded	   by	   the	   respective	   chromosomes,	   and	   that	   the	  stress	   resulting	   from	   extra	   chromosomes	   led	   to	   a	   deregulation	   of	   proteins	  involved	  in	  protein	  degradation,	  folding,	  oxidative	  stress	  response	  and	  innate	  immune	   response.	   Although	   I	   did	   not	   identify	   a	   proteomic	   signature	  attributable	   to	   a	   CIN-­‐specific	   phenotype,	   phosphorylation	   data	   analysis	  revealed	   an	   increased	   phosphorylation	   of	   proteins	   related	   to	   cell	   cycle	  progression	   and	   mitosis,	   in	   all	   generated	   cell	   lines	   (PTAs,	   4N	   and	   trisomic	  clones)	  versus	   parental	   diploid	   cells.	   Finally,	   in	   good	  agreement,	   I	   found	   two	  small	  molecule	  inhibitors	  of	  the	  key	  mitotic	  kinase	  Plk1	  to	  reduce	  cell	  survival	  in	   tetraploid	   as	   well	   as	   post-­‐tetraploid	   aneuploid	   cells.	   Notably,	   all	   these	  findings	   in	   protein	   expression	   and	   phosphorylation	   changes	   were	   not	   too	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dissimilar	   in	   stable	   tetraploid	   and	   descendant	   unstable	   post-­‐tetraploid	  aneuploid	   cells,	   suggesting	   that	   strong	   gain	   of	   chromosome	   mass	   is	   an	  important	   determinant	   of	   cellular	   response,	   regardless	   of	   gene	   balance.	   It	  could	   thus	   be	   that	   elevated	   chromosome	   number	   promotes	   adaptation,	  deregulation	   of	   proteomic	   and	   phospho-­‐proteomic	   pathways	   in	   transformed	  cancer	  cells,	  regardless	  of	  the	  presence	  of	  CIN.	  	  
5.1.	  Inter	  cell	  line	  variation	  as	  a	  source	  of	  heterogeneity.	  In	   order	   to	   pursue	   my	   purpose	   (and	   to	   establish	   proteomics	  methodology)	   I	   initially	   decided	   to	   compare	   a	   panel	   of	   8	   different	   cell	   lines	  showing	   distinct	   karyotype	   states	   and	   stability	   conditions	   28(Gascoigne	   KE	  2008	  Cancer	  Cell).	  Proteomic	  analysis	  revealed	  a	  high	  level	  of	  complexity	  that	  did	   not	   allow	   to	   cluster	   CIN	   and	  non-­‐CIN	   cell	   lines	   based	   on	   their	   proteome	  profiles.	   This	   result	   is	   in	   agreement	   with	   previous	   findings	   that	   had	  documented	  an	  extensive	  degree	  of	  interline	  variation	  28	  (Gascoigne	  KE	  2008	  Cancer	   Cell).	   This	   high	   inter-­‐line	   variation,	   due	   to	   clonal,	   tissue	   origin	   or	  cancer	   type	   differences,	   could	   be	   expected	   to	   render	   the	   identification	   of	  protein	   expression	   patterns	   correlating	   with	   CIN	   difficult,	   at	   least	   at	   the	  experimental	   scale	   used	   in	   our	   pilot	   studies.	   Thus,	   by	   introducing	   different	  karyotype	   states	   in	   the	   same	   isogenic	   parental	   cell	   line	   I	   next	   aimed	   to	  decrease	  inter	  cell	  line	  variability	  and	  focus	  only	  on	  the	  differences	  caused	  by	  chromosome	  mass	  changes	  or	  the	  CIN	  phenotype.	  
5.2	  Factors	  triggering	  of	  chromosomal	  instability.	  5.2.1	  Tetraploidization	  In	   this	   study	   I	   used	   DLD-­‐1colon	   cancer	   cells,	   which	   have	   essentially	   a	  diploid	   karyotype	   and	   show	   microsatellite	   instability	   (MIN).	   It	   has	   been	  previously	   shown	   that	   a	   tetraploidy	   state	   can	   be	   a	   source	   of	   chromosomal	  instability,	   inducing	   both	   aneuploidy	   and	   instability	   83,161(Lv	   et	   al.,	   2012)	  (Sansregret	   et	   al.,	   2011).	  The	  data	  presented	  here	   supports	   these	  previously	  reported	   observations.	   Indeed,	   after	   one	   month	   of	   propagation	   in	   culture,	  posttetraploid	   cells	   displayed	   a	   broad	   variety	   of	   karyotypes.	   Observed	  karyotypes	   ranged	   from	   near-­‐triploidy	   to	   hyper-­‐triploidy,	   and	   median	  chromosome	   numbers	   varied	   between	   different	   posttetraploid	   isolates.	  
	   88	  
Therefore,	   transient	   passage	   through	   a	   tetraploid	   state	   can	   lead	   to	   variable	  aneuploidy.	  	  It	  is	  important	  to	  consider	  that	  DLD-­‐1	  cells	  show	  a	  p53	  deficient	  status	  –Ser241	  èPhe–	   135(Nanda	  R.	  Rodrigues	  Proc.	  Natl.	  Acad.	  Sci	  USA	  1990),	  and	  a	  recent	   study	   supports	   the	   concept	   that	   the	   absence	  of	   a	   p53	   response	   could	  favor	   the	   capacity	   of	   tetraploid	   clones	   to	   proliferate	   after	   chromosome	  mis-­‐segregation.	  In	  particular,	  colon	  cancer	  microsatellite	  instable	  (MIN)	  HCT116,	  upon	  tetraploidization,	  exhibited	  a	  CIN	  positive	  phenotype	  150(Kuznetsove	  AY	  et	   al	   2015	   Cell	   cycle).	   These	   considerations	   could	   explain	   the	   data	   from	   the	  time	  lapse	  experiments	  presented	  here,	  showing	  that	  PTAs	  have	  the	  capacity	  to	   proliferate,	   even	   after	   the	   completion	   of	   a	   cell	   division,	   showing	   a	  spontaneous	   chromosomal	   mis-­‐segregation	   event.	   In	   contrast,	   I	   found	   that	  cells	   carrying	   small	   and	   defined	   chromosome	   mass	   gains,	   notably	   trisomic	  clones,	  showed	  a	  less	  pronounced	  CIN	  phenotype.	  This	  is	  in	  line	  with	  previous	  observations	  showing	  that	  the	  addition	  of	  single	  chromosomes	  can	  both	  drive	  and	  suppress	  the	  emergence	  of	  instability	  120,162(Sheltzer	  JM	  Cancer	  Cell	  2017)	  (Passerini	  V	  2016	  Nat	  Comm).	  In	   conclusion,	   the	   emergence	  of	   a	   CIN	  phenotype	   after	   tetraploidization	  confirms	  previous	  observations	  showing	  that	  doubling	  of	  the	  genome	  can	  fuel	  chromosomal	  instability	  80(Storchova	  Z	  2008	  Journal	  of	  cell	  science)	  and	  that	  loss	   of	   functional	   p53	   favors	   the	   capacity	   of	   aneuploid	   cells	   to	   proliferate	  150(Kuznetsove	  AY	  et	  al	  2015	  Cell	  cycle).	  5.2.1	  Erroneous	  mitosis	  is	  a	  source	  of	  CIN.	  	  Defective	   mitosis	   is	   a	   frequent	   cause	   of	   CIN.	   Consistent	   with	  immunofluorescence	  experiments,	   I	   found	   that	   chromosome	  mis-­‐segregation	  was	   elevated	   in	   post-­‐tetraploid	   cells.	   Additionally,	   karyotype	   analyses	  indicated	  the	  presence	  of	  numerous	  aberrations	  in	  PTAs	  cells,	  in	  particular	  in	  PTA1	   and	   PTA3;	   meanwhile	   in	   PTA2	   and	   PTA4	   less	   frequent	   copy	   number	  alterations	   were	   likely	   masked	   by	   clonal	   heterogeneity	   due	   to	   increased	  chromosome	  mis-­‐segregation	   rates.	   Moreover,	   post-­‐tetraploids	   displayed	   an	  increase	   in	   the	   frequency	   of	   lagging	   chromosomes.	   Anaphase	   lagging	   may	  serve	  as	  indirect	  evidence	  for	  an	  elevated	  frequency	  of	  merotelic	  attachments	  163(Cimini	  et	  al.,	  2001).	   Importantly,	  merotelic	  attachments	  are	  not	  corrected	  by	  the	  SAC,	  and	  have	  thus	  been	  postulated	  to	  constitute	  a	  major	  cause	  of	  CIN	  in	  cancer	  cells	  163	  (Cimini	  et	  al.,	  2001;	  reviewed	  in	  Gregan	  et	  al.,	  2011).	  Therefore,	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an	   increase	   in	   merotely,	   even	   in	   presence	   of	   a	   functional	   SAC,	   may	   lead	   to	  chromosome	  mis-­‐segregation	  and	  aneuploidy.	  However,	  even	  if	  segregated	  to	  a	  proper	  daughter	  cell,	  the	  former	  lagging	  chromosome	  can	  be	  resolved	  into	  a	  micronucleus	   that	   then	   undergoes	   defective	   replication,	   resulting	   in	   the	  accumulation	   of	   DNA	   double-­‐	   strand	   breaks	   in	   the	   subsequent	   interphase	  92,121(Crasta	   et	   al.,	   2012)	   (S.	   Santaguida	   and	   A.	   Amon	   2015	   Nature	   Review).	  This	  can	  potentially	  cause	  fragmented	  chromosomes	  in	  the	  following	  mitosis.	  Taking	   together,	   the	   increased	   occurrence	   of	   lagging	   chromosomes	   in	   post-­‐tetraploids	   is	   likely	   a	   manifestation	   of	   an	   increase	   in	   the	   frequency	   of	  merotelic	   attachments.	   Another	   mitotic	   defect	   prominently	   observed	   in	   our	  post-­‐tetraploids,	   is	   occurrence	   of	   anaphase	   bridges.	   Similar	   to	   lagging	  chromosomes,	   anaphase	   bridges	   often	   break	   in	   mitosis	   and	   result	   in	  micronucleation;	  these	  micronuclei	  contain	  defective	  nuclear	  pore	  complexes	  and	  show	  deregulated	  gene	  transcription	  164(Hoffelder	  et	  al.,	  2004).	  In	  support	  of	  this	  notion,	  I	  observed	  a	  significant	  increase	  of	  the	  formation	  of	  micronuclei,	  anaphase	  bridges	  and	  lagging	  chromosomes	  in	  PTAs	  and,	  less	  prominently,	  in	  Tr7.	   Numerous	   reasons	   can	   cause	   anaphase	   bridges:	   perturbed	   DNA	  replication	  165,166(Chan	  et	  al.,	  2009)	  (Sofueva	  et	  al.,	  2011),	  defective	  homology-­‐directed	   DNA	   repair	   167,168(Acilan	   et	   al.,	   2007)	   (Laulier	   et	   al.,	   2011)	   and	  impaired	  sister	  chromatid	  cohesion	  169(Wang	  et	  al.,	  2008).	  Notably,	  I	  detected	  the	  increase	  of	  UFBs	  positive	  for	  the	  marker	  BLM.	  UFBs	  originate	  either	  from	  DNA	  catenae	  or	   from	  replication	  or	  recombination	   intermediates	   that	  can	  be	  formed,	  for	  example,	  during	  double	  strand	  repair;	  thus,	  the	  occurrence	  of	  UFBs	  can	   be	   indicative	   of	   un-­‐replicated	   or	   abnormal	   DNA	   structures	   144(Chan,	   K	  2011	   Semin.	   Cell	   Dev.	   Biol).	   However,	  when	   I	   checked	   for	   alterations	   in	   the	  expression	   of	   proteins	   related	   to	   DNA	   replication,	   such	   as	   MCM	   and	   ORC	  complexes,	  I	  could	  not	  detect	  any	  significant	  deregulation	  (with	  the	  exception	  of	   one	   PTA	   clone).	   Altogether,	   it	   seems	   plausible	   that	   increased	   merotelic	  kinetochore	  attachments	  and/or	  defective	  DNA	  replication	  may	  be	  responsible	  for	   persistent	   chromosomal	   instability	   in	   these	   cells	   and	   the	   increase	   of	  mitotic	  errors	  in	  post-­‐tetraploid	  cell	  lines.	  	  
5.3	  Intra	  cell	  line	  heterogeneity	  influences	  cell	  proteome	  
response	  to	  CIN.	  By	   using	   a	   model	   where	   different	   cell	   lines	   share	   the	   same	   isogenic	  background,	  I	  aimed	  to	  eliminate	  the	  anticipated	  interline	  variation.	  However,	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it	  was	  striking	  to	  see	  that	  although	  these	  karyotypically	  distinct	  cell	  lines	  were	  derived	   from	   a	   common	   ancestor,	   they	   could	   exhibit	   multiple	   proteome	  responses	   after	   CIN	   had	   occurred	   (Fig.	   24).	   This	   is	   likely	   reflecting	   the	  presence	   of	   CIN	   itself,	   as	   CIN	   leads	   to	   gains,	   losses	   or	   rearrangements	   of	  (partial	   or	   entire)	   chromosomes	   during	   cell	   division,	   contributing	   to	   the	  constant	  evolution	  of	  karyotypes	  7,125(Lengauer,	  et	  al.	  1998)	  (McGranahan,	  et	  al.	  2012).	  5.3.1	  Common	  “aneuploidy	  stress”	  proteome	  signature.	  	  Previous	  comparative	  analyses	  of	  genomic,	  transcriptomic	  and	  proteomic	  profiles	  in	  aneuploidy	  cell	  lines	  yielded	  contradictory	  results	  2,103,136,170(Torres	  at	   al	   2007;	   William	   et	   al	   2008;	   Kvitek	   et	   al	   2008;	   Stenberg	   et	   al	   2009).	   In	  particular,	   both	   positive	   and	   negative	   correlations	   between	   the	   presence	   of	  extra	   chromosomes	   and	   corresponding	   protein	   levels	   have	   been	   reported	  98,106,131,137	   (Torres	  et	  al	  2010)	   (Pavelka	  et	  al	  2010)	   (Stingele	  et	  al	  2012	  Mole	  Syst	  Biology)	  (Rebecca	  R.	  Beach	  Cell	  2017).	  There	  is	  agreement,	  however,	  that	  levels	  of	  subunits	  of	  protein	  complexes	  are	  generally	  adjusted	  to	  maintain	  the	  correct	  stoichiometry	  106(Torres	  et	  al	  2010).	  In	  the	  present	  study,	  I	  have	  found	  that	  changes	  in	  chromosomal	  copy	  number	  exerted	  proportional	  effects	  on	  the	  levels	   of	   proteins	   encoded	   by	   the	   respective	   chromosomes,	   in	   line	   with	   the	  lack	   of	   a	   global	   dosage	   compensation	   system	   for	   autosomal	   aneuploidy	   in	  human	   cells.	   Notably,	   when	   I	   analyzed	   the	   relative	   abundance	   of	   protein	  complexes,	  such	  as	  MCM	  and	  ORC	  proteins,	  I	  noticed	  that	  all	  subunits	  of	  these	  complexes	  showed	  very	  similar	  relative	  abundances.	  These	  findings	  are	  in	  line	  with	   the	   conclusion	   that,	   in	   aneuploid	   cells,	   the	   stoichiometry	   of	   protein	  complex	   subunits	   is	   maintained.	   Every	   protein	   encoded	   by	   an	   unbalanced	  chromosome	   that	   functions	   in	   a	   protein	   complex	   and	   lacks	   its	   binding	  partner	  (or	   partners)	   risks	   to	   form	   aggregates	   and	  be	   insoluble;	   hence,	   such	  proteins	  are	  degraded	  104(Tyedmers	  J.	  2010	  Nat.	  Rev.	  Mol.	  Cell.).	  In	  agreement,	  I	   found	   that	   the	   relative	   abundance	   of	   proteins	   functioning	   in	   protein	  proteolysis,	  protein	   folding	  and	  oxidative	   stress	   responses	  were	  upregulated	  in	   the	   presence	   of	   aneuploidy.	   Notably,	   this	   effect	   concerned	   only	   cell	   lines	  showing	   big	   chromosome	  mass	   gain,	   such	   as	   tetraploidy	   and	   PTAs,	   but	   not	  cells	  with	  minor	  chromosome	  gains	  (i.e.	  the	  trisomic	  lines).	  	  An	   unbiased	   proteome	   analysis	   on	   generated	   cell	   lines	   revealed	   yet	  another	   change	   in	   the	   protein	   levels	   triggered	   by	   massive	   chromosome	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increase,	  namely	  the	  deregulation	  of	  type	  I	  interferon-­‐signaling	  components	  in	  tetraploid	  or	  post-­‐tetraploid	  cells.	  Previous	  studies	  reported	  that	  the	  presence	  of	  chromosomal	  lesions	  leads	  to	  an	  increased	  abundance	  of	  cytoplasmic	  DNA	  fragments,	   which	   then	   trigger	   a	   DNA	   damage	   response	   and	   thereby	   the	  induction	  of	  type	  I	  interferon	  signaling	  115,140,142,143(Samantha	  et	  al.,	  Immunity,	  May	  2016)	  (Erdal	  et	  al.	  Genes	  Dev	  March	  2017)	  (Shen	  et	  al.	  Cell	  Reports	  2015)	  (Karen	  J	  Mackenzie	  Nature	  2017).	  This	  hypothesis	  has	  been	  further	  confirmed	  by	  BrdU	  staining,	   in	  non-­‐denaturing	  conditions,	   that	  allowed	  me	  to	  detect	  an	  increased	   presence	   of	   cytoplasmic	   ssDNA.	   Moreover,	   a	   further	   observation	  tending	  to	  support	  this	  hypothesis	  was	  obtained	  by	  stainings	  with	  antibodies	  against	   BLM,	   revealing	   an	   increased	   frequency	   of	   UFBs	   in	   the	   trisomic,	  tetraploid	  and	  PTA	  cells,	  compared	  with	  controls,	  which	  could	  be	  indicative	  of	  double	  strand	  repair	  142(Erdal	  et	  al.	  Genes	  Dev	  March	  2017).	  Interestingly,	  one	  study	  suggested	  that	  an	  IFN-­‐related	  DNA	  damage	  resistance	  signature	  (IRDS)	  is	   associated	   with	   resistance	   to	   DNA-­‐damaging	   cancer	   therapy,	   due	   to	   a	  constitutive	  activation	  of	   the	   IFN	  pathway	  141(Weichselbaum	  et	  al.	  PNAS	  Nov	  2008).	   It	   could	   thus	   be	   that	   elevated	   chromosome	   numbers	   promote	  adaptation	   and	   immune	   evasion	   in	   transformed	   cancer	   cells.	   In	   favor	   of	   this	  interpretation,	  a	  recent	  study	  from	  the	  Amon	  laboratory	  shows	  that	  cells	  with	  complex	  karyotypes,	   raised	  after	  chromosome	  mis-­‐segregation,	  produce	  pro-­‐inflammatory	  signals	  that	  then	  promote	  their	  clearance	  by	  the	  immune	  system	  86(Santaguida	   S.	   2017	   Dev	   Cell).	   Moreover,	   a	   link	   between	   the	   presence	   of	  micronuclei	   and	   innate	   immunity	   has	   recently	   been	   reported	   115(Karen	   J	  Mackenzie	   Nature	   2017).	   In	   particular,	   cGAS,	   a	   cytosolic	   sensor	   of	   double-­‐stranded	   DNA,	   was	   shown	   to	   be	   activated	   by	   DNA	   damage	   and	   found	   to	  localize	   to	   micronuclei	   arising	   from	   lagging	   chromosomes	   or	   anaphase	  bridges.	   The	   presence	   of	   cytosolic	   dsDNA	   structures	   would	   thus	   lead	   to	   a	  proinflammatory	   response	   and	   stimulate	   the	   immune	   system	   115	   (Karen	   J	  Mackenzie	   Nature	   2017).	   The	   observed	   IFN	   proteins	   overexpression	   in	   the	  generated	  PTAs	  and	  polyploidy	  cells,	  and	  as	  well	   in	  Hela	  S3,	  SW480,	  SW837,	  HT29,	  nicely	  correlate	  with	  the	  proposed	  model.	  These	  data	  are	   in	   line	  with	   the	   current	  understanding	  of	   the	   immediate	  and	   long-­‐term	   effects	   of	   chromosome	   mis-­‐segregation	   and	   aneuploidy,	   in	  particular	   with	   the	   concept	   of	   aneuploidy-­‐associated	   stresses.	   It	   has	   been	  proposed	  that	  a	  mixture	  of	  common	  features	  and	  traits,	  such	  as	  transcriptional	  and	  post-­‐transcriptional	  responses	  and	  proteotoxic	  stress,	  are	  responsible	  for	  the	  effects	  of	  aneuploidy	  on	  cellular	  fitness	  88-­‐90(Santaguida	  S	  et	  al.	  Genes	  Dev.	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2015)	  (Dominigues	  PH	  Cancer	  Res	  2017)	  (Torres	  EM	  2008	  Genetics).	  Thus	  it	  could	   be	   that	   the	   stress	   resulting	   from	   strong	   increases	   in	   chromosome	  numbers	   leads	   to	   a	  deregulation	  of	  proteins	   involved	   in	  protein	  degradation	  and	   folding,	   as	  well	   as	   an	   oxidative	   stress	   response,	   and	   as	   shown	   recently,	  also	  to	  an	  IFN	  response.	  5.3.2	  Aneuploidy	  induces	  clonal	  heterogeneity	  in	  response	  to	  CIN	  Since	   massive	   increases	   in	   chromosome	   numbers	   brought	   about	   a	  common	  proteome	  response,	  as	  discussed	  in	  the	  previous	  paragraph,	  I	  decided	  to	   check	   for	   the	   existence	   of	   common	  CIN-­‐specific	   gene	   imbalances,	   through	  focus	   on	   a	   CIN-­‐inclusion	   list	   (i.e.	   a	   list	   comprising	   proteins	   previously	  implicated	   in	   CIN).	   Unfortunately,	   however,	   I	   could	   not	   detect	   a	   common	  proteomic	  answer	  and/or	   the	  deregulation	  of	  CIN-­‐specific	  genes	   in	   response	  to	   an	   increase	   in	  CIN	  phenotype.	  A	  possible	   explanation	   could	  be	   that	   a	   CIN	  signature	   is	  masked	   by	   the	   general	   deregulations	   that	  were	   triggered	   by	   an	  increase	   in	   ploidy,	   or	   due	   to	   clonal	   heterogeneity	   caused	   by	   elevated	  chromosome	   mis-­‐segregation	   rates	   in	   CIN	   cells.	   Alternatively,	   changes	   may	  simply	  have	  been	  too	  small	   to	  detect.	   Importantly,	  however,	   the	   fact	   that	   the	  major	  changes	  observed	  in	  CIN	  cells	  were	  also	  characteristic	  of	  the	  tetraploid	  progenitor	   cell	   line	   suggest	   that	   strong	   gains	   of	   chromosome	   mass	   are	   an	  important	   determinant	   of	   cellular	   response,	   regardless	   of	   gene	   balance.	   In	  agreement	   with	   this	   hypothesis,	   I	   have	   found	   that	   changes	   in	   protein	  expression	  and	  phosphorylation	  (discussed	  below)	  are	  not	  very	  dissimilar	   in	  tetraploid	  and	  descendant	  post-­‐tetraploid	  aneuploid	  cells.	  	  
5.4	  Phospho-­‐proteome	  changes	  in	  mitotic	  proteins	  might	  
reflect	  response	  to	  massive	  chromosomes	  mass	  gain.	  Since	  many	  of	  the	  proteins	  regulating	  mitosis	  are	  kinases	  I	  decided	  to	  also	  investigate	  possible	  phospho-­‐proteomic	  alterations	  in	  the	  generated	  cell	  lines.	  In	  agreement	  with	  the	  previous	  conclusion	  emerging	  from	  this	  study,	  i.e.	  that	  chromosome	  mass	  increase	  is	  a	  stronger	  determinant	  of	  proteomic	  alterations	  than	  CIN,	  I	  found	  that	  changes	  in	  protein	  phosphorylation	  correlated	  primarily	  with	   the	   increase	   in	   ploidy.	   This	   suggests	   that	   readily	   detectable	   changes	   in	  protein	   phosphorylation	   occur	   in	   response	   to	   the	   challenges	   imposed	   by	   a	  large	   number	   of	   chromosomes,	   rather	   than	   by	   an	   increase	   in	   chromosome	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mis-­‐segregation	  rate.	  Notably,	  through	  unbiased	  phospho-­‐proteome	  analysis	  I	  found	   that	   in	   PTAs	   and	   tetraploid	   cultures	   alterations	   in	   protein	  phosphorylation	   concerned	   processes	   directly	   associated	   with	   regulation	   of	  transcription	  and	  translation	  pathways.	  Previous	  work	  on	  aneuploid	  cells	  had	  identified	  several	  responses,	  such	  as	  the	  increase	  of	  oxidative	  and	  proteotoxic	  stress	   and	   DNA	   damage	   as	  well,	   and	   these	  were	   reflected	   in	   transcriptional	  responses	  95,96(Sheltzer	  J.M.	  2012	  PNAS)	  (Durrbaum	  M.	  2014	  BMC	  Genomics).	  This	   concept	   is	   in	   line	   with	   the	   observations	   described	   in	   the	   unbiased	  proteome	   analysis	   showing	   the	   up-­‐regulation	   of	   protein	   lysis,	   folding	   and	  oxidative	  stress.	  	  Moreover,	   unbiased	   phospho-­‐proteome	   analysis	   performed	   on	   the	  generated	   cell	   lines	   revealed	   yet	   another	   change	   in	   the	  mitotic	   spindle	   and,	  generally,	   in	   the	   cell	   cycle.	   Single	   chromosome	  gain	   in	   trisomic	   cells	   showed	  the	   same	   effect	   on	   the	   phospho-­‐proteome	   even	   if	   less	   pronounced.	   This	  conclusion	  was	   further	  confirmed	  when	   I	  performed	   targeted	  analysis,	  using	  the	   CIN/cell	   cycle	   inclusion	   list.	   The	   significant	   enrichment	   of	   the	   above	  mentioned	   pathways	   in	   both	   tetraploid	   and	   PTAs	   cell	   lines	   leads	  me	   to	   the	  hypothesis	   that	   large	   chromosome	   mass	   gains	   significantly	   increase	   the	  burden	   on	   spindle	   check	   point	   proteins	   and	  mitotic	   proteins.	   This	   is	   in	   line	  with	   the	   increase,	   even	   if	   very	   subtle,	   of	   erroneous	   k-­‐MT	   attachments	  observed	  in	  these	  cells.	  	  It	  is	  important	  to	  notice	  that	  CIN/Cell	  cycle	  related	  proteins	  were	  affected	  only	  at	   the	   level	   of	   phosphorylation,	   while	   no	   corresponding	   deregulation	   was	  detected	   in	   the	   relative	   abundance	   of	   the	   corresponding	   proteins.	   This	  difference	  could	  also	  be	  confirmed	  by	  other	  techniques,	  notably	  IFA.	  Different	  explanations	  can	  be	  proposed	  for	  this	  interesting	  difference	  in	  responses.	  The	  changes	   in	   protein	   levels	   could	   be	   very	   subtle	   and	   weak,	   thus	   difficult	   to	  detect,	   but	   at	   the	   same	   time	   they	   could	   act	   in	   a	   synergistic	   fashion.	   On	   the	  other	   hand,	   changes	   in	   phosphorylation	   could	   exert	   major	   physiological	  effects.	   Plk1	   levels,	   for	   example,	   were	   not	   detectably	   affected;	   on	   the	   other	  hand,	   increased	   phosphorylation	   of	   Plk1’s	   T-­‐loop	   suggested	   an	   increased	  activity,	   as	   shown	   by	   both	   IFA	   and	   proteomic	   data.	   Another	   possible	  explanation	   is	   that	   PTAs,	   as	   well	   as	   their	   tetraploid	   progenitor	   cells,	  preferentially	   regulate	   activation-­‐deactivation	   of	   proteins	   previously	  associated	  with	  cell	  division,	  rather	  than	  their	  relative	  abundance.	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Notably,	   between	   differentially	   phosphorylated	   proteins	   included	   in	   the	  CIN/Cell	   cycle	   list	   I	   observed	   a	   strongly	   increased	   phosphorylation	   of	   the	  mitotic	  protein	  TPX2,	   as	  well	   as	   the	  T-­‐loops	  of	   the	   spindle	  kinases	  Aurora	  A	  and	  Plk1.	  TPX2	  is	  an	  important	  regulator	  of	  the	  mitotic	  spindle,	  and	  it	  activates	  the	   mitotic	   kinase	   Aurora	   A	   (AURKA)	   through	   stimulation	   of	  autophosphorylation.	  It	  is	  interesting,	  therefore,	  that	  TPXw	  was	  reported	  to	  be	  frequently	   deregulated	   in	   aneuploid	   cancer	   cells	   171(de	  Castro	  &	  Malumbres,	  Genes	  &	  Cancer	  2012),	  showing	  strong	  correlation	  with	  CIN	  9(Carter	  et	  al.	  Nat.	  Genet.	   2006).	   Aurora-­‐A,	   in	   turn,	   is	   required	   for	   the	   activation	   of	   the	  mitotic	  spindle	   regulator	  PLK1	   172(Erikson	  et	   al.	   PNAS	  2002)	   (Macurek	   et	   al.	  Nature	  2008)	   and	   both	   kinases	   are	   highly	   active	   in	   aneuploid	   cancer	   cells.	   These	  observations	  therefor,	  support	  the	  notion	  that	  increases	  of	  chromosome	  mass	  can	   lead	   to	   hyper-­‐activation	   of	   key	   regulators	   of	   the	  mitotic	   spindle.	   This	   in	  turn	   could	   make	   cells	   sensitive	   to	   changes	   affecting	   spindle	   function	   and	  render	   them	  prone	   to	   subsequent	   elevation	   of	   chromosome	  mis-­‐segregation	  rates.	  
5.5	  Targeting	  CIN	  therapeutically.	  The	  emergence	  of	  CIN	  can	  have	  important	  implications	  for	  the	  resistance	  of	   cancer	   cells	   to	   therapy,	   and	   this	   for	   three	   main	   reasons:	   first,	   innate	  resistance,	   perhaps	   reflecting	   a	   necessity	   of	   cancer	   cells	   to	   tolerate	  chromosomal	   instability	   and	   aneuploidy,	   may	   provide	   a	   higher	   threshold	   of	  tolerance	   to	   some	   therapeutic	   agents;	   second,	   acquired	   resistance,	   due	   to	   a	  high	   intra	   cell	   line	   variation	   (generated	   prior	   to	   treatment),	   provides	   a	   high	  probability	  that	  a	  sub-­‐clone	  carrying	  protection	  against	  the	  therapeutic	  agent	  is	   already	  present	   in	   the	   tumor	   culture	   173(Greaves	   and	  Maley	   2012);	   finally	  adaptive	   resistance,	   where	   a	   resistant	   sub-­‐clone	   may	   not	   exist	   before	   to	  treatment,	   but	   may	   be	   generated	   due	   to	   the	   selective	   pressure	   following	  therapy	  treatment.	  	  At	  the	  same	  time,	  as	  already	  anticipated,	  CIN	  and	  aneuploidy	  can	  have	  a	  negative	   impact	  on	  cellular	   fitness.	   In	  particular,	   some	  studies	  analyzing	  CIN	  levels	   in	   relation	   to	   tumor	   outcome	   found	   that	   high	   levels	   of	   CIN	   were	  associated	   with	   better	   outcomes	   compared	   to	   intermediate	   levels	   of	   CIN	  9,130(Carter	   SL.	   Nat	   Genet	   2006)	   (Birbak	   NJ	   2011	   Cancer	   Res).	   However,	   as	  reported	   in	   the	   same	   study,	   examples	   of	   ovarian,	   gastric	   and	   lung	   cancers	  presented	   the	   poorest	   outcome,	   even	   though	   they	   also	   showed	   an	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intermediate	   level	   of	   CIN,	   suggesting	   a	   complex	   relation	   between	   survival	  outcome	  and	  presence	  of	  instability	  130(Birbak	  NJ	  2011	  Cancer	  Res).	  The	  idea	  that	   CIN	   can	   have	   an	   ambivalent	   role	   in	   cancer	   treatment	   finds	   a	   good	  agreement	  also	  with	  my	  findings.	  I	  showed	  that	  two	  small	  molecule	  inhibitors	  of	  Plk1	  reduced	  cell	  survival	  in	  tetraploid	  as	  well	  as	  post-­‐tetraploid	  aneuploid	  cells,	   when	   compared	   to	   diploid	   parental	   cells,	   but	   not	   in	   trisomic	   clones.	  These	   data	   suggest	   that	   a	   pronounced	   increase	   in	   chromosome	   number	  imposes	  a	   stress	  on	  cell	   that	   is	  already	  present	   in	   tetraploid	  progenitor	  cells	  and	  that	  is	  permissive	  towards	  CIN	  in	  descendant	  aneuploid	  cells.	  On	  the	  other	  hand,	  additionon	  of	  a	  single	  chromosome	  in	  the	  trisomic	  lines	  brought	  about	  a	  less	  pronounced	  CIN	  phenotype	  and	  also	  a	  reduced	  survival	  rate	  upon	  cancer	  drug	  treatments.	  In	   conclusion,	   the	   relation	   between	   CIN	   and	   prognosis	   after	   drug	  treatments	  is	  not	  yet	  clear.	  Thus,	  much	  further	  work	  will	  be	  required	  to	  fully	  understand	  the	  mechanisms	  behind	  CIN,	  and	  to	  decipher	  how	  CIN	  contributes	  to	  cancer	  progression.	  The	  hope	  remains	  that	  a	  better	  understanding	  of	  these	  processes	  will	  eventually	  lead	  to	  better	  cancer	  treatment.	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6.	  Materials	  &	  Methods	  	  
6.1	  Experimental	  approaches.	  6.1.1	  Culturing	  of	  cell	  lines.	  	  Colon	   carcinoma	   lines	  HCT116,	  RKO,	  HT29,	   SW480,	   SW837	   (a	   gift	   from	  Dr.	   Steven	   Taylor,	   The	   University	   of	   Manchester,	   UK)	   were	   cultured	   as	  previously	  described	   28(Gascoigne	  KE	  2008	  Cancer	  Cell).	  HeLa	  S3	   cells,	  were	  grown	  in	  DMEM-­‐Glutamax	  medium	  (Invitrogen,	  CA,	  USA),	  supplemented	  with	  10%	   heat-­‐inactivated	   fetal	   calf	   serum	   (FCS)	   (PAN	   Biotech,	   Aidenbach,	  Germany)	  and	  penicillin-­‐streptomycin	  (Pen-­‐Strep;	  100	  IU/ml	  and	  100	  mg/ml,	  Gibco	   Life	   Technologies,	   Zug,	   Switzerland).	   hTERT-­‐RPE1	   cells	   and	   were	  cultured	   in	   F12	   DMEM	   (Sigma	   Aldrich,	   MO,	   USA)	   supplemented	   with	   10%	  heat-­‐inactivated	  FCS,	  L-­‐glutamine	  (2	  mM;	  PAN	  Biotech,	  Aidenbach,	  Germany),	  sodium	   bicarbonate	   (0.35%;	   Sigma-­‐Aldrich,	  MO,	   USA)	   and	   Pen-­‐Strep.	   DLD-­‐1	  2N	  and	  4N	  were	  kindly	  provided	  by	  Dr.	  Spiros	  Linardopoulos	  and	  maintained	  according	   to	   the	  supplier’s	   recommendations	   63(Drosopoulos	  K.	  2014	  Nature	  Communications).	   H2B-­‐GFP	   cultures	   were	   generated	   by	   retrovirus	  transduction,	   the	   plasmid	   was	   pLPCX	   based,	   a	   gift	   from	   Dr.	   Steven	   Taylor	  28(Gascoigne	   et	   al.	   Cancer	   Cell	   2008),	   selected	   in	   presence	   of	   2	   μg/ml	  puromycin	   for	   72	   hours	   and	   maintained	   after	   in	   presence	   of	   0.5	   μg/ml	  puromycin.	   All	   lines	  were	   grown	   at	   37°C	   in	   a	   humidified	   5%	  CO2	   incubator.	  DLD-­‐1	  PTA	  and	  trisomic	  clones	  were	  generated	  as	  described	  below.	  	  6.1.2.	  Generation	  of	  trisomic	  and	  PTA	  clones	  To	   generate	   DLD-­‐1	   containing	   an	   additional	   chromosome	   7,	   microcell	  fusion	   was	   performed	   by	   microcell-­‐mediated	   chromosome	   transfer,	   in	  collaboration	  with	  Dr.	  Zuzana	  Storchova,	  as	  previously	  described	  120(Passerini	  V.	   2016	   Nat	   Commun.).	   Clonal	   populations	   arising	   from	   single	   cells	   after	  chromosome	   transfer	   were	   isolated	   and	   further	   expanded	   in	   presence	   of	   2	  μg/ml	  puromycin	  and	  G418	  0.2	  mg/ml.	  Tetraploid	   DLD-­‐1	   populations	   were	   kindley	   provided	   by	   Dr.	   S.	  Linardopoulos	  and	  generated	  as	  indicated	  previously	  63	  (Drosopoulos	  K.	  2014	  Nature	   Communications).	   Spontaneously	   arising	   posttetraploid	   aneuploidy	  (PTA)	  clones	  were	  derived	  from	  a	  tetraploid	  DLD-­‐1	  parental	  culture	  by	  sorting	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according	   to	   DNA	   content,	   using	   a	   BD	   FACS	   Aria	   cell	   sorter.	   4N	   cells	   were	  harvested	   in	   trypsin,	   washed	   in	   phosphate-­‐buffered	   saline	   (PBS),	   and	  resuspended	  for	  30	  min	  at	  37°	  in	  50	  mg/ml	  RNase	  A	  and	  1	  mg/ml	  propidium	  iodine.	   After	   sorting,	   single	   cells	   were	   placed	   into	   three	   96-­‐well	   plates	   and	  cultured	   in	  medium	  without	  antibiotics.	  After	  visual	   inspection	  to	  ensure	  the	  presence	   of	   single	   cells	   and	   1	  mo	   of	   clonal	   expansion,	  multiple	   clones	  were	  obtained	   and	   four	   could	   be	   validated,	   by	   FACS,	   aCGH,	   and	   chromosome	  spreads,	  as	  PTA	  clones.	  (see	  below).	  	  
6.2	  Cell	  line	  characterization	  6.2.1.	  Chromosome	  spreads	  	  The	   cells	   were	   treated	   with	   50ng/ml	   colchicine	   (Sigma-­‐Aldrich)	   for	  5	  hours	  to	  depolymerize	  microtubule.	  Cells	  were	  then	  collected	  and	  swollen	  in	  75	  mM	  KCl	  in	  a	  37°C	  water	  bath	  for	  15	  minutes,	  fixed	  drop	  by	  drop	  with	  iced	  cold	   Carnoy	   solution	   (75%	  methanol	   and	   25%	   acetic	   acid)	   and	   spread	   on	   a	  glass	   slide.	   The	   slides	   were	   dried	   at	   42°C	   and	   stained	   with	   DAPI	   dye	   (Life	  Technologies)	  or	  further	  stained	  by	  whole	  chromosome	  FISH.	  	  6.2.2.	  Whole	  chromosome	  FISH	  Multicolor	  FISH	  was	  performed	  with	  a	  DNA	  probe	  mixture	  according	   to	  the	  manufacture	  (Chromosome	  specific	  painting	  probe	  kit,	  ChromBios	  GmbH,	  Nussdorf,	  Germany).	  We	  used	  probes	  directly	  label	  with	  red	  fluorochrome	  for	  chromosome	  3	  and	  5	  and	  probes	  label	  with	  digoxin	  for	  chromosome	  4	  and	  7.	  In	   brief	   after	   chromosome	   spread	   cells	   were	   incubated	   with	   probe	  mixture	  (1ml	   each	   probe	   and	  HybMix	   buffer	   up	   to	   10ml),	   coverslip	  was	   applied	   and	  sealed.	   After	   denaturation	   at	   72°	   for	   6	  minutes	   slides	  were	   kept	   at	   37°	   in	   a	  humid	   chamber	   over	   night.	   Coverslip	   was	   then	   sucked	   off	   and	   slides	   were	  washed	   for	  5	  minutes	   in	  2X	  SSC	   solution,	   then	   for	  1	  minute	   in	  prewarm	  70°	  0.4X	  SSC	  0.1%Tween	  solution	  and	  finally	  to	  4X	  SSC	  0.1%	  Tween	  solution	  for	  5	  minutes	   at	   room	   temperature.	   The	   slides	   were	   then	   incubated	   at	   least	   30	  minutes	   at	   37°	   with	   100ml	   FITC	   Mouse	   Anti-­‐Digoxin	   (Jackson	  ImmunoResearch)	  solution	  (1:300	  in	  4X	  SSC/0.1%	  Tween).	  Slides	  were	  finally	  washed	  twice	  in	  45°	  prewarm	  4X	  SSC/0.1%	  Tween	  solution	  for	  5-­‐10	  minutes.	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Finally	  DAPI	   staining	  was	  performed.	  The	  analysis	  was	  carried	  out	  using	  Fiji	  for	  visual	  inspection	  of	  the	  images.	  	  6.2.3.	  Fluorescent	  microscopy,	   image	  processing,	  quantification	  and	  live	  cell	  imaging.	  Cells	  were	  grown	  on	  coverslips	  and	  fixed	  in	  PTEMF	  buffer	  (20	  mM	  PIPES,	  pH	  6.8,	  0.2%	  Triton	  X-­‐100,	  10	  mM	  EGTA,	  1	  mM	  MgCl2,	  4%	  formaldehyde).	  Z-­‐stacks	   of	   randomly	   selected	   cells	   were	   acquired	   using	   a	   DeltaVision	  microscope	  (GE	  Healthcare)	  on	  an	  Olympus	  IX71	  base	  (Applied	  Precision,	  WA,	  USA),	   equipped	   with	   a	   Plan	   Apochromat	   N	   60x/NA1.42	   oil	   immersion	  objective	   (Olympus)	   and	   a	   CoolSNAP	   HQ2	   camera	   (Photometrics).	  Deconvolution	   and	   projection	   were	   done	   using	   SoftWorx	   software	   (GE	  Healthcare).	  Statistical	  analysis,	  were	  done	  from	  2-­‐3	  independent	  experiments	  and	   parametric	   t-­‐test	   two	   tails	   was	   done	   with	   GraphPad	   Prism	   software.	  Standard	  deviation	  (SD)	  is	  represented	  by	  error	  bars.	  For	   time-­‐lapse	   imaging,	   cells	   were	   imaged	   using	   a	   Nikon	   ECLIPSE	   Ti	  microscope	   equipped	   with	   a	   CoolLED	   pE-­‐1	   illumination	   system	   and	   a	  20x/NA0.75	   air	   Plan	   Apochromat	   objective	   (Nikon)	   in	   a	   climate-­‐controlled	  environment.	  Images	  were	  acquired	  every	  9	  minutes	  for	  72hs.	  MetaMorph	  7.7	  software	   (MDS	   Analytical	   Technologies,	   Sunnyvale,	   CA,	   USA)	   was	   used	   for	  acquisition	  and	  processing	  of	  data.	  	  6.2.4.	  Array-­‐comparative	  genomic	  hybridization	  Array-­‐comparative	   genomic	   hybridization	   (aCGH)	   was	   performed	   as	  previously	  described	  (Juskevicius,	  D.	  et	  al	  2016	  Leukemia)	  (Ruiz,	  C	  Proc	  Natl	  Acad	  2011),	  with	  minor	  modifications.	  In	  brief,	  1	  μg	  of	  sample	  DNA	  (cell	  lines	  DLD1	  2N,	  4N,	  PTA	  and	  trisomic	  clones)	  and	  equal	  amounts	  of	  female	  reference	  genomic	  DNA	  (Promega	  46/XX,	  Madison,	  WI,	  USA)	  were	  digested	  with	  DNaseI	  to	   a	   size	   range	   of	   200-­‐500bp.	   Subsequent	   labelling	   of	   sample	   and	   reference	  DNA	   with	   Cy3-­‐dUTP	   and	   Cy5-­‐dUTP,	   respectively,	   was	   performed	   with	   the	  BioPrime®	   Array	   CGH	   Genomic	   Labeling	   System	   	   (Invitrogen,	   Carlsbad,	   CA,	  USA).	  Labelling	  efficiency	  was	  quantified	  by	  measuring	  the	  specific	  activity	  of	  the	  incorporated	  dyes	  with	  a	  Nanodrop	  (Thermo	  Fischer	  Scientific,	  Waltham,	  MA,	  USA).	  Reference	  and	  sample	  DNA	  were	  mixed	  and	  hybridized	  to	  180k	  CGH	  arrays	  (Agilent	  Technologies,	  Santa	  Clara,	  CA,	  USA)	  for	  24	  hours	  in	  a	  rotating	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oven	   at	   67ºC.	   Microarray	   slides	   were	   scanned	   with	   the	   Agilent	   2565C	   DNA	  scanner	   and	   images	   were	   analysed	   with	   Agilent’s	   Feature	   Extraction	   using	  default	   settings.	   Feature	   extracted	   array	   CGH	   data	   were	   evaluated	   using	  Agilent’s	   CytoGenomics	   software	   v3.0.1.1.	   Aberrations	   were	   called	   with	   the	  aberration	   detection	   algorithm	  ADM2	   set	   to	   a	   threshold	   of	   12.0,	  with	   Fuzzy	  Zero	   and	   GC-­‐content	   (window	   size:	   2kb)	   correction.	   A	   minimum	   of	   three	  probes	  was	  necessary	  to	  call	  an	  aberration.	  	  6.2.5.	  Cell	  proliferation	  assay	  	  All	  the	  compounds	  were	  dissolved	  in	  100%	  DMSO.	  Cells	  were	  dispensed	  in	   a	   384-­‐well	   plate	   at	   optimal	   density.	   Compound	   diluition	   series	   was	  performed	   using	   Biomek	   FX	   Lab	   Auomation	  Workstation,	   the	   concentration	  range	  of	  0.32	  nm	   to	  32	  μM,	   and	  5	  μl	   of	   compound	  dilution	  was	  added	   to	   the	  cells	   after	   24hours.	   After	   72	   hours	   25	   μl	   of	   ATPlite	   1Step™	   (PerkinElmer,	  Groningen,	  The	  Netherlands)	  solution	  was	  added	  to	  each	  well.	  Luminescence	  read	   out	   was	   performed	   on	   an	   Envision™	   multimode	   reader	   (PerkinElmer,	  Waltham,	  MA,	  USA).	  IC50s	  were	  fitted	  by	  non-­‐linear	  regression	  using	  XLfit™5.	  A	  two-­‐tailed	  Student's	  t-­‐test	  was	  performed	  to	  determine	  whether	  differences	  in	  sensitivity	  (ΔpIC50)	  were	  statistically	  significant	  (pValue	  <	  0.1).	  	  
6.3	  Proteome	  and	  phosphoproteome	  analysis.	  6.3.1.	  Sample	  preparation	  and	  Tandem	  Mass	  Tag	  labeling	  Cells	  were	  cultured	  as	  described	  before	  and	  synchronized	  in	  G2/M	  phase	  incubating	  cells	  24	  hours	  with	  thymidine	  2mM	  and	  subsequentially	  with	  STLC	  10mM	  for	  12	  hours.	  Cells	  were	  collected	  by	  mitotic	  shake	  off	  and	  lysate	  in	  8M	  Urea	   (Sigma),	   0,1M	   ammonium	   bicarbonate	   in	   presence	   of	   phosphatase	  inhibitors	  (Sigma	  P5726&P0044).	  From	  each	  cell	  1	  mio	  cells	  were	  collected	  by	  mitotic	   shake	   off,	   centrifugate	   and	   cell	   pellets	  were	  washed	   twice	  with	   PBS.	  Cells	  were	  lysed	  in	  200	  μl	  lysis	  buffer	  (2%	  sodium	  deoxycholate	  (SDC),	  0.1	  M	  ammoniumbicarbonate)	   using	   strong	   ultra-­‐sonication	   (two	   cycles	   of	  sonication	  S3	  for	  10	  seconds,	  Hielscher	  Ultrasonicator).	  Protein	  concentration	  was	  determined	  by	  BCA	  assay	  (Thermo	  Fisher	  Scientific)	  using	  a	  small	  sample	  aliquot.	   50μg	  of	   proteins	  were	  digested	   as	   described	  previously	   138(Ahrné	  E.	  2016	   J.	   Proteome	   Research).	   TMT	   10	   plex	   labeling	   procedure,	   protein	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identification	   and	   relative	   abundance	   calculation	   were	   extensively	   already	  described	   138	   (Ahrné	  E.	  2016	   J.	   Proteome	  Research).	   In	  brief	  protein	   relative	  quantification	   was	   performed	   using	   the	   in-­‐	   house	   developed	   SafeQuant	   R	  package.	  This	  analysis	   included	  adjustment	  of	   reporter	   ion	   intensities,	  global	  data	   normalization	   by	   equalizing	   the	   total	   reporter	   ion	   intensity	   across	   all	  channels,	   summation	   of	   reporter	   ion	   intensities	   per	   protein	   and	   channel,	  calculation	  of	  protein	  abundance	  ratios	  and	  testing	  for	  differential	  abundance	  using	   empirical	   Bayes	  moderated	   t-­‐statistics.	   Finally	   the	   calculated	   p-­‐values	  were	  corrected	  for	  multiple	  testing	  using	  the	  Benjamini−Hochberg	  method.	  	  6.3.2.	  Phosphopeptide	  enrichment	  Phosphorylated	   peptides	   were	   selectively	   enriched	   by	   titanium	   dioxide	  beads.	  Cells	  were	  cultured	  and	  synchronized	  as	  described	  in	  previous	  section.	  2mg	  of	  proteins	  were	  lysate,	  digested	  and	  clean	  up	  with	  C18	  column	  before	  the	  following	  phosphopeptide	  enrichment.	  A	  piece	  of	  C18	  material	  was	  plugged	  at	  the	   constricted	   end	   of	   a	   Mobicol	   columns	   (Mobitec)	   tip,	   and	   an	   equivalent	  amount	  of	  2	  mg	  of	  titanium	  dioxide	  resin	  (Sachtopore)	  was	  transferred	  to	  each	  of	   the	   microcolumns	   for	   2mg	   of	   peptides.	   The	   microcolumns	   were	   washed	  with	  200	  μl	  of	  HPLC	  water	  (Chemie	  Brunswick),	  subsequentially	   in	  Methanol	  (Sigma)	  and	  finally	  Buffer	  A	  (mixture	  of	  80%	  Acetonitrile	  (Thermo	  Scienitfic)	  and	  2.5%	  trifluoroacetic	  acid	  (Pierce)	  saturated	  with	  phtalic	  acid	  100mg/ml)	  freshly	   prepared.	   Digested	   peptides	  were	   redissolved	   in	   300μl	   Buffer	   A	   and	  incubate	  to	  resin	  for	  35	  minutes	  using	  head	  rotator,	  allowing	  phosphorylated	  peptides	  to	  bind	  to	  the	  titanium	  dioxide	  beads.	  The	  beads	  were	  spin-­‐down,	  the	  flow-­‐trough	   containing	   non	   phosphopeptide	   was	   kept,	   and	   after	   several	  washing	   with	   Buffer	   A,	   Buffer	   B	   (mixture	   of	   80%	   Acetonitrile	   and	   0.1%	  trifluoroacetic	  acid)	  and	  Buffer	  C	  (0.1%	  trifluoroacetic	  acid),	  phosphopeptide	  were	   elute	  with	  0.3M	  ammoniumhydroxide.	   Elute	  was	   acidified	   at	   pH	  below	  2.5	  with	  2M	  HCl	   and	  5%	   trifluoroacetic	   acid).	   Before	   LC-­‐MS	   analysis	   sample	  were	  further	  purified	  with	  C18	  column.	  	  	  6.3.3.	  Enrichment	  analysis	  Relative	  protein	  quantification	  was	  performed,	  as	  described	  above,	  for	  all	  cell-­‐lines,	  using	  the	  DLD-­‐1	  2N	  cell-­‐line	  as	  control.	  The	  quantified	  proteins	  were	  sorted	   by	   increasing	   p-­‐value	   and	   the	   300	   most	   significantly	   deregulated	  
	   101	  
proteins	   for	  each	  cell-­‐line	  were	  subject	   to	   functional	  enrichment	  analysis.	  To	  this	  end,	  Biological	  Process	  Gene	  Ontology	  (GO)	  (Ashburner	  et	  al.)	  annotations	  were	  mapped	  to	  all	  identified	  proteins	  using	  the	  R	  package	  GO.db	  v.3.4.1.	  Next,	  GO-­‐term	  enrichment	  was	  investigated	  for	  each	  set	  of	  300	  deregulated	  proteins	  with	  respect	  to	  the	  set	  of	  non-­‐deregulated	  proteins.	  Here,	  the	  R	  package	  topGO	  was	  used,	  setting	  the	  nodeSize	  filter	  to	  10	  and	  calculating	  enrichment	  p-­‐values	  for	  each	  GO-­‐term	  using	  a	  one-­‐sided	  Fisher’s	  exact	  test	  174(Alexa	  et	  al.).	  Similarly,	   enrichment	   of	   CIN/Cell	   cycle	   INCLUSI0N	   LIST,	   OGs	   and	   TSGs	  amongst	   deregulated	   proteins,	   with	   respect	   to	   the	   set	   of	   non-­‐deregulated	  proteins,	   was	   assessed	   using	   a	   one-­‐sided	   Fisher’s	   exact	   test.	   CIN/Cell	   cycle	  inclusion	   list	   was	   created	   compiling	   protein	   hits	   identified	   from	   previous	  studies.	   In	   particular	   it	   included	   the	   protein	   identifier	   from	   CIN70	   gene	  expression	  list	  9(Carter	  SL	  Nat	  Genet	  2006);	  572	  validated	  mitotic	  genes	  from	  mitocheck	   consortium	   http://www.mitocheck.org	   146(Neumann	   B	   2010	  Nature);	  and	   finally	  all	   the	   identifiers	  corresponding	  to	  mitotic	  and	  cell	  cycle	  related	   GO	   terms	   (Included	   GO	   identifiers:	   GO:0007094;	   GO:0007051;	  GO:0005828;	   GO:0005813;	   GO:0007059;	   GO:0005813;	   GO:0007049;	  GO:1905115.	   Annotation	   source	   http://www.uniprot.org.	   OGs	   and	   TSGs	   list	  (550	  in	  total)	  was	  previously	  published	  in	  Davoli	  T	  2017	  Science.	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7.	  Supplementary	  material	  
7.1.	  Supplementary	  table	  
Supplementary	  table	  S1:	  Tumor	  suppressor	  (TSG),	  oncogene	  (OG)	  and	  Chromosomal	  instable	  inclusion	  list	  	  
	  
TSGs	   	   	   	   	   	  TP53	   NAA25	   CSDE1	   RNF43	   SOX21	   SRSF11	   ID3	  PTEN	   MLLT4	   PRRC2C	   ARHGAP35	   CCDC144NL	   MKRN1	   SMAD2	  CDKN2A	   PHF6	   HLA-­‐DRB1	   ZC3H13	   LUC7L3	   TYRP1	   NOTCH2	  ARID1A	   TCF12	   SESTD1	   RASA1	   RPL5	   VPS13A	   TBL1XR1	  APC	   KMT2A	   CD58	   STK11	   AMBRA1	   PRKRA	   ZFP36L1	  PBRM1	   DNER	   ZNF319	   CDKN1A	   CSNK2A1	   NCOR2	   SMARCB1	  RB1	   MGA	   PTPRK	   EP300	   ZMYM4	   DAAM1	   RBMX	  VHL	   CYLD	   CHD3	   CDKN1B	   AXIN1	   PUS7	   AJUBA	  NF1	   TMCO2	   RPL18	   ARID1B	   FAS	   BTG3	   TET2	  MAP3K1	   HS6ST1	   PPM1D	   B2M	   INPPL1	   PRPF40A	   CDK12	  SMAD4	   GIGYF2	   BRE	   KDM5C	   EPHA2	   NIPBL	   ELF3	  KDM6A	   TP53BP1	   SPCS1	   IL32	   HERC1	   SLC23A2	   WT1	  GATA3	   CCDC88A	   SPSB2	   FUBP1	   DACH1	   CDC27	   KEAP1	  ARID2	   EIF2AK3	   TMPO	   TGFBR2	   PTCH1	   KCNT2	   PLEKHA6	  SETD2	   USP9X	   ZNF750	   KANSL1	   CNOT3	   MOAP1	   HLA-­‐B	  KMT2D	   GSE1	   TMEM30A	   BCOR	   CTDNEP1	   GAPVD1	   NF2	  NPM1	   JMJD1C	   SPRED2	   GPS2	   EXO5	   RBM15	   RBM10	  ATRX	   CBFB	   RXRB	   SMARCA4	   ATAD2	   SMC4	   CHD8	  FBXW7	   FANCM	   BRWD3	   LARP4B	   RGS12	   SCRN3	   ZC3H18	  KMT2C	   IWS1	   PCDH7	   NSD1	   SPRED1	   UBR5	   CEBPA	  PIK3R1	   FOXA1	   ZBTB18	   HLA-­‐A	   PLAC4	   RNF111	   DDX3X	  CASP8	   ZNF292	   DEPDC5	   CRIPAK	   AMOT	   WDR47	   MYO6	  CDH1	   ZNRF3	   BTBD7	   AOAH	   ARHGAP5	   DOPEY1	   ZNF318	  CTCF	   BRCA1	   BCL10	   CREBBP	   DENND6A	   WBP1	   MBD6	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ATM	   TCF7L2	   GNPTAB	   TNRC6B	   RUFY2	   MAGED1	   COL4A2	  CIC	   CHD2	   PLEKHM3	   ACVR1B	   ZMYM3	   TCEB3	   TRIP12	  RUNX1	   SOX9	   TAOK1	   DNMT3A	   MED23	   ZNF234	   KMT2B	  RPL22	   WDR33	   DIP2C	   ACVR2A	   ASXL2	   GLTSCR1	   CCAR1	  STAG2	   EMG1	   NFATC4	   RERE	   RAD21	   FAM58A	   SEC22A	  FAT1	   MTFR1L	   ADAMTS19	   ASXL1	   GGCT	   KIAA0907	   ERRFI1	  NOTCH1	   TRAF3	   TTC18	   NCOR1	   HNF1A	   BRD7	   MORC4	  MAP2K4	   AMER1	   CERK	   USP28	   LIMCH1	   PPP3CC	   MEN1	  BAP1	   SIN3A	   IFNGR2	   THRAP3	   CTNND1	   FOSL2	   TBX3	  ZFP36L2	   MBD1	   PEX2	   STX7	   LDB1	   THUMPD3	   MAP3K4	  CPEB2	   HGF	   MYO1B	   COQ9	   PHACTR4	   CLGN	   INO80	  HMCN1	   SNRPN	   TBC1D10C	   LEMD2	   BRCA2	   BMPR2	   CUL3	  NUP98	   YLPM1	   SPATA6	   ATR	   AFF4	   BIRC6	   RIMS2	  IDH2	   HAUS8	   SMARCA1	   COL8A2	   INO80	   CCDC38	   PSIP1	  EPB41L4A	   SIK3	   BAX	   DYRK1A	   CUL3	   RAPGEF6	   DUSP16	  ANKRD46	   KDM3B	   PNISR	   UGT2A2	   RIMS2	   SUZ12	   UPF3B	  ANO3	   CCDC120	   WAC	   PABPC3	   PSIP1	   WWC2	   ATG5	  RBBP6	   TEX11	   C2CD5	   GPR174	   DUSP16	   GGNBP2	   SFPQ	  NEK9	   B3GNT5	   CCDC38	   WWC2	   UPF3B	   TNIK	   APPBP2	  RBM26	   KBTBD7	   RAPGEF6	   GGNBP2	   DPY19L4	   CACUL1	   KBTBD7	  HDAC2	   HNRNPD	   SUZ12	   TNIK	   ABCA10	   KBTBD7	   	  
	  
OGs	   	   	   	   	   	   	  BRAF	   MYCN	   TOR1A	   EBPL	   FMNL3	   HIST1H3B	   UGT8	  KRAS	   MEF2B	   HGF	   IFITM1	   HARS2	   SLC35G3	   RIMS2	  PIK3CA	   MB21D2	   HIST1H2BF	   MFF	   STXBP6	   TLL1	   CDC73	  IDH1	   HRAS	   PDE7B	   GABRG1	   MDGA2	   PDYN	   TXNRD1	  CTNNB1	   CARM1	   ZNF117	   CUL1	   CACNG3	   ABI1	   C16orf80	  AKT1	   DKK2	   MAGI2	   EPHA6	   IRF2	   DICER1	   CCND3	  IDH2	   MBOAT2	   RIT1	   MYOT	   SMARCA2	   ZFR	   KLK8	  NRAS	   ERBB3	   BTBD11	   KLHL5	   MLLT11	   UBE2QL1	   GRIA2	  RAC1	   EEF1B2	   NSMCE1	   PRRX1	   BCLAF1	   TLL2	   SAP30	  EGFR	   GNAS	   UBQLN2	   CPB1	   PRPF8	   FGFR3	   SMOC2	  NFE2L2	   NUTM2F	   DCLK1	   NRAP	   ARHGEF33	   STXBP1	   MRPL49	  EZH2	   TAF1	   MFAP5	   ZNF181	   NBPF10	   PSMC3IP	   SRC	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U2AF1	   RHOA	   COL5A2	   RGPD3	   BRWD3	   GTF2I	   BZW2	  SF3B1	   PTN	   ABCB1	   RBM39	   GPR141	   MICU3	   IREB2	  PGM5	   ALK	   TUSC3	   GNG4	   MECOM	   ASCC3	   ENAH	  PPP6C	   PTPN11	   KCNQ5	   HMCN1	   PTPRF	   IL5RA	   NBPF1	  PPP2R1A	   ACADS	   SKAP2	   GRIA3	   XPOT	   GNA15	   MAPK8IP2	  MAPK1	   MED12	   INTS7	   NSFL1C	   ALDH1L2	   JUN	   SEC63	  FGFR2	   SULT1C4	   METTL14	   SEMG2	   LPA	   ITM2C	   CCDC132	  AQP2	   ZNF799	   XYLT1	   CRISPLD1	   STAT3	   POLE	   RHBDL3	  MTOR	   LHFPL1	   FAM8A1	   HLF	   PLCL1	   TM2D3	   SOS1	  KRT15	   ARF4	   JAKMIP2	   CMAS	   OR4M2	   ZNF479	   TKTL2	  MEF2BNB	   KCND3	   SOX17	   CCDC36	   TMEM11	   CDH7	   NNMT	  CHD4	   MYC	   LSM11	   SMO	   PIK3CB	   REXO2	   LPHN3	  MAP2K1	   CAPRIN2	   GRXCR1	   SEPT14	   PSPH	   GK2	   MYO3A	  TRIM48	   MFGE8	   GRID1	   EIF1AX	   WNT11	   ZFP2	   OPRM1	  ERBB2	   LUM	   OR5I1	   SIAH2	   STRIP2	   CSNK1E	   C3orf27	  SPOP	   TBX18	   GRM5	   AK8	   MAPK8	   KAT8	   TOX	  KRTAP4-­‐11	   TRIM23	   MYF5	   MRPL32	   POTEG	   CD163	   PPP1R9A	  FLT3	   MS4A8	   MYH2	   C16orf45	   MARCO	   GRID2	   WDR17	  MYD88	   PRKCI	   CSMD3	   WBSCR17	   SPPL3	   IL21	   PTPRU	  RRAS2	   GOT2	   PLK2	   NRG3	   NENF	   BRSK1	   PIK3R5	  MAX	   LZTR1	   ZNF844	   LIN9	   DTX1	   SOCS5	   CADPS	  KRTAP4-­‐5	   	   ACBD3	   C16orf87	   GABRA5	   SCN3A	   CIZ1	  ZBTB7A	   ZNF559	   SBNO1	   NDUFS5	   PCMTD1	   GABRA2	   SHB	  COL9A1	   GJB3	   TES	   TBX15	   ZNF878	   TRPC6	   	  
	  
CIN	  	   	   	   	   	   	   	   	  ATAD2	   GRPE1	   CROCC	   PKN2	   VPS4A	   PHP14	   THOC5	   ARP8	  STK26	   CTCF	   F177A	   RAB9A	   PCF11	   PELO	   MIER1	   TOP2B	  CK5P3	   CEP83	   CHMP5	   ABLM1	   PDS5B	   RIC8B	   RBMX2	   MAEA	  UBL5	   NMNA1	   MAPK2	   CKAP2	   CBP	   PCNA	   LCOR	   NEDD1	  PIEZ1	   KAP2	   NDE1	   NU133	   SPAST	   SC23A	   ATRIP	   CCNB2	  ASCC3	   EVI5	   RL36L	   ANCHR	   CDK2	   CENPH	   MACC1	   DLG1	  SPG20	   CLAP1	   CHD3	   CHK1	   NDUC2	   NEUA	   NSUN2	   TOPK	  ARL8B	   USP9X	   ODPB	   K1161	   HAUS4	   RM18	   SIR3	   CLPB	  DLRB1	   CDCA3	   NPM3	   U2AF2	   CLIC4	   KI18A	   MIPT3	   KIF3A	  PKHA7	   PB1	   KDM1B	   PP1B	   IL18	   MYPT1	   DCK	   TPX2	  TIPRL	   LZIC	   RBM5	   RS20	   ANLN	   SPAG5	   GNA13	   MMS19	  DLDH	   SPF27	   KIF15	   MEN1	   BECN1	   AKT1	   XRCC3	   TAOK2	  ECM29	   MGLL	   RMD3	   CAPG	   HOOK3	   KIF2C	   CND3	   RD23A	  BRCA1	   WDR81	   CHM2B	   RABL6	   TBCC	   CD81	   PML	   PAR6B	  DDB1	   CI114	   PP1G	   DC1I2	   CCND1	   DDX18	   KI13A	   CCDB1	  UBP16	   RAB8A	   ZWINT	   CHRD1	   NUBP1	   CASC5	   SF3A1	   LIMD1	  TACC3	   RNH2B	   XPC	   CDK7	   MK14	   CTDP1	   REEP4	   PRC1	  IST1	   CDC7	   SAHH3	   LIS1	   MET15	   PPP5	   IFT81	   TAGL2	  H15	   GTR1	   GALT7	   PIGS	   ZW10	   YETS4	   CCNK	   2AAA	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REQU	   NOC3L	   DPH7	   COTL1	   PP1A	   APC5	   RBMS2	   NH2L1	  CE350	   RM14	   CD123	   PTN11	   C1QBP	   SMC1A	   MARE3	   MYCBP	  UBP1	   CDC5L	   FA64A	   CSK22	   APC	   APC4	   HNRH1	   CLPX	  PDK1	   UB2E1	   NTF2	   MD1L1	   NEMP1	   SRSF1	   RS6	   COG7	  AXIN2	   GOGA2	   HEXA	   SNUT1	   RL32	   CISY	   CUL3	   TBB5	  UXT	   SDC1	   RAB3I	   CEP76	   CND1	   RFA2	   PSMG2	   CHD4	  ENSA	   B3GLT	   BUB3	   ARL3	   NIT2	   USF1	   HAUS6	   TYW1	  GORAB	   XYLK	   F136A	   RGAP1	   NUMA1	   CDK1	   WDR61	   NEB2	  MOT1	   PCID2	   SAS6	   SSA27	   CCNT1	   NKAPL	   CCAR2	   CD11B	  CP250	   DI3L2	   PAPD5	   GNAI3	   TCPQ	   SMC4	   GSK3B	   NU107	  DHYS	   CKS2	   MCMBP	   TKFC	   CSN3	   RMD1	   PSMD6	   ST14	  CENPI	   SENP6	   PCGF5	   MYD88	   ELYS	   B2L15	   KIFC1	   SSRG	  DDX41	   PDC6I	   UBP33	   CUL7	   U5S1	   MRE11	   BUB1B	   SGT1	  AL9A1	   TBG1	   QORX	   CATA	   SRP14	   RED	   UBP28	   SNW1	  ACAD9	   GWL	   NDC80	   THOC1	   SETMR	   EMAL3	   BRCC3	   NUDC	  PGTB2	   AR2BP	   RIOK3	   TCPE	   TXND9	   MLH1	   MARE2	   RUVB2	  TOPB1	   APEX1	   AURKB	   CENPF	   MCCB	   HAUS1	   SNP29	   TEST	  NOL3	   NED4L	   TS101	   CA109	   SF3B1	   KIF3B	   FANCJ	   TXN4A	  NUDC2	   CHAP1	   FBX30	   ZN511	   ORC2	   GTF2I	   GTPB1	   TBC17	  RL24	   MSH2	   VPS4B	   EAF6	   ARPC2	   TPR	   NUSAP	   CTF18	  ARHG2	   FEN1	   PHF6	   DTL	   RAGP1	   EHD1	   SUMO3	   ASUN	  CSK21	   TP53B	   PCH2	   GCP3	   I2BPL	   IGSF8	   RBGP1	   SYNE2	  CCNA2	   MRP	   RBM10	   TRIM2	   CUL4A	   PIGU	   ULA1	   HAUS3	  ARFP2	   G6PD	   CC124	   IFT25	   DJB11	   ITA11	   PSN1	   TOP1	  MCM2	   UIMC1	   PARD3	   APC1	   ACTZ	   CHM4B	   PIGG	   MSH6	  PRP8	   ZN207	   NDK7	   ETHE1	   AAAS	   NSL1	   BOREA	   ANM1	  BRE	   IFT27	   RB	   PSMD8	   BUB1	   TIM	   ECT2	   CCNB1	  IL18	   SGO2	   DCAM	   FZR	   SART3	   NTM1A	   ARMX3	   PCBP1	  CPSF5	   KIF14	   SEM3C	   CHM2A	   CNDD3	   ELAV1	   NU205	   RFC4	  DC1L2	   BIRC5	   DICER	   PRCC	   CIAO1	   AURKA	   DYLT1	   HMGA2	  TMUB1	   RS3	   RO52	   SKAP	   PDS5A	   TOP2A	   DIAP3	   MB12A	  HOOK1	   SMAD4	   HJURP	   TIM44	   PAF15	   FA83D	   TRUB1	   CHM1A	  STK39	   GL8D1	   CDC27	   E41L5	   KIF11	   KMT5A	   MDHC	   DOK1	  NDUBA	   UBQL2	   SMC5	   BABA1	   PLEC	   CEP41	   PSMD6	   NDK6	  KMT2C	   NHRF1	   APC10	   F173A	   DYHC1	   AKP8L	   ADT2	   CEP55	  BLM	   ESPL1	   RFA1	   KAPCA	   CCNY	   UBE2C	   IMP3	   ECSIT	  PSRC1	   HAUS8	   ASPM	   XPO1	   GCP4	   PTER	   ACL6A	   EPCR	  INO80	   ZC3H4	   WAC	   CETN2	   ARP2	   IDH3B	   GNAI2	   CFDP1	  RRAS2	   DHX9	   HPSE	   OBSL1	   UB2G1	   BCAR1	   DNLI4	   ATM	  PALMD	   DCMC	   NU214	   ACPM	   B2L13	   RFWD3	   KIF23	   PRP19	  ZHX2	   SMC3	   TBA1C	   RECQ5	   UBL7	   TTYH3	   INT3	   PSB5	  SDCG8	   UGDH	   MZT1	   MARE1	   UBC9	   KNTC1	   ERP44	   MYL6B	  RUVB1	   SPC25	   MCM3	   EXOC3	   APC7	   CDC23	   SLU7	   KIF2A	  TOIP1	   CEP44	   SPDLY	   KI20A	   U119A	   KC1A	   KC1D	   DSN1	  PTTG1	   CDC20	   NUP37	   CDK5	   TYW1	   RPGP2	   NXT1	   FR10	  STAG1	   CETN3	   	   	   	   	   	   	  
	  
Supplementary	   table	   S2:	   Protein	  membership	   to	   the	  Venn	  diagram	   in	  PTA	  clones	  and	  4N	  NF1	  SLC12A2	  AHNAK	  MSF	  ZC3H13	  DPF2	  MARCKS	  KDM3B	  
OSBPL11	  PDLIM5	  KIF20A	  NUSAP1	  ANLN	  FTSJ3	  PCYT1A	  TPX2	  
CRK	  ASPM	  NUP98	  PPP1R12A	  HNRNPM	  TJP2	  HMGN4	  NPM1	  
TLE3	  MKI67	  TCOF1	  LARP4	  NUMA1	  FLNA	  DYNC1LI1	  NOLC1	  
ACIN1	  DDX24	  NUCKS1	  GTSE1	  CENPF	  MAP2	  ADD3	  ATRX	  
NUP153	  MDC1	  NCAPH2	  RANBP2	  LAD1	  NUP133	  PCM1	  SRRM2	  
TP53BP1	  PHF6	  HNRNPA1	  HSP90AA1	  MAP4	  FAM83H	  SPAG9	  DENND4	  
HTT	  CHAMP1	  TOP2A	  FLNB	  ARID1A	  NCL	  SCRIB
	  Protein	  membership	  to	  the	  Venn	  diagram	  in	  Trisomic	  clones	  and	  4N	  RSRC2	  CGN	  SRSF10	  ZC3H13	  RTN4	  REEP4	  LRRFIP1	  CLSPN	  ZRANB2	  CHERP	  
SHROOM3	  IWS1	  C17orf75	  MAPK1	  PPP1R12A	  SON	  BAZ1B	  MICALL2	  EEF2	  CTNND1	  
SVIL	  AHNAK	  MARCKS	  SNX1	  SND1	  SRRM1	  CEP170B	  MAP1S	  MARCKSL1	  SERBP1	  
PDCD4	  SCRIB	  TRIP12	  GPATCH8	  TP53BP1	  MAP2	  TRA2A	  PHACTR4	  FLNA	  OXSR1	  
AKAP11	  ZNF185	  UNG	  SRRM2	  TACC2	  CUX1	  RBL1	  TMX1	  PTPN14	  BIN1	  
ADAR	  NUCKS1	  YAP1	  HIST1H1E	  FAM83H	  RBM27	  COIL	  MAPK3	  TJP2	  ACIN1	  
AFDN	  TCOF1	  HMGA1	  MCM2	  PDAP1	  RRM2	  PLEC	  TBC1D4	  EIF2AK2	  MTA1	  
TPR	  LMO7	  SRFBP1	  PROSER2	  RRP1B	  
	  
Supplementary	   table	   S3:	   List	   of	   compounds	   tested	   in	   diploid,	   tetraploid,	  aneuploidy	  and	  trisomic	  DLD-­‐1	  clones	  
Name	   Target	   Pathway	   Highest	  concentration	  in	  assay	  (mM)	   Incub	  time	  (days)	  5-­‐fluorouracil	   thymidylate	  synthase	   DNA-­‐RNA	  Synthesis	   10	   3	  ABT-­‐737	   Bcl-­‐2	   Apoptosis	   10	   5	  actinomycin-­‐D	   interfering	  with	  mRNA	  synthesis	   DNA-­‐RNA	  Synthesis	   0,316	   3	  afatinib	   EGFR/HER2	  	   Cell	  growth	   10	   3	  AMG-­‐900	   pan	  Aurora	   SAC	   10	   3	  
AT-­‐7519	   multi-­‐CDK	  inhibitor	  for	  CDK1,	  2,	  4,	  6	  and	  9	   Cell	  cycle	  progression	   10	   3	  BI-­‐2536	   Plk1	   SAC	   1	   3	  BIIB021	   HSP90	   Protein	  folding	   1	   3	  bortezomib	   Proteasome	   Protein	  folding	   1	   3	  CHIR-­‐124	   Chk1	   Cell	  cycle	  progression	   1	   3	  cobimetinib	   MEK1	   Cell	  growth	   10	   3	  danusertib	   panAurora	  inhibitor	   SAC	   10	   3	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daunorubicin	   DNA	  and	  RNA	  synthesis	  	   DNA-­‐RNA	  Synthesis	   1	   3	  
dinaciclib	   CDK	  inhibitor	  for	  CDK2,	  CDK5,	  CDK1	  and	  CDK9	   Cell	  cycle	  progression	   0,316	   3	  docetaxel	   microtubule	   Microtubule	  Assembly	   1	   5	  epothilone	  B	   microtubule	   Microtubule	  Assembly	   0,0316	   3	  fasudil	   ROCK-­‐II,	  PKA,	  PKG,	  PKC,	  MLCK	  	   Energy	  stress	   10	   3	  GSK-­‐1070916	   Aurora	  B/C	   SAC	   10	   3	  GSK-­‐461364	   Plk1	   SAC	   10	   3	  KU-­‐60019	   ATM	   DNA	  repair	   10	   3	  MK-­‐1775	   Wee	   Cell	  cycle	  progression	   10	   3	  MK-­‐5108	   Aurora	  A	   SAC	   10	   3	  MLN-­‐8054	   Aurora	  A	   SAC	   10	   3	  MPI-­‐0479605	   TTK/MPS1	   SAC	   10	   3	  MPS1-­‐IN-­‐1	   TTK	   SAC	   10	   3	  NMS-­‐P715	   TTK	   SAC	   1	   3	  olaparib	   PARP1/2	   DNA	  repair	   10	   3	  paclitaxel	   microtubule	   Microtubule	  Assembly	   10	   5	  palbociclib	   CDK4,	  CDK6	   Cell	  cycle	  progression	   10	   3	  PHA-­‐793887	   CDK2,	  CDK5	  and	  CDK7	  	   Cell	  cycle	  progression	   10	   3	  roscovitine	   CDK	   SAC	   10	   3	  SCH-­‐900776	   Chk1	   SAC	   10	   3	  venetoclax	   Bcl-­‐2	   Apoptosis	   10	   3	  vincristine	   tubulin	   Microtubule	  Assembly	   3,16	   3	  volasertib	   Plk1	   SAC	   3,16	   3	  VX-­‐680	   pan-­‐Aurora	  	   SAC	   10	   3	  BAY	  320	   Bub1	   SAC	   10	   3	  doxorubicin	   topoisomerase	  II	   DNA-­‐RNA	  Synthesis	   3,16	   5	  	  
7.2.	  Figure	  legends	  	  
Figure	   1:	   mechanisms	   that	   generate	   aneuploidy	   (from	   Bernardo	   Orr,	  Aneuploidy	  2015	  current	  Biol).	  
Figure	   2:	   the	  mitotic	   checkpoint:	   a	   safeguard	   to	   protect	   against	   aneuploidy	  (from	  1Andrew	  J.	  Holland	  and	  Don	  W.	  Cleveland	  July	  2009	  Nature	  Reviews).	  
Figure	   3:	   scheme	   showing	   different	   attachment	   configurations	   between	  chromosomes	  and	  microtubules	  from	  175	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Figure	   4:	   scheme	   showing	   kinetochore	   structure	   (from	   32Godek	   K,	   DA	  Compton.	  Nature	  Reviews	  Molecular	  Cell	  Biology	  2015).	  
Figure	   5:	   scheme	  showing	  Cohesin	  structure	   (from	  47Raquel	  A.	  Oliveira,	  Kim	  Nasmyth.	  2010	  Biochem	  Soc	  Trans).	  	  
Figure	  6:	  the	  formation	  of	  lagging	  chromosomes	  in	  anaphase	  could	  be	  due	  to	  an	   accumulation	   of	   unresolved	   merotelic	   kinetochore-­‐	   microtubule	  attachments	  due	  to	  the	  extra	  centrosome	  (from	  58Ganem	  et	  al.,	  2009).	  
Figure	   7:	   merotelic	   attachment	   fates	   (Adapted	   from	   121S.	   Santaguida	  and	  A.	  
Amon	  2015	  Nature	  Review).	  
Figure	   8:	   table	   listing	  ploidy	  and	  chromosome	  numbers	   for	  8	  human	  cancer	  cell	  lines	  used	  in	  the	  pilot	  experiment	  
Figure	   9:	   hierarchical	   clustering	  based	  on	   the	  LC-­‐MS/MS	   results	   for	   the	   cell	  lines	  listed	  in	  S1	  using	  the	  tandem	  mass	  tag	  (TMT)-­‐labeling	  approach.	  
Figure	  10:	  a	  Schematic	  showing	  the	  approach	  to	  human	  DLD-­‐1	  colon	  cancer	  cell	  line	  generation	  and	  analysis.	  
Figure	   11:	   histograms	   represent	   flow	   cytometric	   results	   the	   cell	   lines	  generated	  and	  used	  in	  this	  study.	  
Figure	  12:	  microcell	  Fusion	  workflow.	  Adapted	  from	  98Stingele	  S.	  et	  al.	  2012	  Mol	  Syst	  Biol.	  
Figure	  13:	  chromosome	  numbers	  in	  DLD-­‐1	  2N,	  4N,	  posttetraploid	  derivatives	  and	  trisomic	  clones.	  	  
Figure	  14:	  chromosome	  mis-­‐segregation	  rate	  in	  DLD-­‐1	  2N,	  4N,	  posttetraploid	  derivatives	  and	  trisomic	  clones.	  
Figure	  15:	  micrographs	  showing	  mitotic	  spreads	  of	  indicated	  cell	  lines,	  
Figure	  16:	  spindle	  geometry	  measurements	  in	  metaphase	  cells.	  
Figure	  17:	  interkinetochore	  distance	  in	  generated	  cell	  lines	  
Figure	  18:	  centrioles	  and	  centrosomes	  numbers	  in	  generated	  cell	  lines.	  
Figure	  19:	  time-­‐lapse	  microscopy	  of	  asynchronously	  growing	  cultures	  
Figure	  20:	  comparative	  genomic	  hybridization	  assay	  in	  generated	  DLD-­‐1	  
Figure	  21:	  comparative	  genomic	  hybridization	  assay	  in	  DLD-­‐1,	  from	  Thomas	  Ried	  lab	  
Figure	   22:	   relative	   protein	   abundance	   in	   generated	   cell	   lines	   ordered	   by	  chromosomes	  
Figure	   23:	   the	   number	   of	   significant	   down-­‐	   and	   up-­‐regulations	   of	   protein	  expression	  in	  relation	  to	  the	  false	  discovery	  rate.	  
Figure	  24:	  box	  whisker	  plot	  showing	  relative	  abundance	  of	  proteins	  related	  to	  protein	  proteolysis,	  protein	  folding	  and	  oxidative	  stress	  response	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Figure	   25:	   Venn	   diagrams	   representing	   the	   number	   of	   shared	   protein	  deregulations	  across	  the	  generated	  cell	  lines.	  
Figure	  26:	  list	  of	  the	  11	  proteins	  commonly	  deregulated	  across	  tetraploid	  and	  PTAs	  
Figure	   27:	   list	  of	  18	  proteins	   that	  are	  commonly	  deregulated	  across	  4N	  and	  Tr7	  clones.	  
Figure	   28:	   box	   whisker	   plots	   showing	   the	   relative	   abundance	   of	   proteins	  involved	  in	  type	  I	  interferon	  signaling	  across	  microsatellite	  instable	  (MIN)	  and	  chromosomally	  instable	  (CIN)	  cell	  lines.	  
Figure	   29:	   box	   whisker	   plots	   showing	   the	   relative	   abundance	   of	   proteins	  involved	   in	   type	   I	   interferon	   signaling	   across	   tetraploid,	   post-­‐tetraploid	   and	  trisomic	  cell	  lines	  
Figure	  30:	  micrographs	  of	  cells	  treated	  with	  BrdU	  and	  stained	  with	  anti-­‐BrdU	  and	  DAPI	  
Figure	  31:	  plot	  showing	  the	  percentage	  of	  cells	  showing	  UFBs	  marked	  by	  BLM	  staining	  
Figure	  32:	  enrichment	  analysis	  of	  the	  300	  most	  deregulated	  proteins	  per	  cell	  line	  based	  on	  the	  TSG/OG.	  
Figure	  33:	  enrichment	  analysis	  of	  the	  300	  most	  deregulated	  proteins	  per	  cell	  line,	   considering	   tetraploid	   and	   PTAs,	   based	   on	   CIN/cell	   division	   inclusion	  lists.	  
Figure	   34:	   dot	   plots	   showing	   the	   relative	   abundance	   of	   selected	   mitotic	  proteins	  in	  4N,	  PTA	  and	  Tr7	  clones.	  
Figure	  35:	  dot	  plots	  showing	  the	  relative	  abundance	  of	  proteins	  belonging	  to	  the	  MCM	  and	  ORC	  complexes	  in	  4N,	  PTA	  and	  Tr7	  clones	  
Figure	   36:	   numbers	   of	   significant	   down-­‐	   and	   up-­‐regulations	   of	   phospho-­‐peptide	  counts	  in	  relation	  to	  the	  false	  discovery	  rate.	  
Figure	  37:	  Venn	  diagrams	  representing	  the	  number	  of	  statistically	  significant	  shared	  protein	  deregulations	  across	  the	  indicated	  cell	  lines	  
Figure	   38:	   Cluster	   analysis	   of	   based	  on	   the	  500	  most	  deregulated	  phospho-­‐peptides	   (FDR	  of	  <10%,	  yielding	  a	   total	  of	  1410	  phospho-­‐peptides	   from	  807	  proteins)	  per	  condition	  using	  the	  fuzzy	  C-­‐means	  algorithm	  “MFuzz”	  
Figure	   39:	   Cluster	   analysis	   of	   based	  on	   the	  500	  most	  deregulated	  phospho-­‐peptides	   (FDR	  of	  <10%,	  yielding	  a	   total	  of	  1410	  phospho-­‐peptides	   from	  807	  proteins)	  per	  condition	  using	  the	  fuzzy	  C-­‐means	  algorithm	  “MFuzz”.	  
Figure	   40:	   results	   of	   gene	   ontology	   (GO)-­‐term	   enrichment	   analysis	   of	  phospho-­‐peptides	  up-­‐regulated	  across	  PTA	  clones	  and	  4N	  plus	  PTA	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Figure	  41:	  gene	  ontology	  (GO)-­‐term	  enrichment	  analysis	  of	  phospho-­‐peptides	  up-­‐regulated	   across	   Trisomic	   clones	   (upper	   panel);	   and	   4N	   plus	   Trisomic	  clones	  
Figure	   42:	   STRING	   functional	  network	  analysis	  of	   the	  phospho-­‐peptides	  up-­‐regulated	  in	  PTAs	  
Figure	   43:	   STRING	   functional	   network	   analysis	   of	   the	   phospho-­‐peptides	   in	  PTAs	  and	  4N	  
Figure	   44:	   STRING	   functional	   network	   analysis	   of	   the	   phospho-­‐peptides	   in	  trisomic	  clones	  and	  trisomic	  plus	  4N	  
Figure	   45:	   tables	   showing	   an	   enrichment	   analysis	   of	   the	   500	   most	  deregulated	   phospho-­‐peptides	   per	   cell	   line	   using	   the	   CIN/cell	   division	  inclusion	  list.	  
Figure	  46:	  dot	  plots	  showing	  the	  phospho-­‐peptide	  ratios	  of	  detected	  proteins	  belonging	  to	  the	  CIN/cell	  division	  inclusion	  list	  deregulation	  in	  4N	  and	  PTA	  
Figure	  47:	  dot	  plots	  showing	  the	  phospho-­‐peptide	  ratios	  of	  detected	  proteins	  belonging	   to	   the	   CIN/cell	   division	   inclusion	   list	   deregulation	   in	   4N	   and	  Trisomic	  clones	  
Figure	   48:	   STRING	   functional	   network	   analysis	   ofphospho	   peptide	  deregulated	  in	  4N,	  4N	  plus	  PTAs,	  Trisomic	  clones	  and	  Trisomic	  clones	  plus	  4N	  
Figure	   49:	   dot	   plots	   showing	   the	   significance	   and	   IC50	   difference	   obtained	  using	  the	  kinase	  drugs	  listed	  in	  table	  S7	  
Figure	   50:	   dot	   plot	   showing	   selected	   detection	   ratios	   of	   regulatory	  phosphorylation	  sites	  of	  the	  centrosome	  and	  mitotic	  spindle	  kinase	  Aurora	  A	  (AURKA	  P-­‐T288),	  the	  mitotic	  kinase	  Cdk1	  (CDK1	  P-­‐T14,	  P-­‐Y15),	  the	  cell	  cycle	  checkpoint	  kinase	  Chk1	  (CHK1	  P-­‐S286,	  CHK1	  P-­‐S301)	  and	  the	  mitotic	  spindle	  kinase	  Plk1	  (PLK1	  P-­‐T210)	  
Figure	   51:	   table	   listing	   the	   p-­‐values	   for	   phospho-­‐peptide	   measurements	  shown	  in	  Figure	  49.	  
Figure	   52:	   graphs	   showing	   dose-­‐response	   curves	   using	   the	   Plk1	   inhibitor	  Volasertib	  on	  generated	  cell	  cultures	  
Figure	   53:	   micrographs	   of	   cells	   stained	   with	   anti-­‐Plk1,	   pT210	   Plk1,	   CREST	  and	  DAPI.	  
Figure	   54:	   micrographs	   of	   metaphase	   cells	   stained	   with	   anti-­‐	   α-­‐tubulin,	  CREST	  and	  DAPI.	  	  
7.3	  Table	  legends	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Table	   1:	   frequent	   impairment	   of	   the	   mitotic	   checkpoint	   in	   human	   cancers	  (From	   Beth	   AA	   Weaver,	   Don	   W	   Cleveland	   Current	   Opinion	   in	   Cell	   Biology	  2006)	  
Table	   S1:	   inclusion	   list	   of	   tumor	   suppressor	   genes	   (TSGs),	   oncogenes	   (OGs)	  and	   chromosomal	   instable	   genes	   (CIN)	   considered	   during	   the	   targeted	  analysis.	   These	   inclusion	   lists	   were	   generated	   as	   described	   in	   material	   and	  method	  section.	  
Table	  S2:	  Venn	  diagram	  analyses.	  List	  of	  proteins	  common	  in	  PTAs	  and	  4N	  or	  4N	   plus	   trisomic	   clones.	   Venn	   diagrams	  were	   obtained	   by	   selecting	   the	   500	  most	  deregulated	  phospho-­‐peptides	  per	  cell	   line	   (based	  on	  an	  FDR	  of	  <10%,	  yielding	  a	   total	  of	  1410	  phospho-­‐peptides	   from	  807	  proteins).	  Note	   that	   this	  experiment	  was	  performed	  in	  biological	  triplicates.	  	  
Table	   S3:	  Drug	  screening	  assay	  spreadsheet.	  List	  of	   targets,	   incubation	   time	  and	  concentrations	  for	  each	  of	  the	  tested	  compounds.	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8.	  Abbreviations	  	  ABC	  aCGH	  	  APC/C	  	  ATCC	  	  ATM	  Bub1	  Bub3	  BubR1	  CDC20	  CDK1	  CENP	  A	  CENP	  E	  CENP	  F	  CHK1	  CPC	  	  CREST	  	  	  CIN	  DCB	  	  DLD-­‐1	  DMEM	  	  DSB	  	  FISH	  GFP	  HPV	  HSF1	  HSP90	  IFA	  INCENP	  k-­‐MT	  KNL1	  KT	  MAD1	  MAD2	  ATP	  binding	  cassette	  
Array	  comparative	  genomic	  hybridization	  Anaphase-­‐promoting	  complex/cyclosome	  American	  type	  culture	  collection	  Ataxia	  telangiectasia	  mutated	  Budding	  uninhibited	  by	  benzimidazoles	  1	  Budding	  uninhibited	  by	  benzimidazoles	  3	  budding	  uninhibited	  by	  benzimidazoles-­‐related	  1	  	  Cell	  division	  cycle	  protein	  20	  cyclin-­‐dependent	  kinase	  1	  Centromere	  protein	  A	  Centromere	  protein	  E	  Centromere	  protein	  F	  Checkpoint	  kinase	  1	  chromosome	  passenger	  complex	  	  calcinosis,	  Raynaud's	  syndrome,	  esophageal	  dysmotility,	  sclerodactyly,	  telangiectasia	  Chromosome	  Instability	  dihydrocytochalasin	  B	  Dukes’s	  Type	  C,	  colorectal	  adenocarcinoma	  	  Dulbecco's	  modified	  Eagle's	  medium	  	  Double	  strand	  break	  Fluorescence	  hybridization	  in	  situ	  	  Green	  fluorescent	  protein	  Human	  papilloma	  virus	  Heat	  shock	  factor	  1	  Heat	  shock	  protein	  90	  Immunofluorescente	  assay	  Inner	  centromeric	  protein	  Kinetochore	  microtubule	  Kinetochore	  null	  protein	  1	  Kinetochire	  Mitotic	  arrest-­‐deficient	  1	  Mitotic	  arrest-­‐deficient	  2	  MAPs	  MCC	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MEF	  MIN	  	  MT	  PI	  	  PP2A	  PT	  PVDF	  PTA	  PLK1	  RPE1	  hTERT	  ROS	  SAC	  SD	  SEM	  	  TMT	  Microtubule	  associated	  proteins	  
Mitotic	  checkpoint	  complex	  Murine	  embryonic	  fibroblast	  Microsatellite	  instability	  Microtubule	  Propidium	  iodide	  Serine/threonine	  protein	  phosphatese	  2A	  Post	  Tetraploid	  Polyvinylidene	  disluoride	  membrane	  Posttetraploid	  aneuploid	  Polo	  like	  kinase	  1	  Retinal	  pigment	  epithelium	  cell	  line	  reactive	  oxygen	  species	  Spindle	  assembly	  checkpoint	  Standard	  deviation	  Standard	  error	  of	  mean	  Tandem	  mass	  tag	  labeling	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